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Abstract 
This study has been part of the project “Development of versatile bacterial expression systems 
for use in recombinant protein production, metabolic engineering, and systems biology”, a 
collaboration between NTNU, SINTEF (Department for Biotechnology) and SU (Saarland 
University, Germany). The major goal of both the project and this study was to develop and 
apply advanced biological tools for control of gene expression.  
 
Recombinant DNA, created by artificially producing genetic sequences, can be transferred to 
microorganisms and change their properties. One new possible property is the production of 
specific recombinant proteins, which have potential for use in both industry and medicine. 
The most intensely studied and attractive heterologous (recombinant) protein producer is to 
date E. coli. Although there are several advantages using E. coli, some of its related 
disadvantages can cause low volumetric yield of specific proteins. When this occurs, there is a 
need for alternative producers and therefore a gene expression system that functions in diverse 
bacterial species. The Pm/XylS expression cassette, which has proven useful for industrial 
level production of recombinant protein, is used as a basis for this study’s expression system.  
 
Expression vectors harbouring Pm/XylS and genes for the human proteins IFN-α2b and GM-
CSF were constructed. Protein expression from these vectors was evaluated in Pseudomonas 
species under different cultivation conditions. During cultivations of P. fluorescens SBW25 in 
shake flasks, instability of the relevant expression plasmids was detected.  Evaluation of 
alternative Pseudomonas strains revealed that the same plasmids were stable in P. putida 
KT2440. Furthermore it was found that P. putida KT2440 was easy to cultivate in both rich 
and minimal media, and it was therefore chosen for further use in this study.  
 
Production of IFN-α2b and GM-CSF from KT2440 was obtained under optimized shake flask 
experiments and fed batch fermentations, but in low quantities. To further examine KT2440s 
production potential, the expression plasmids was genetically engineered. This was done by 
incorporating a copy number mutation and codon optimizing target genes and signal sequence 
pelB. Exchange of trfA (the gene for replication protein TrfA) with trfAcop271C yielded 
approximately 3.5-fold increase of plasmid number in KT2440, the same as previously 
reported for E. coli. After this modification, the production of both model proteins was 
estimated to have increased 3.5-fold or more. Additionally, soluble IFN-α2b was detected, 
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which was not reported for E. coli under the same conditions in a previous study. Codon 
optimization of the target genes and signal sequence did not have expected effects on protein 
production in KT2440 under conditions tested, when compared to wild type copy number 
expression plasmids. Combination of codon optimized sequences and increased copy number 
had negative effect under the conditions tested. 
 
Further evaluation of the genetically modified expression plasmids was performed in fed 
batch fermentations of KT2440. Plasmid stability was found to be high, but the protein 
production obtained was lower than expected from results in the previous shake flask 
experiment. During fed batch fermentations, an observed increase in metabolism at induction 
indicated that the inducer was consumed. Since induction here is performed when substrate is 
limited, in contrast to the conditions in shake flask experiments, it is possible that the inducer 
is metabolized instead of inducing protein production.  This would explain the observed 
differences in production and should therefore be tested.  
 
 P. putida KT2440 have through this study proved as a potential industrial protein producer 
based on its growth properties and the fact that simple genetic modifications of expression 
plasmids proved to positively affect the production of model proteins. 
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1 Introduction 
1.1 The history of recombinant DNA in biotechnology 
The term biotechnology was first used in 1917 by Karl Ereky to describe the large-scale 
breeding of pigs (Glick et al., 2010). The use, on the other hand, has a longer history. 
Domestication of plants and animals can be traced back as far as 10 000 years ago. The use of 
microbes for food fermentation has also excised for a long time, and many of the techniques 
for beer, wine and cheese production have developed from old biotechnology (Parekh, 2004). 
Today biotechnology can be defined as technology using, for the most part microorganisms 
(Glick et al., 2010), but also plant-, animal- and human cells (Regjeringen.no).  
 
In 1944, Avery, MacLeod and McCarty discovered that the genetic information is not stored 
in proteins, as previously believed, but in deoxyribonucleic acid (DNA) and ribonucleic acid 
(RNA). For many, this discovery marks the beginning of the recombinant DNA (rDNA) 
technology that would forever change biotechnology. From time-consuming screening of 
microbial mutants, the biotechnology today has efficient tools for creating  microorganisms 
with specific genetic attributes (Glick et al., 2010). This is done by the use of  rDNA 
molecules  which consist of DNA fragments, either from the same or from different sources, 
artificially joined together (Børresen-Dale, 2009).  
 
In addition to discovery of the genetic material, several other important milestones are worth 
mentioning in the history of rDNA technology. In 1953 the structure of DNA was determined 
by Watson and Crick and in 1966 the genetic code  was established (Emery and Malcolm, 
1995). Even though the previous events were crucial, many consider the following to be the 
starting point for rDNA technology (Emery and Malcolm, 1995). In the early 1960s’ Werner 
Arber discovered bacteria’s restriction endonucleases ability to cleave foreign DNA at 
nonspecific sequences (Nelson and Cox, 2008), and in 1970 Hamilton Smith detected 
sequence-specific restriction endonucleases (Emery and Malcolm, 1995). After experiments 
with these enzymes done by Daniel Nathans in 1969, Werner Arber, Daniel Nathans and 
Hamilton Smith were awarded with the Nobel Prize in Physiology or Medicine in 1978. The 
basis for this award was "for the discovery of restriction enzymes and their application to 
problems of molecular genetics" (Nobelprize.org).  
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The restriction endonucleases, also called restriction enzymes, cut DNA molecules to protect 
the bacteria against viruses. When viruses attack, their DNA or RNA is imported into the cell. 
The viruses start controlling metabolism and the host begins to produce viral proteins that can 
form new viruses. These new reproduced viruses exit the cell and attack new ones (Henriksen 
and Bøvre, 2010). The restriction enzymes could protect the bacteria against such virus 
attacks by digesting the viral DNA. When, among other contributors, Nathans published that 
restriction enzymes cut at specific nucleotide sequences in viral DNA, methods for inserting 
specific fragments into other DNA molecules were soon developed. It now became possible 
to clone specific DNA sequences and make microorganisms produce proteins from specific 
genes. These proteins are referred to as recombinant proteins because they originate from 
rDNA. Figure 1 illustrates how recombinant DNA plasmids, circular DNA, can be made by 
the use of restriction enzymes.  
 
Figure 1: Illustration of how restriction enzymes cuts at specific sites in bacterial plasmids (top left) and 
DNA of interests (top right) to join the fragments in recombinant DNA (bottom) (Learning, 2002) 
1.2 Recombinant DNA technology in biotechnology today 
The knowledge and techniques within recombinant DNA and biotechnology has since the 
1970s evolved at rapid rate. Some of the important milestones over these years are the 
construction of a recombinant plasmid in 1972 (Jackson et al., 1972) development of 
sequencing techniques in 1976, production of human insulin in E. coli in 1978, and 
completion of sequencing of the human genome in 2001, to name a few (Glick et al., 2010). 
The work and research done based on these technologies have enabled us to develope 
efficient methods for sequencing, modifying, cloning and synthesis of genes and gene 
fragments (Berg and Mertz, 2010). 
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One of the new fields arisen from the new knowledge and techniques is synthetic biology. 
The fact that it is possible to make synthetic DNA fragments has emerged in the goal to make 
synthetic life and in 2010 researchers at the J. Craig Venter Institute (JCVI) manage to create 
the first self-replicating synthetic bacteria cell (Gibson et al., 2010).  Synthetic biology tries to 
describe biological networks and regulation with the help of several fields. The goal for this 
work is to engineer biological networks, or circuits, for manipulation of the cellular control 
and thereby building novel bimolecular components, networks and pathways. This constructs 
can then be used to rewire and reprogram organisms. The potential of this field is large and 
many researchers believe that these re-engineered organisms will change our lives in the 
future by leading to cheaper drugs, eco-friendly fuels and therapies for diseases (Khalil and 
Collins, 2010).  
 
1.2.1 Applications of Recombinant DNA Technology in medicine and 
industry 
In medicine and industry, rDNA technologies have given opportunities to solve existing or 
prevent upcoming problems. One good example was made in 1977 when the human 
neurotransmitter somatostatin was first produced. By chemically synthesizing the gene for 
this protein, fusing it inside a circular DNA (plasmid) and transferring this to E. coli cells, 
expression of the protein was made possible. Somatostatin was believed to have therapeutic 
values in, among other diseases, acute pancreatitis (Itakura et al., 1977). Soon after the 
production of somatostatin, human insulin was made replacing the need for insulin extracted 
from pigs and cows (Watson et al., 1992).  
 
Production of recombinant proteins has become one of the main applications for rDNA 
technology. The production of these proteins is explained in the next section, but to shed light 
on the importance of recombinant protein production, some of the different applications of 
recombinant proteins are illustrated in Figure 2.  
Introduction 
 
6 
 
 
Figure 2: Illustration of some applications of recombinant proteins. (Reproduced from presentation after 
permission from Trond Erik Vee Aune, Vectron Biosolutions) 
 
1.2.2 Protein synthesis 
One of the main functions for rDNA molecules is the production of recombinant proteins as in 
the examples with somatostatin and insulin. Mechanisms for protein synthesis consist of the 
same elements, whether the protein is recombinant or not. The transcription of DNA to 
messenger RNA (mRNA) is the first step.  DNA is the genetic material in both prokaryotic 
and eukaryotic cells. It is made up by individual units for nucleotides linked together in a long 
strand. Each nucleotide consists of a five-carbon sugar, a phosphate group and a nitrogen base 
which is either cytosine (C), adenine (A), guanine (G) or thymine (T). Two polynucleotide 
strands form a double helix by hydrogen bonds between the nitrogen bases. The interactions 
between the bases are specific (C binds to G and A binds to T) and called base pairs (bp). 
During transcription, one strand of the double stranded DNA is used to synthesize a 
complementary single strand of mRNA (Glick et al., 2010).   
 
The transcription and composition of genes and genetic elements differ between prokaryotic 
and eukaryotic cells, however some parts are equal. This includes the general mechanism for 
mRNA synthesis, which is done by the enzyme RNA polymerase (RNAP), and the 
mechanism for transcription of mRNA to proteins performed by the ribosomes.  
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In prokaryotes, protein synthesis can be generalized as shown in Figure 3. RNAP binds to the 
promoter region (p), a nucleotide sequence upstream the gene sequence. The protein coding 
sequence of the synthesised mRNA transcript is called the structural gene. Downstream this 
region is a transcription termination region (t) where transcription is terminated.  
 
Figure 3: Schematic representation of a prokaryotic structural gene. The promoter region (p), the site of 
initiation and direction of transcription (the right-angled arrow), and termination sequence for RNAP (t) 
are depicted. A prokaryotic structural gene is transcribed into mRNA and then directly into protein. 
Figure adapted from (Glick et al., 2010) 
 
Since prokaryotes have no nucleus and no spatial separation of the protein synthesis events, 
translation of the mRNA starts while the transcription is still ongoing. During translation, 
ribosomes read three bases at the time called codons. Transfer RNA molecules (tRNA), with 
complementary sequences to these codons, transfer a specific amino acid to the poly peptide 
chain (protein) forming. Established of the genetic code (Figure 4) in 1966 (Chapter 1.1) 
revealed what each of the 64 codons coded for, an amino acid or transcription termination.  
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Figure 4: The genetic code. The inner circle is the first base of the codon, thereafter the second and the 
third in the following circles. The outer circle shows the amino acid or termination sequences coded by the 
sequence. Figure adapted from (Merkel and Budisa, 2006) 
 
Gene expression in prokaryotes can be regulated at many levels, but transcriptional regulation 
is the most common. This is performed by regulator proteins and effector molecules. These 
two elements either facilitate the binding of RNAP or prevent it and therefore determine if the 
structural gene shall be transcribed. If the regulator protein is required for gene expression, it 
is said to be under positive control mechanisms. If the regulator proteins shuts off the 
expression, the control mechanisms is called negative (Snustad and Simmons, 2010).   
 
Many of the prokaryotic structural genes encoding proteins that are required for a single 
metabolic pathway are arranged as contiguous genes in the chromosome. These genes are 
under control of the same promoter and transcription will generally yield a large mRNA 
molecule. This arrangement of genes is called an operon (Glick et al., 2010).  
 
In contrast to prokaryotic cells, the genetic material in eukaryotes is present in a nucleus. 
While transcription and translation are coupled in prokaryotes, this location separates the 
events because RNAP is part of the nucleus environment while ribosomes are not. The details 
in eukaryotic gene regulation will not be discussed here since the main focus of this study is 
on prokaryotes and their protein production. The structural gene of eukaryotes, shown in 
Figure 5, usually consists of both protein coding regions, called exons, and non-coding 
regions, called introns. The entire structural gene is transcribed by RNAP into a primary 
transcript often called pre-mRNA. Before the transcript is transported out of the nucleus, the 
introns are removed and a methylated G-cap is added to the 5’ end and poly-A-tail to the 3’ 
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end. The excision of introns enables alternative splicing because some exons may be excised 
together with the introns. After the introns are deleted, the functional transcript is translated in 
the cytoplasm or on the endoplasmic reticulum (ER) (Glick et al., 2010).  
 
Figure 5: Schematic representation of a eukaryotic structural gene. The promoter region (p), the site of 
initiation and direction of transcription (the right-angled arrow) and the termination sequence for RNAP 
(t) are depicted. The numbers 1 to 5 mark the exons of the structural gene, and the introns a to d mark the 
introns. The primary transcript is polyadenylated at the 3’ end and capped with a modified G (G) 
nucleotide at the 5’ end. Processing of the primary transcript removed the introns. The functional RNA is 
translated into protein. Figure adapted from (Glick et al., 2010) 
 
One other element of eukaryotic protein synthesis important mentioning is posttranslational 
modifications. The proteins produced by ribosomes connected to ER are either inserted into 
its membrane or secreted into the lumen, where they are processed further. The addition of 
sugar molecules to specific amino acids (glycosylation) is one example of modification that 
may be performed. Another example is the formation of disulfide bonds inside the protein. 
Gram negative bacteria (prokaryotes) also have the capacity of forming these bounds if the 
protein is sent to the intracellular compartment called periplasm (Glick et al., 2010). There 
have also been reports that prokaryotic glycosylation is performed by more bacteria than 
previously thought (Schaffer et al., 2001).  
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Modifications of the proteins are often necessary for their activity or stability. A good 
example is proteins produced as inactive precursor polypeptides only active after being 
cleaved by proteases at specific sites. This can be a control mechanism to ensure that the 
active form of the protein only is present at specific locations. Correct folding of the protein is 
essential for both protein activity and protection of regions that proteases otherwise would 
recognize Chaperones, which exists in both prokaryotes and eukaryotes, assists in this 
modification. Additional control mechanisms for eukaryotic proteins is performed in the 
Golgi apparatus or outside the cell, making sure that only correctly folded proteins are 
released (Glick et al., 2010).  
 
1.2.3 Heterologous protein expression platforms 
The single cell is the basic unit in every living organism. Characteristic for a living organism, 
whether it is single-celled or multi-cellular, is its ability to reproduce and metabolize 
components in the environment. Viruses do not have this ability, are by some still defined as 
living organisms (Godal et al., 2010). One essential feature for reproduction and metabolism 
is the production of proteins, which is described in Chapter 1.2.2. The similar mechanisms 
between protein synthesis in prokaryotic and eukaryotic cells have been utilized in the 
development of expression platforms. Expression platforms are cells or organisms used for 
heterologous (recombinant) protein production. 
 
The need for new suitable expression platforms increases with the number of gene-targets for 
various industrial branches. Expression platforms already in use range from bacteria, yeast 
and filamentous fungi to cells of higher eukaryotes. When choosing among these cells, both 
economic and qualitative aspects have to be considered. Industrial production relies on the use 
of inexpensive medium components and high anticipated economic yield from the product. 
The quality of the produced compound is also essential, especially in medicine where human 
pharmaceuticals production is regulated under strict safety aspects (Gellissen, 2005).   
 
Prokaryotic platforms are widely used to produce single subunit recombinant proteins. These 
platforms can easily be manipulated genetically by well-known methods and cultivated in low 
costing medium. Prokaryotic cells can be grouped in gram-positive and gram-negative cells, 
based on their cell wall structure. Both of these groups have well established representatives 
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in the field of recombinant protein production. For gram-negative bacteria, Escherichia coli is 
the most studied, while Bacillus subtilis is a well known gram-positive producer of 
recombinant proteins (Watson et al., 1992). There are several challenges using prokaryotic 
cells for protein expression. Most of them will be discussed in greater detail later, but protein 
insolubility and low expression levels (especially mammalian proteins) or post-translational 
modifications are some of the most challenging problems (Gellissen, 2005).  
 
In theory, prokaryotic hosts can express any gene, but in practice the proteins produced do not 
always have the desired biological activity or stability. In addition, toxic components from the 
bacteria may contaminate the final product. When producing a protein intended for medical 
use, all properties of this protein must be identical to the natural protein. Eukaryotic cells 
share many molecular, genetic and biochemical features, making them an alternative to 
prokaryotic expression of proteins. Today, a variety of fungal expression platforms are 
available, but initially the baker’s yeast Saccharomyces cerevisiae was most widely used. 
Like most fungi, S. cerevisiae have the same growth advantages as prokaryotes (rapid growth 
in low cost medium). In addition it has been widely used as a model organism for cell 
function research making its biochemistry, genetics and cell biology well known. Today, a 
number of proteins have been produced using this host, including proteins for use as vaccines, 
pharmaceutical products and for diagnostics (Glick et al., 2010).  
 
Protein producing mammalian cell lines, like CHO (Chinese Hamster Ovary), BHK (Baby 
Hamster Kidney) and NS0 (Mouse myeloma), have an advantage in the production of human 
proteins because they are able to glycosylate proteins in the same pattern as higher 
eukaryotes. Since this can result in recombinant proteins identical to their human 
counterparts, the possibility for producing a functioning protein increases. Still there are some 
disadvantages leading to the need for alternative producers. Mammalian cell lines are 
demanding in needing specialized medium that may lead to high costs compared to 
prokaryotic host. Furthermore in fermentations, their growth kinetics are slow, they have low 
cell densities and are sensitive to stress (Gellissen, 2005).   
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1.2.3.1 Escherichia coli as host 
One of the most intensely studied and attractive heterologous protein producer is E. coli. E. 
coli is a gram negative rod-shaped bacterium, which in humans and animals normally is found 
in the intestine. This bacterium is part of the Enterobacteriaceae family and is facultative 
anaerobe meaning it is capable of living without oxygen. Its optimum temperature is 37°C 
(Sussman, 1997) .  
 
The reasons for the many studies and broad usage of this bacterium are the many advantages. 
One important feature of E. coli is its short generation time. Under optimal conditions, E. coli 
is capable of dividing every 20 – 30 minutes (Snustad and Simmons, 2010). It is also capable 
of living on inexpensive substrates and can grow to high cell densities. These features enable 
possibilities for high yields and low costs when E. coli is used for recombinant protein 
production. Because of the advantages associated with E. coli, it has often been chosen for 
recombinant production of proteins and for genetic studies. This has lead to new knowledge 
and development of many tools such as controllable expression systems specific for E. coli 
with the best known example being the lac operon (Gellissen, 2005).  
 
There are also problems related to the use of E. coli as production host. Some recombinant 
proteins end up as part of an insoluble fraction in the cytoplasm. These proteins are often 
called inclusion bodies (IB) and consist of inactive protein aggregations which have to be 
treated to form the right folded proteins. An additional treatment leads to higher costs and 
may affect the proteins activity. It is therefore desirable to use hosts where IB are avoided 
(Leonhartsberger, 2006). For production of therapeutic proteins, accumulation of endotoxins 
(LPS), which are pyrogenic in humans, is another problem related to E. coli. As for IB, this 
cause additional steps with purification before the recombinant protein can be used for its 
original purpose. Other possible problems are plasmid or mRNA instability, toxic 
recombinant protein or translational problems caused by difference in codon usage (Terpe, 
2006).  
 
The problems described above may also occur in other hosts, but by having different bacterial 
expression systems one can choose the strain most suitable for each case. The ultimate goal 
would be to have a universal system that functioned in a variety of organisms, but several 
reasons suggest that this will be impossible to accomplish. Control elements are known to 
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behave different among species (Terpe, 2006), inducers of inducible systems may cause 
problems (metabolized, not taken up or causing physiological changes) and it is likely that 
host dependent differences in translation will occur.  
1.2.3.2 Pseudomonas species as host 
One alternative gram-negative production host might be one of the members of Pseudomonas 
species. The Pseudomonas species are normally found in the nature in soil and water. They 
are rods without spores and with one or several flagellum. Most of the members of the species 
are considered aerobic, but some can live under anaerobic conditions in the presence of nitrate 
(Degré et al., 2004). Some of the Pseudomonas species have the ability to synthesize alginate 
which is a commercially used component in food, clothes and medicaments (Onsøyen, 1996).  
 
Of all Pseudomonas species, Pseudomonas aeruginosa is the most studied pathogen for 
humans. It is opportunistic, but can cause severe infections in immunocompromised hosts 
(Cornelis, 2008). Pseudomonas fluorescens is another member of the family. This strain has 
been proven to function as a recombinant protein producer. It can be cultivated to high cell 
densities and have several times been proven to produce soluble proteins when E. coli 
produces insoluble (Squires et al., 2004). As an example, it was recently reported that P. 
fluorescens was able to produce soluble fractions of the human granulocyte stimulation factor 
(G-CSF) in high quantities. This protein is often synthesized as IB in E. coli (Jin et al., 2011).   
1.2.3.2.1 Pseudomonas putida KT2440 
The results from expression experiments with P. fluorescens provides confidence in 
alternative expression host solving problems with E. coli and contributing in production of 
recombinant proteins important for human health.  The curiosity of which strain or strains that 
will become new key producers of recombinant proteins enables research on unknown as well 
as established prokaryotes. Because of the features of P. fluorescens, this study chose to 
explore the possibilities lying in Pseudomonas species. One of the interesting strains here is 
Pseudomonas putida.  
 
Phenotypic the Pseudomonas species can be divided in to two groups based on their ability to 
produce pigments that fluoresce under UV radiation with low wave length (around 260 nm). 
P. putida is part of the group that has this ability (Cornelis, 2008). The putida strain KT2440 
was sequenced in 2002 and found to have a G+C content of 61.6 % (Nelson et al., 2002). It is 
now a well characterized saprophytic laboratory Pseudomonad. KT2440 is a plasmid free 
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derivative of the toluene-degrading strain P. putida mt-2 which original was designed 
Pseudomonas arvilla strain mt-2. KT2440 is certified as a host-vector biosafety (HV1) which 
means that it is a vector system that provides moderate level of containment (Cornelis, 2008). 
KT2440 has recently been reported to produce yields up to 3.5 mg/l of pure, soluble, active 
antibody fragment scFv (Dammeyer et al., 2011) proving its potential as production host. 
1.2.4 Expression of recombinant proteins 
Heterologous protein production in eukaryotic and prokaryotic hosts requires different 
regulatory elements combined with the gene of interest (GOI). While the basics of these 
elements are similar, they have to be adapted to the host of choice. This includes the 
transcriptional promoter, transcriptional and translational stop sequences and selectable 
marker genes. If the vector, where all of these elements are gathered, is designed for 
integration into the chromosomal DNA, complementary sequences to DNA have to be part of 
the vector. Elsewhere, when the vector is designed for extra-chromosomal replication, an 
origin (ori) of replication has to be integrated in the vector. This sequence will initiate DNA 
synthesis so that the expression vector is replicated. In addition, poly-linker sequences have to 
be assembled in the expression vector to facilitate insert of a GOI (explained later) (Glick et 
al., 2010).  
 
Eukaryotic host cells have the advantage of post-translational modifications) of the produced 
proteins (Chapter 1.2.2. The eukaryotic expression vectors are therefore poised with A-codons 
which will be attached to the pre-mRNA strand. Because it is technically difficult to perform 
rDNA procedures in eukaryotic cells, the vectors have often an additional ori of replication 
suitable for a prokaryote host, typically E. coli. These vectors are called shuttle vectors and 
can replicate in two different organisms.  Examples of eukaryotic expression vectors are the 
yeast 2 μm plasmid and yeast artificial chromosomes (YAC) (Glick et al., 2010).  
 
Introduction 
 
15 
 
One example of a prokaryote expression vector functioning as an expression system is the 
plasmid shown in Figure 6.  
pJBn
9460 bps
2000
4000
6000
8000
NcoI
NdeI
BstXI
PciI
Bsu36I
XbaI
NotI
sok RNA
GOI
pelB
Pm
Ps1
Ps2
xylS
oriT
kan
oriV
trfA
t
hok
t
 
Figure 6: Illustration of a typical expression vector in a prokaryotic expression platform. oriV: origin of 
vegetative replication, trfA: replication initiation protein: t: transcription termination, sok RNA and hok: 
potential killing mechanism, GOI: recombinant gene of interest, pelB: signal sequence, Pm, Ps1, Ps2: 
promoters, xylS: transcription regulator, oriT: origin of transfer, kan: kanamycin resistance. The different 
elements are described in Chapter 1.2.4.  
  
As already mentioned expression vectors have several basic elements, but three are often 
considered as essential. The first of these features is the poly-cloning site. This is a short 
sequence where several restriction enzymes have sites for digestion. The function of this poly-
cloning site is to enable cloning of a broad range of genes. By having a large number of 
possible enzymes for digestion of both gene and vector the possibility of finding a match of 
enzymes increases. Ligation of fragments cut with the same enzymes yield complementary 
single strands. These will join together under appropriate renaturation conditions with the help 
of DNA ligase (Snustad and Simmons, 2010). An example of a poly-cloning site is shown in 
Figure 6 where restriction sited is marked with their corresponding enzyme names.   
 
Another feature considered essential is a selectable marker gene.  This gene facilitates 
selection of cells containing the vector versus cells without it. Usually this is done by an 
antibiotic resistance gene. By adding the antibiotic into the growth media or plates, only 
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bacteria carrying the plasmid will grow. In Figure 6 the gene kan encodes a protein leading to 
kanamycin resistance.  
 
The last essential feature is the origin of replication which is needed for the plasmids ability to 
replicate (Snustad and Simmons, 2010). Ori V (origin of vegetative replication) shown in 
Figure 6 has its origin in the broad host plasmid called RK2. While some replicons function is 
single or related bacteria, this replicon have the ability to replicate in unrelated species. This is 
one of two feature making the plasmid called RK2 broad host functioning where trfA 
(described later in this chapter) is the last one (Perri et al., 1991). 
 
There are also other elements in the pJBn vector in Figure 6 worth describing. The hok – sok 
system is a plasmid stabilization system ensuring that only daughter cells containing the 
expression plasmid will survive. The hok gene is a potent killing protein while the sok gene 
codes for an anti-sense complementary to hok mRNA and function as the antidote by 
eliminating hok mRNA. The mRNA from the hok gene is stable and will be transferred from 
mother to daughter cells. The anti-sense sok mRNA on the other hand is unstable and will not 
be transferred. If the daughter cells not receive the expression plasmid, they will be killed 
when mother hok mRNA is expressed (Gerdes, 1988).  
 
While oriV as described is the origin of vegetative replication, ori T is the origin of transfer 
and enables transferring of the vector during conjugation. The process of conjugation is 
described under Chapter 2.4.8.3. In addition to oriV, trfA is part of the two necessary elements 
for broad host replication originating from RK2. This gene codes for a replication initiation 
protein called TrfA. RK2s copy number is regulated by the interaction of these two necessary 
elements and have been determined to be 2 to 3 per bacteria cell in Pseudomonas and 4 – 6 in 
E. coli (Funnell and Phillips, 2004). Different mutations in trfA have been proven to elevate 
the plasmids copy number in mutations called copy-up. The mutation named trfAcop271C 
cause an amino acid substitution in the TrfA protein primary sequence leading to an 3.5-fold 
increase of copy number in E. coli (Durland et al., 1990).  
 
The Pm sequence is a promoter where RNAP attach. The promoter is usually upstream of the 
gene and the sequence will align the RNAP so that the transcription will initiate at a specific 
nucleotide (Glick et al., 2010). Pm is a constituent of the Pm-xylS cassette described later, but 
there are also other examples of promoters and regulatory systems used for expression of 
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recombinant proteins. The lac system regulated by the T7 promoter is a good example. The 
expression vector of this system contains a T7 promoter which is transcribed by a T7 RNAP. 
This RNAP is supplied in form the host and not part of the expression vector. The polymerase 
is either supplied by infecting the host with a T7 phage or by using the phage λDE3(Gellissen, 
2005).  
 
The last two elements part of the general expression vector pJBn in Figure 6 is pelB and GOI. 
pelB is a signal sequence connected to the GOI to export the recombinant protein from the 
inner cell membrane to the periplasm of the bacteria. This process is called translocation. The 
signal sequence is often an N-terminal extension that will be cleaved off the protein during the 
translocation process. There are several reasons for wanting proteins to be exported to 
periplasm. As described earlier it is only here disulfide bridges can be formed, which for some 
proteins is necessary for correct folding. Other proteins need to be protected from the many 
proteases present in the cytoplasm or need the cleavage of the signal sequence in periplasm to 
remove the methionine amino acid encoded by the start codon (Gellissen, 2005). Secretion to 
the periplasm also makes its purification less costly and easier to perform, because there are 
fewer proteins located there than inside the cytoplasm (Glick et al., 2010).Other examples of 
signal sequences are ompA and synthetic CSP. Even though the presence of a signal sequence 
does not guarantee a high rate of secretion, the choice of signal sequence could influence the 
production and translocation of the recombinant protein (Sletta et al., 2007).  
 
GOI is the DNA sequence of the recombinant protein. The different synonymous of codons 
(Chapter 1.2.2, Figure 4) do not have the same frequencies between different organisms and 
even internal in a genome (Grantham et al., 1980). Recombinant genes may therefore have 
“foreign” codon usage leading to lower expression of the protein. Today, one can analyse this 
in different databases. By inserting the nucleotide or amino acid sequence and the new host 
strain, the data base will give you an estimated nucleotide sequence specialized for the host. 
The amino acid sequence will of course be the same, but the codons may have changed. 
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1.2.4.1.1 The Pm/XylS cassette 
The Pm/XylS expression cassette is derived from the Pseudomonas putida TOL plasmid 
pWW0 which was first described in 1974 by Williams and Murray. This plasmid consists of 
two operons responsible for the degradation of aromatic hydrocarbons. The upper operon 
encodes the enzymes responsible for oxidizing toluene/xylenes to benzoate/toluates while the 
other operon, called the meta- cleavage pathway operon, encodes enzymes that oxidize the 
produced benzoates or toluates. The genes or gene products of these operons and the genes for 
the regulator proteins have the prefix xyl. The two regulator genes xylS and xylR,, which are 
located at the 3’end of the meta- cleavage pathway operon, are transcribed from divergent 
promoters called Ps1/Ps2 and Pr respectively. The Ps2 promoter ensures constitutively low 
expression of XylS regulator, while the Ps1 promoter is stimulated by active XylR regulator. 
The transcription of this regulator is auto-regulated. Activation is achieved when 
toluenes/xylenes, the substrates for the upper operon, are part of the environment. In addition 
to increasing the XylS-production, activated XylR leads to transcription from the Pu-promoter 
and therefore enable oxidization of the toluenes/xylenes to benzoates. Since this is the 
substrate for meta-operon, it activates XylS regulator and leads to stimulation of the Pm 
promoter and transcription of the meta-cleavage pathway genes (Marqués and Ramos, 1993).  
 
XylR regulates both the upper operon and the expression of XylS. When XylR is active and 
both Ps1 and Ps2 are stimulated, XylS is hyper-expressed. As a response to this, the XylS 
overfload leads to activation of the Pm promoter even in the absence of the benzoate effector 
(Marqués and Ramos, 1993). 
 
The Pm/XylS cassette consists of the Pm promoter and xylS coding for the positive regulator 
transcription protein XylS. By placing the recombinant gene downstream the Pm-promoter, 
transcription of this gene can be controlled by the presence of substrates for XylS benzoates 
like m-toluic acid. When this is present, XylS is activated and binds to Pm stimulating 
transcription by recruiting RNAP. The induction of recombinant protein production based on 
Pm/XylS system is illustrated in Figure 7.  
Introduction 
 
19 
 
 
Figure 7: Illustration of the Pm/XylS- expression cassette. The regulation of the Pm promoter and 
transcription of the recombinant gene (here GOI) by RNAP is controlled by addition of m-toluic acid to 
the growth medium. Figure created by (Aune, 2008).  
 
The Pm/XylS-expression cassette was chosen for the present study because of previous studies 
and advantages. As discussed, the fact that few alternative prokaryotic hosts have been 
developed as an alternative to E. coli limits the possibilities to produce functional 
recombinant proteins. One of the most important features is the fact that this cassette has been 
proven to function in a broad range of gram negative bacteria including, Aeromonas 
hydrophila, Aerobacter aerogenes, Serratia marcescens, Erwinia carotovora, E. coli and 
most importantly for this thesis, Pseudomonas subspecies (Mermod et al., 1986).  
 
The inducers of Pm/XylS expression systems are carboxylic acids in the form of benzoates. m-
Toluic acid is often chosen because it is a non-toxic and a relatively inexpensive inducer 
inactively taken up by the cells in the undissociated form (Marques et al., 1994). Other 
examples of inducers are o-toluic acid and 2-chloro-benzoic acid (Ramos et al., 1990). pH has 
been observed to effect is ability to induce the Pm/XylS system. For expression in an extended 
period, pH 6.8 is been reported as preferred (Winther-Larsen et al., 2000b).   
 
Even though this study emphasises on the need for an alternative system to E. coli, this strain 
in many cases will still be the host giving the highest recombinant protein yield compared 
with alternatives. Thus, the results achieved here should be compared to production in E. coli 
so that the optimal platform is chosen for each case. The Pm/XylS- cassette has been proven to 
produce high levels of different recombinant proteins in E. coli, including GM-CSF and 
IFNα-2b (Sletta et al., 2007).  
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1.2.5 Cultivation for production of recombinant proteins 
After genetic fusing the GOI into a vector and transferring it a host organism, the expression 
of recombinant protein has to be evaluated. This is often done in a small-scale usually carried 
out using shake flasks of 250-ml to 1-litre capacity. These small-scale experiments can be 
used to determine optimal conditions for growth and production of recombinant proteins. 
While these experiments are performed with low cell densities, the next step for developing a 
new recombinant-DNA-derived product is to scale-up the process. Ideally the protein 
production is proportional with the amount of cells. These up-scaled experiments will 
therefore involve high cell density cultivation (HCDC) using the conditions that optimized 
growth and production in the small-scale. The first stage here might be a 1- to 3-litre 
bioreactor where the cultures and different features of the organism are closely monitored. 
Examples are oxygen requirement, growth rates and consummation of nutrients (Doran, 
1995).  
 
There are several terms used to describe different processes that may be used as a system for 
the bioreactor. A batch process describes a closed system where all material is added at the 
start, while a semi-batch either allows input or output. During a continuous process, there is 
flow of material in and out of the system during the entire process (Doran, 1995). The last 
term is fed-batch processes, the kind of process used for this study. This process allows 
supplement of one or more nutrients while the cells and products remain inside the fermentor.  
A relatively low concentration of substrate (typically the carbon source) is present before 
input is started and this will avoid high growth rates. The purpose of this is to not create an 
oxygen demand higher than can be supplied and the fact that high concentrations of substrate 
may switch on undesirable metabolic pathways or be inhibitory for growth. Fed-batch 
cultivations are therefore designed to be beneficial to the productivity and yield of the desired 
product (Lee et al., 1999) and are often used for protein production (Sletta et al., 2007, Sletta 
et al., 2004, Brautaset et al., 2010).  
 
Typical fed-batch fermentations can be divided in three phases. Initially, the culture 
experience free growth following the equation:  
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Where μ is the growth rate (h-1), t1 and t2 are the culture times for optical density (OD) 
measurements at 600 – 660 nm x1 and x2 respectively.  
 
The next phase is initiated when the carbon source initially added is completely utilized.  
Exponential substrate feeding is started controlling the cultures growth rate. This exponential 
feeding can be continued until oxygen transfer becomes a problem and the third phase starts. 
From now on feeding is constant. During this period, the cells will still be growing but their 
specific growth rate will decrease.  
 
1.3 IFN-α2b and GM-CSF: Important therapeutic model proteins 
Since the 1950s the research in human health and disease has been pinpointed towards 
naturally produced proteins that have obvious therapeutic applications by being part of the 
human immune system. The potential of these proteins have been rendered impractical 
because of their tiny quantities in which they are naturally produced, but since the advent of 
recombinant DNA technology this problem and many others have diminished. Source 
availability and product safety have been overcome and it provides an alternative to direct 
extraction from inappropriate sources. In addition it facilitates engineered therapeutic proteins 
that may have advantages over the native protein (Walsh, 2007).   
 
Examples of naturally produced proteins with therapeutic potential are the cytokine group 
interferones and growth factors called colony-stimulation factors. Cytokines function as 
chemical communicators by binding to specific receptors located on different cells and 
triggering various intracellular events. The interferons (IFNs) of this group are substances 
secreted by virally infected cells and the biological effect is among other induction of cellular 
resistance to viral attack and regulation of growth and differentiation of many cell types. 
Humans produce at least three different kinds of interferons named IFN-α, IFN-β and IFN-γ 
(Walsh, 2007).  
 
Introduction 
 
22 
 
The growth factors, which also might be called cytokines, are the most important regulators of 
differentiation, growth and division for many cell types. They have a mitogenic effect on a 
characteristic range of cells meaning that they promote cell division.  One important group of 
growth factors getting attention from the pharmaceutical industry is the haematopoietic 
growth factors. Haematopoietic stem cells are the origins of all blood cells and therefore an 
important part of the human immune system by the development of white blood cells. 
Granulocyte macrophage colony-stimulation factor (GM-CSF) is one example of 
haematopoietic growth factors (Walsh, 2007). GM-CSF is also able to act on macrophage 
populations, reflecting an important role in inflammatory processes (Hamilton et al., 1980).  
 
Because of their natural importance, human cytokines have become important tools for 
treatment of microbial and virus infections and vaccination against cancer. IFN-α2b have 
mainly been used to treat hepatitis C, but also some types of cancer (Neves et al., 2004) and 
GM-CSF have been proven to reduce the risk associated with bone marrow transplantation 
(Metcalf, 1991). Both IFN-α2b and GM-CSF have been produced recombinant in E. coli 
RV308 by fusion with N-terminal secretion signal sequences. This gave volumetric yields 
from high –cell-density cultivations of 1.7 and 0.6 g/litre respectively (Sletta et al., 2007).  
 
1.4 Objectives and strategy of the present study 
Most of the research focusing on recombinant protein production is executed in E. coli. When 
this host fails to produce, alternatives have to be tested. If there existed an expression vector 
that, with little necessary genetic modification, could function in different platforms, the 
optimal production host could easily be chosen. This principle is illustrated in Figure 8. 
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Figure 8: Illustration of how the broad host system would simplify the search after the optimal prokaryote 
platform for protein production compared to regular protein production. 
 
In regular protein production, different expression vectors are tested in different platforms. 
This may be time consuming because of the many possible combinations of platform and 
vector. The goal of the broad host system is to have an expression vector that function in 
different platforms, and therefore will decrease the possible combinations.  
  
In this study, the expression cassette Pm/XylS and RK2 plasmids broad host elements has 
been used for production of the two model proteins IFN-α2b and GM-CSF. The platforms 
chosen for this study was the Pseudomonas strains P. fluorescens and P. putida.  
 
The plasmid pDI-8_MV-ifna2 was the starting point and the expression vectors pIFNpelB and 
pGMpelB (see Chapter 2.2) with wild type copy number was the first plasmids constructed by 
replacing the ifn-α2 gene with ifn-α2b and gm-csf respectively. The vectors was transferred to 
SBW25 (P. fluorescens), NCIMB (P. fluorescens) and KT2440 (P. putida) before growth and 
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production is evaluated. The Pseudomonas strain that showed the highest potential for the 
production was selected for further study.  
 
When cultivation conditions had been adapted to the chosen stain, genetic modification to the 
vectors will be made. This modification was chosen to be copy-up mutations of the trfA gene 
and codon optimization of gene targets and signal sequence for the chosen host. In addition, 
different combinations of these modifications were evaluated. After optimizing the different 
parameters, high density cultivations was performed to compare the system generated against 
previously tested E. coli RV308 (Sletta et al., 2007). A sketch of the execution is illustrated in 
Figure 9.  
 
Figure 9: Sketch of the execution of the study.  
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2 Materials and methods 
2.1 Media and supplements 
Luria-Bertani (LB) medium 
10 g/l NaCl (Merck) 
10 g/l Trypton (Bacto) 
5 g/l Yeast extract (Oxoid) 
Autoclaved at 120°C for 20 minutes 
 
Luria-Bertani agar (LA) 
10 g/l NaCl (Merck) 
10 g/l Trypton (Bacto) 
5 g/l Yeast extract (Oxoid) 
20 g/l Agar (Oxoid) 
Autoclaved at 120°C for 20 minutes and kept at 50°C until distributing on petri dishes (VWR) 
with 9 or 14 cm diameter   
 
PIA- medium 
 20 g/l Pepton (Oxoid) 
 1.4 g/l MgCl2·6H2O (Riedel deHaën) 
 10 g/l K2SO4 (Riedel deHaën) 
 5 g/l NaCl (Apotekerproduksjon) 
 23.5 g/l Glycerol (Sigma) 
Autoclaved at 120°C for 20 minutes 
 
PIA-10GLU-medium 
The same concentration of pepon, MgCl2·6H2O, K2SO4 and NaCl as in PIA-medium  
 10 g/l Glucose (Apotekerproduksjon) 
Autoclaved at 120°C for 20 minutes  
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PIA agar– Pseudomonas Isolation Agar 
45 g/l  PIA (BD Difco) 
20 ml Glycerol bidistilled 99.5 % (VWR) in 1000 ml water  
Autoclaved at 120°C for 20 minutes and kept at 50°C until distributing on petri dishes 
 
Kanamycin stock (kan) (40 mg/ml) 
40 mg/ml Kanamycinsulfat (Sigma-Aldrich)  
Dissolved in distilled water. Sterile filtered with 0.2 μl filter (Sarstedt). Stored at – 20°C. 
Used to give final concentrations 40 μg/ml.  
 
Ampicillin stock (amp) (100 mg/ml) 
100 mg/ml Ampicillin Natriumsalz (AppliChem) 
Dissolved in distilled water. Sterile filtered with 0.2 μl filter (Sarstedt). Stored at – 20°C. 
Used to give final concentrations 100 μg/ml.  
 
500 mM m-toluic acid 
68.25 g m-Toluic acid (Fluka) per litre ethanol (Kemetyl) 
Stored at 4°C 
 
500 mM o-toluic acid 
68 g m-Toluic acid (Sigma) per litre ethanol (Kemetyl) 
Stored at 4°C 
 
500 mM 2-chloro-benzoic acid 
78.25g 2-Chlorobenzoic acid (Sigma) per litre ethanol (Kemetyl) 
Stored at 4°C 
 
Psi-medium 
5 g/l Yeast extract (Oxoid) 
20 g/l Trypton (Bacto) 
10.24 g/l MgSO4·7H2O (Sigma-Aldrich) 
pH adjusted to 7.6 with 1 M KOH 
Autoclaved at 120°C for 20 minutes 
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TFB1 
2.94 g/l (30 mM) Porasium acetate (Merck) 
12.1 g/l (100 mM) Rubidiumcloride (Aldrich) 
1.945 g/l (10 mM) Kalsiumcloride·2H2O (VWR) 
15.73 g/l (50 mM) Mangan(II)cloride·4H2O (Riedel-deHäen) 
150 ml (15 v/v %) Glycerol bidistilled 99.5 % (VWR) 
About 180 ml distilled water was added before adjusting pH to 5.8 with diluted acetic acid. 
The solution was then added distilled water to at total volume of 200 ml 
Sterile filtered with Stericup-GP 0.22 μm (Millipore). Stored at 4°C 
 
TFB2  
2.1 g/l (10 mM) MOPS (AppliChem) 
11.0 g/l (75 mM) Kalsiumklorid·2H2O (VWR) 
1.21 g/l (10 mM) Rubidium Chloride (Aldrich) 
150 ml (15 v/v %) Glycerol bidistilled 99.5 % (VWR) 
pH adjusted to 6.5 with NaOH or HCl. Distilled, ion free water added to a total volume of 
1000 ml. Sterile filtered with Stericup-GP 0.22 μm (Millipore). Stored at 4°C 
 
SOC-medium 
20 g/l Trypton (Bacto) 
5 g/l Yeast extract (Oxoid) 
0.5 g/l  NaCl (Merck) 
25 g/l KCl (Merck) 
3.6 g/l Glucose (Apotekerproduksjon) 
10.8 g/l MgCl2∙6 H2O (Merck) 
Autoclaved at 120°C for 20 minutes 
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M9 medium 
6.0 g/l Na2HPO4 (Sigma-Aldrich) 
3.0 g/l KH2PO4 (Riedel-deHäen) 
1.0 g/l NH4Cl (Riefel-deHäen) 
0.5 g/l NaCl (Apotekerproduksjon) 
Autoclaved at 120°C for 20 minutes and thereafter added the following sterile stock solutions:  
1 ml/l TMS 
1 ml/l of stock solution CaCl2  
1 ml/l of stock solution MgSO4  
0.8 % (w/v) of stock solution Glucose 
 
Stock solution for M9 medium 
TMS 
0.5 g/l ZnSO4·7H2O (VWR International) 
0.5 g/l FeSO4·7H2O (Riedel-deHäen) 
0.5 g/l MnSO4·7H2O (Riedel-deHäen) 
 14.71 g/l CaCl2 (Sigma-Aldrich) 
246.47 g/l MgSO4·7H2O (Riedel-deHäen) 
250 g/l Glucose (Apotekerproduksjon) 
Sterile filtered with Stericup-GP 0.22 μm (Millipore). 
 
M9-10GLU medium 
M9 medium with glucose stock concentration increased to 1.0 % (w/v) 
 
0.8 % Agarose gel 
3.2 g Agarose  (SemKem LE Agarose) 
400 ml TAE buffer 
Heated in microwave oven at 650 W for 10 minutes or until all agarose is dissolved. Kept at 
65°C   
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2.1.1 SDS-PAGE 
3 x Sample Buffer (20 ml) 
1.50 ml 2M Tris, pH 6.8 
7.54 g Glycerol (AnalaR Normapur) 
1.2 g Sodium dodecyl sulphate (SDS) (GPR RECTAPUR) 
0.06 g Bromophenol Blue (Sigma) 
0.93g Ditiotreitol (DTT) (VWR) 
 
Blotting buffer (Transfer buffer) 
12.5 ml/l Tris-HCl stock solution 
14.4 g/l Glycine (Sigma) 
200 ml/l Methanol (Sigma Aldrich) 
5 ml/l SDS stock solution 
Distilled water to total volume 2 L 
Stored at 4°C 
 
TBS 
10 ml/l 2 mM Tris-HCl, pH 7.5 (stock solution) 
8.8 g/l  NaCl (Apotekerproduksjon) 
 
Stock solution blotting buffer and TBS 
315.2 g/l Tris-HCl (Sigma), pH adjusted to 7.5  
100 g/l Sodium Dodecyl Sulphate (GPR Rectapur) 
 
TBST 
500 ml TBS  
250 µl  Tween 20 (Sigma Aldrich) 
 
Blotto 
10 g/l Skim milk (Oxoid) 
1000 g/l TBS 
5 ml/l SDS stock solution 
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Stock solution Blotto 
 200 g/l Sodium Dodecyl Sulphate (GPR Rectapur) 
 
2.1.2 DNA gel electrophoresis  
0.8 % Agarose gel 
 8 g/l SeaKem® LE Agarose (Lonza) in TAE buffer 
Dissolved by heating. Stored at 65°C. 
 
0.8 % Agarose gel + 20 or 30 μl GelRed 
400 ml 0.8 % Agarose gel was added 20 or 30 μl GelRed (Biotium)  
 
TAE buffer (premade by the laboratory staff) 
40 mM Tris  
20 mM Acetic Acid  
1 mM Na2EDTA  
pH adjusted to 8.0  
 
Loading buffer 
400 g/l Glycerol (Sigma) 
2.5 g/l Bromophenol blue (Sigma) 
 
2.1.3 Diverse 
 
Tris-EDTA (TE) Buffer 
 10 ml 1M Tris-Cl 
 2.0 ml 0.5M EDTA pH 8.0 
 
0.9 % NaCl 
9 g/l NaCl (Apotekerproduksjon) 
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100 mg/ml lysozyme 
100 mg Lysozyme from chicken egg white - lyophilized powder (Sigma) 
or 
200 mg Lysozyme from chicken egg white - dialyzed, lyophilized, powder (Fluka) 
Diluted in 1 ml TBS 
 
DNaseI 
 for 1 mg/ml: 2 mg (Sigma) in 1 ml of stock solution with 
  10 mM Tris-HCl (pH 7.5) 
  150 mM NaCl 
  1 mM MgCl2 
 Dissolved before adding 1 ml Glycerol (Sigma).  
Stored at – 20°C 
 
Stock solution for DNaseI 
 1.58 g/l Tris-HCl (Sigma) diluted in e.g. 200 ml ion free water and pH adjusted to 7.5  
 0.58 g/l NaCl (Apotekerproduksjon) 
 0.21 g/l MgCl2·6H2O (Riedel-deHäen) 
 
10 mg/ml Benzonase 
0.05 ml Benzonase (Sigma)  
Diluted in 1 ml TBS 
 
Sucrose stock solution 
400 g/l Sucrose (Sigma) 
100 ml/l 0.5 M Tris-HCl, pH 8 (autoclaved) 
100 ml/l 2 mM EDTA (Triplex) (VWR), pH 8 (autoclaved)  
 
2 M Tris-HCl  
 315.2 g/l Tris-HCl (Sigma) 
pH adjusted to wanted value 
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0.5 M Tris-HCl 
 78.8 g/l Tris-HCl (Sigma) 
pH adjusted to wanted value   
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2.2 Bacteria strains and plasmids 
Table 1: Bacterial strains used in experiments of this study with relevant genotype information and source 
Bacteria Description Source 
E. coli DH5α General cloning host Bethesda Research 
Laboratories 
E. coli RV308 Production strain ATCC 31608 
E. coli S17.1 Strain used for conjugation (de Lorenzo et al., 
1993) 
E. coli ER2925 Cloning host, dam
-
 , dcm
-
 New England 
BioLabs 
P. fluorescens SBW25 Wild type (Rainey et al. , 
1996) 
P. fluorescens NCIMB10525 Nonmucoid Pseudomonas 
fluorescens wild type 
NCIMB 
P. putida KT2440 mt-2 hsdR Achieved from J. 
L Ramos 
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Relevant characteristics for the plasmids used in this study are summed up in Table 2. Genes 
marked with “s” after the genes name indicate that the sequence has been codon optimized for 
P. putida KT2440.  
Table 2: Bacterial plasmids used in experiments of this study with genotype information and source 
Plasmids Relevant characteristics Source 
pDI-8_MV_ifna2 Used as vector after deletion of ifn-α2, trfA, 
Pm/xylS, Kan
r
 
Roman Netzer,  
SINTEF Dep. of 
Biochemistry 
pAT64 Source of the gene ifn-α2b, trfAcop271C, Ampr Sletta et al. 2007 
(here called 
pIFN30SpelB) 
pMV11 Source of the gene gm-csf, trfAcop271C, Amp
r
 Sletta et al. 2007 
(here called 
pGM29pelB) 
pHH100 Used for plasmid stability evaluation, Kan
r
 (Homberset, 2003) 
Here called pIB6-
wtleader-luc 
pJB861 Expression vector, Pm/xylS, Kan
r
 Blatny et al., 1997 
pIFNpelB ifn-α2b, pelB, trfA, Pm/xylS, Kanr This study 
pGMpelB gm-csf, pelB, trfA, Pm/xylS , Kan
r
 This study 
pCR.1-IFNspelBs Harbours ifn-α2b codon optimized for P. putida 
KT2440, Amp
r
  
Eurofins MWG Operon 
pCR2.1-GMspelBs Harbours gm-csf codon optimized for P. putida 
KT2440, Amp
r
 
Eurofins MWG Operon 
pIFN271pelB ifn-α2b, pelB, trfAcop271C, Pm/xylS, Kanr This study 
pGM271pelB gm-csf, pelB, trfAcop271C, Pm/xylS, Kan
r
 This study 
pIFNs271pelB ifn-α2bs, pelB, trfAcop271C, Pm/xylS, Kanr This study 
pGMs271pelB gm-csfs, pelB, trfAcop271C, Pm/xylS, Kan
r
 Not successfully 
constructed 
pIFNs271pelBs ifn-α2bs, pelBs, trfAcop271C, Pm/xylS, Kanr This study 
pGMs271pelBs gm-csfs, pelBs, trfAcop271C, Pm/xylS, Kan
r
 This study 
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2.3 Construction of plasmids for protein production in 
Pseudomonas 
In this study, two Pseudomonas strains are evaluated as alternative expression platforms to E. 
coli. For the evaluation of recombinant protein production, IFN-α2b and GM-CSF are chosen 
as model proteins. These proteins have the size 23.7 kDa and 19.7 kDa respectively.   
 
The plasmid pDI-8_MV_ifna2 (Figure 10) was used as a basis for construction of expression 
vectors for IFNα2b and GM-CSF. This plasmid was chosen because it already harbours the 
kan gene which allows for selection on kanamycin. In addition it contains the Pm-XylS system 
proven as a functioning expression cassette in different hosts. pDI-8_MV_ifna2 originally 
harbours a version called ifn-α2.  
pDI-8_MV_ifna2
9460 bps
2000
4000
6000
8000
NcoI
NdeI
MunI
AhdI
SexAI
NotI
sok RNA
i
pelB
Pm
Ps1
Ps2
xylS
oriT
kan
oriV
trfA
t
hok
t
H/C
  
Figure 10: Physical map of the vector pDI-8_MV_ifna2 used for construction of expression vectors in this 
study. oriV: origin of vegetative replication, trfA: replication initiation protein: t: transcription 
termination, sok RNA and hok: potential killing mechanism, H/C: his6/c-myc, I: recombinant gene, pelB: 
signal sequence, Pm, Ps1, Ps2: promoters, xylS: transcription regulator, oriT: origin of transfer, kan: 
kanamycin resistance. For details se text in Chapter 1.2.4  
 
Detailed information about the different components of the vector is given in Chapter 1.2.4.  
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The restriction sites surrounding the gene and signal sequence (here pelB) shown in Figure 10 
enable the possibility both exchange and deletion of signal sequence. More details can be seen 
in Figure 11.  
 
 
Figure 11: Physical map of part of the expression cassette in pDI-8_MV_ifna with relevant restriction sites 
for changing the signal sequence and the recombinant gene, here represented by pelB and Ifn-a2 
respectively.  tLPP (t), transcription terminator, his6/c-myc (H/C) and Pm, promoter. Figure based on 
illustration from (Sletta et al., 2007) 
 
The two proteins IFN-α2b and GM_CSF are encoded by the plasmids pAT64 and pMV11 as 
shown in Figure 12.  
pAT64
8914 bps
2000
4000
6000
8000
MunI
AhdI
SexAI
NotI
sok RNA
xylS
oriT
bla
oriV
trfA cop271C
terminator
hok
t H/C
IFN-a2b
pelB
Pm
 
pMV11
8800 bps
2000
4000
6000
8000
MunI
NotI
sok RNA
xyls
oriT
bla
oriV
trfA cop271C
terminator
hok
t H/C
GM-CSF
pelB
Pm
 
Figure 12: Source of IFN-α2b, pAT64 (pIFN30SpelB) and source of GM-CSF, pMV11 
 
Both of the plasmids pAT64 and pMV11 contained the bla gene. This gene codes for 
resistance against the antibiotic ampicillin (amp).  
 
The genes ifn-α2b and gm-csf were cloned into the plasmid pDI-8_MV_ifna2 by digestion 
with NotI and MunI. Thereafter, the strategy for modifications of the genes and expression 
vector is illustrated in Figure 13. 
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pIFNpelB and pGMpelB and modified plasmids were constructed with the same strategy. 
pIFNpelB will therefore function as an example for what was further done, but the same will 
account for pGMpelB, pGM271pelB and pGMs271pelBs, only then with the gm-csf gene 
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pIFNpelB
9460 bps
2000
4000
6000
8000
AhdI
SexAI
NotI
NcoI
NdeI
MunI
sok RNA
oriT
kan
oriV
trfA
t
hok
          His6c-myc
IFN-a2b
pelB
Pm
xylS
 
 
pIFN271pelB
9460 bps
2000
4000
6000
8000
AhdI
SexAI
NotI
NcoI
NdeI
MunI
sok RNA
oriT
kan
oriV
trfA cop271C
t
hok
          His6c-myc
IFN-a2b
pelB
Pm
xylS
 
   
 
 
pIFNs271pelB
9460 bps
2000
4000
6000
8000
AhdI
SexAI
NotI
NcoI
NdeI
MunI
sok RNA
oriT
kan
oriV
trfA cop271C
t
hok
c-myc
IFNs
pelB
Pm
xylS
  
pIFNs271pelBs
9460 bps
2000
4000
6000
8000
AhdI
SexAI
NotI
NcoI
NdeI
MunI
sok RNA
oriT
kan
oriV
trfA cop271C
t
hok
c-myc
IFNs
      peBs
Pm
xylS
 
    
Figure 13: Strategy for construction for construction of expression plasmids relevant for this study. For 
details see text 
Step 4: Insertion of 
codon optimized 
gene and signal 
sequence 
Ligation of NdeI and 
NotI site from 
pIFN271pelB 
(8894bp) and codon 
optimized IFNspelBs 
(566 bp) from 
pCR.1-IFNspelBs 
Step 1: Construction of wild type copy number 
plasmids 
pIFNpelB originating from ligation of NotI and 
MunI site from pAT64 (1987 bp) in pDI-
8_MV11_ifna2 (7473 bp) 
 
Step 2: Exchange of trfA with trfAcop271C 
Ligation of SexAI and AhdI site from 
pAT64 (2368 bp) and from pIFNpelB 
(7092 bp) yielding pIFN271pelB 
Step 3: Insertion of codon optimized 
sequence 
Ligation of NcoI and NotI site from 
pIFN271pelB (8956 bp) and codon 
optimized IFNspelBs (504 bp) from 
pCR.1-IFNspelBs 
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2.4 Methods 
2.4.1 Growth of bacteria 
Growth of precultures from colonies on plates, culture or frozen in stocks 
A sterile tooth picker was used to pick a colony on plate or from a cell stock. This was 
transferred to the desired volume of LB medium (or the medium of interest) in sterile tubes or 
sterile shake flasks with baffles. Antibiotics were added to the medium depending on the 
wanted selection.  
 
As mentioned in the introduction, plasmids can contain genes for resistance against certain 
antibiotics. This can be used to select bacteria which have the plasmid versus bacteria 
without. In the cases where selection was wanted the following concentrations of antibiotics 
were made:  
40 μg/ml kanamycin 
100 μg/ml ampicillin 
Unless otherwise is stated, all cultivation of bacteria was done in medium containing 
antibiotics following the genotype in Chapter 2.2.  
 
The shake flasks were placed in a shaking incubator (Infors) for 200 rpm overnight.  
The temperature in the incubator depended on the bacteria strain; E. coli cultures were 
incubated at 37°C while Pseudomonas cultures were incubated at 25 - 30°C.  
 
Growing bacteria on plates 
The agar medium was made as described under Media and supplements (Chapter 2.1). After 
autoclavation the medium was cooled to 50 – 60°C while standing on magnet stirrer. Before 
pouring the medium into petri dishes (VWR) with wanted size, and if selection was wanted 
the medium was added antibiotic.  
 
Unless otherwise is stated, all cultivation of bacteria was done in medium containing 
antibiotics following the genotype in Chapter 2.2.  
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Storing cultures in stocks 
Overnight cultures or cell samples were added 16 – 20 % sterile glycerol before incubating on 
ice for 30 minutes. The cells were stored at – 80°C.  
 
2.4.2 Growth and pH measurements  
The cell density was measured by optical density at wave length 600 or 660 nm. It is shown 
that OD660=3-4 equals to 1 g dry weight cells per litre P. putida (Attachment F, Table F- 23). 
The spectrophotometer (Shimadzu UV160A) in use has a linear area from OD = 0.1 to 0.3, so 
most of the cultures had to be diluted with medium or 0.9 % NaCl to this area.   
 
Cultures and solutions pH were measured on PHM210 Standard pH Meter (Radiometer 
analytical) after validated calibration.  
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2.4.3 Plasmid isolation 
Plasmid isolation: Wizard Plus SV Minipreps DNA Purification System (Promega) 
Plasmid isolation was used to isolate the initial plasmids and to isolate ligated plasmids.  
- 1.5 ml of the overnight cultures was transferred to sterile 1.5 ml tubes (Eppendorf) and 
centrifuged at 10 000 rpm for 5 minutes (Heraeus). The supernatant was removed and 
cells resuspended in 250 μl Cell Resuspension Solution 
- To lysis the cells and bring the plasmids into solution, 250 μl Cell lysis buffer was 
added before inverting the tubes 4 times. The mixture was incubated for 1.5 minutes 
until the cell suspension appeared clear 
- 10 μl Alkaline Protease Solution was added before the tubes again were inverted 4 
times. This was incubated for 5 minutes in room temperature. Alkaline Protease 
inactivates proteins released from the bacterial cells and endonucleases.  
- To neutralize the protease, 350 μl Neutralization Solution was added before the cell 
lysate was centrifuged for 15 minutes, 13 000 rpm.  
- The lysate was transferred to Spin Column in 2 ml Collection tubes and centrifuged 
for 1 minute at 13 000 rpm (Heraeus) 
- The flow-through was discarded before adding 750 µl Column Wash Solution and  
centrifuged at 13 000 rpm for 1 minutes (Heraeus) 
- The column was washed again by removing the flow-through and adding 250 µl 
Column Wash Solution before it was centrifuged for 2 minutes, 13 000 rpm (Heraeus)  
- To eluate the DNA molecules the Spin Columns were transferred to sterile 1.5 ml 
tubes (Eppendorf) and added 30 µl sterile water and centrifuged at 13 000 rpm for 1 
minutes 
- After elution the Spin Columns were removed and plasmid preparations stored  
at – 20°C 
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2.4.4 Restriction digestion  
As described in Chapter 1.1, bacteria use restriction enzymes as protection against viral 
attacks. Specific restriction enzymes have specific recognition sites in the nucleotide 
sequence. Most of the sequences are four to six nucleotides long, but there are examples of 
enzymes with longer recognition sites. The patterns of the cut also differ between enzymes. 
The cut can produce either blunt or sticky ends. Blunt ends is made if the nucleotide strand is 
cut at the same nucleotide pair, while sticky ends is made if offset cuts are made (Klug et al., 
2009).  
 
Restriction digestion was used to select the right gene fragments and vector. In addition it was 
used to verify the ligation and transformation of produced plasmids.  
 
The following restriction mixtures were made:  
8 μl isolated plasmid (concentration ranging from 20 – 150 μg/μl) 
1 μl enzyme (NEB) 
0. 5 μl BSA (if necessary) (NEB) 
2 μl 10x concentrated buffer (1-4, specified for each enzyme) (NEB) 
Sterile water to a total volume of 20 μl  
If double digestion was of interest and the buffers of the two enzymes agreed, 1 μl of each 
enzyme were added in the same mixture.  
 
The restriction mixture was incubated 37°C for 1. 5 hours. The restriction enzymes used in 
this study is shown in Attachment B 
2.4.5 Separation of DNA fragments by gel electrophoresis 
Electrophoresis is a technique that can be used to separate small molecules, like DNA 
fragments, from each other with the help of an electrical field. When a mixture of molecules 
is placed in a porous substance and influenced of the electrical field, it forces the molecules to 
migrate different lengths determined by the different sizes and net charge of the molecules. If 
two molecules have the same charge but different size, the porous substance, for example a 
gel, will separate them based on the size. Smaller molecules will migrate faster than the larger 
molecules (Klug et al., 2009).  
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2 – 3 μl loading buffer was added to the restriction mixtures. Separation of DNA fragments 
was then executed in Model B1A or B2 (Thermo Scientific) and with Power Pac 200 
(BioRad). UV-light from Gel Doc 2000 (BioRad) was used to visualize the gel fragments 
after one of the following staining procedures. The program Quantity One 4.1.1 (BioRad) was 
used to handle the pictures.  
 
2.4.5.1 Ethidium bromide (EtBr) staining 
The most commonly used staining method for DNA fragments separated in agarose gels use 
the fluorescent dye ethidium bromide. It forms a complex with the DNA which can be 
visualized by UV-light (Sambrook and Russell, 2006).   
 
 
Samples were run in a 0.8 % Agarose gel at 90 – 110 V for 50 – 80 minutes depending on the 
fragment- and gel sizes. The standard used was 1 kb DNA Ladder (Attachment C, Figure C- 
1). The gel was transferred to a bath containing 5 μg/ml EtBr (Merck) for 10 minutes. 
Afterwards, decolorization for 25 minutes.  
2.4.5.2 GelRed staining 
EthBr is toxic (ECOonlineAS, 2007). An alternative for staining gel was therefore adopted 
during the study. This method uses GelRed (Biotium) which have been shown to be 
nonmutagenic and noncytotoxic. GelRed (and GelGreen) DNA-binging stain is developed to 
reduce genotoxity by preventing the dye to enter living cells (Biotium, 2009).  
 
Samples were run in a 0.8 % Agarose gel containing 20 - 30 µl GelRed at 90 – 110 V for 50 – 
80 minutes depending on the fragment- and gel sizes. The standard used was GeneRuler
TM
 
DNA Ladder Mix 0.5 μg/μl 50 μg (Attachment C, Figure C- 2).  
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2.4.6 Extraction of DNA fragment from agarose gel  
After identifying the desired fragments, they were cut out from the gel using a clean scalpel. 
The gel fragments were kept in a 1.5 ml tubes (Eppendorf) at 4°C until extraction of DNA.  
 
Isolation of plasmids from gel fragments: QIAquick (Qiagen) 
- 300 μl QG buffer was added to the 1.5 ml tubes (Eppendorf) and incubated at 50°C for 
10 minutes or until the gel was completely dissolved 
- 100 μl isopropanol was added and mixed together by flicking the tubes. This will 
precipitate the DNA   
- QIAquick spin columns were placed into collection tubes before the 
Agarose/DNA/isopropanol mixtures were transferred to the columns and centrifuged 
for 2 minutes 13 000 rpm (Heraeus)  
- The DNA was now bound to the column material. The flow-through was removed 
before adding 500 μl QG buffer and centrifuge as above 
- The flow-through was removed before adding 750 μl of the wash PE buffer. The tubes 
were then let standing for 5 minutes before spinning for 2 minutes (13 000 rpm) 
(Heraeus). The flow-through was discarded.  
- To remove the ethanol completely ,the columns before spinning for 2 minutes at 
15 000 rpm (Heraeus) 
- The columns were moved to sterile 1.5 ml tubes (Eppendorf) and DNA was eluated 
with sterile water and left for 5 minutes before centrifugation at 15 000 rpm for 2 
minutes (Heraeus) 
 
QIAEX II Agarose Gel Extraction Protocol (Qiagen)  
- 450 μl of the solubilisation and binding buffer QX1 and 300 μl sterile H2O was added 
to the gel fragments  
- The QIAEX II suspension was resuspended by vortexing for 30 minutes before adding 
10 μl into each tube. QIAEX II suspension consists of silica gel particles which 
selectively absorbs nucleic acids  
- The mixtures were incubated for 20 minutes to solubilise the agarose and bind the 
DNA. To keep the QIAEX II in suspension, the mixtures were vortexed every 2 
minutes 
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- The samples were centrifuged at 13 000 rpm for 1 minute (Heraeus). The supernatant 
was removed 
- The pellet was washed with 500 μl Buffer QX1 before centrifuging at 13 000 rpm for 
1 minute (Heraeus) 
- After removing the supernatant, the pellet  was washed twice with 500 μl wash buffer 
PE (13 000 rpm for 1 minute (Heraeus)) 
- The pellet was air-dried for 15 minutes or until the pellet became white 
- Eluting the DNA was accomplished by adding 20 μl sterile H2O, centrifuging as above 
and carefully pipetting the supernatant to a clean 1.5 ml tube (Eppendorf) 
2.4.7 Ligation of DNA fragments  
As described earlier restriction enzymes make specific cuts in DNA strands. If two DNA 
fragments with complementary sticky ends are mixed together in the right proportions, they 
can anneal by base pairing their single strands. This situation can be made by using the same 
enzyme on two different DNA strands. By adding a DNA-ligase in the solution, covalent 
linkages will form between the fragments and give a recombinant DNA molecule as product 
(Klug et al., 2009).  
 
The following ligations were made:  
 
2 μl  Vector DNA 
15 μl Insert DNA 
1 μl DNA-ligase T4 (NEB) 
2 μl T4 DNA Ligase Reaction Buffer (NEB) 
 
The ligation mixture tubes was left at the top of a box containing ice overnight 
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2.4.8 Transformation of bacteria 
Bacteria have the ability to transfer and take up DNA in three ways; transformation, 
transduction and conjugation. During transformation, DNA from the environment is taken up 
by the cell. Transduction is uptake from a bacteriophage and conjugation is DNA transfer 
between two bacteria. Several laboratory methods utilize these biological principles for 
production of recombinant strains. To ensure the uptake selection based on resistance against 
a certain antibiotic can be used (Klug et al., 2009). 
2.4.8.1 Transformation 
Transformation is the bacterial uptake of extracellular DNA through receptor sites at the cell 
surface. The bacteria containing these receptor sites are called competent. When DNA binds 
to the sites, it is passed into the cytoplasm in an active process. (Klug et al., 2009)   
Competent cells 
- An 1 % inoculum was made from an overnight culture in Psi medium and incubated to 
OD600 =0.400 
- The cells were incubated on ice for 15 minutes and centrifuged at 4 500 rpm for 5 
minutes (Heraeus) 
- The supernatant was removed and the pellet resuspended in 40 ml cold TFB1 
- The cells were incubated on ice for 5 minutes and centrifuged (4 500 rpm, 5 minutes 
(Heraeus)) 
- The supernatant was removed and pellet resuspended in 3 ml cold TFB2 
- The resuspantion was distributed in sterile 1.5 ml tubes (Eppendorf) (0,1 ml per tube) 
and quickly frozen in a mixture of ethanol and dry ice 
- Stored at – 80°C 
 
Transformation of plasmid to competent cells 
- 10 μl ligation mixture or 3 µl plasmid preparation was added to 100 µl competent cells  
- The mixture was kept on ice for 30 minutes 
- The tubes were incubated in a 42°C water bath for precisely 35 seconds, then placed 
back on ice for 2 minutes  
- 1 ml preheated (37°C) SOC was added and incubated for 60 minutes at 37°C 
- The transformation mixture was plated out on LA with selection and incubated 
overnight 
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2.4.8.2 Electro transformation 
Electro transformation is a quick and efficient method for introducing molecules into a cell. A 
quick electric pulse is used to make cells competent i.e. the membrane permeable for DNA 
(Eynard and Teissié, 2000).  
 
Electro competent cells 
- An 1 % (v/v) inoculum in100 ml pre-warmed LB was made from an overnight culture 
in 10 ml LB 
- The culture was grown for 2.5 hours before kept on ice for 15 – 30 minutes.  
- The cells was harvested by centrifuging (5000 rpm, 15 minutes) (Eppendorf) 
- The medium was removed and the cells washed 3 times in 100, 50 and 10 ml 10 % 
sterile glycerol. Between each wash, the cells were centrifuged as above. After the last 
wash the cells was resuspended in 0.5 – 1.0 ml 10 % glycerol  
- 40 μl of the competent cells was frozen in a mixture of ethanol and dry ice. The cells 
were kept at – 80 ◦C  
 
Transforming plasmids to electro competent cells 
- The following setting was made on a BIO RAD Gene Pulser XCell: 
Voltage:   2.5 kV 
Capacitance:   25 microF 
Resistance:   200 Ω 
Time constant:  5.6 – 5.8 mSec 
Cuvette (mm): 2 
- Competent cells made for electro transformation was kept on ice (40 μl per tube) and 
added 2 μl DNA. This was transferred to a cold and clean optical cell.  
- The cells were given pulse and cell-DNA mixture before adding and resuspending in 1 
ml LB. The mixture was then moved to a sterile Eppendorf tube. 
- The culture was grown at 30 ◦C for 1 – 2 hours or overnight before plating out on LA 
with selection 
2.4.8.3 Conjugation  
Conjugation is a process where genetic information is transferred from one bacterium to 
another. For conjugation to be possible the plasmid has to be conjugative, i.e. encode genetic 
information that enables cell-to-cell contact. The host bacteria need to have the gene coding a 
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pili structure. These pili can attach to an OmpA protein on the surface of another bacterium 
that does not contain the plasmid. Connection between pili-OmpA lead to a cell-to-cell 
contact   where the DNA from one bacterium can be transferred to the other with the help of 
an enzyme which starts to digest in oriT. This starts the “rolling circle”; a DNA replication at 
the 3’ end. After the conjugation, both bacteria have the plasmid (Degré et al., 2004).  
 
- LB overnight cultures of bacteria with plasmids of interest were used to make 1 % 
(v/v) inoculums in LB. The receiver strain culture was inoculated 2 hours earlier than 
the plasmid harbouring strains. After this, the cultures were left for 2 hours.  
- 2 ml of plasmid strains was mixed with 2 ml of the receiver strains and spun at 4000 
rpm for 5 minutes. The supernatant was removed and the cell pellet was resuspended 
in 100 μl LB 
- The resuspention was placed in a droplet on LA plates. The droplets were not plated 
out but left as one deposit and incubated at 30°C overnight 
- The droplets were harvested and resuspended in 1 ml LB. 10-2, 10-4 and 10-6 dilutions 
of this was plated out on suitable agar with selection and incubated overnight at 
preferred temperature 
2.4.9 Production of proteins in HCDC (fermentation) 
HCD cultivations are used to increase the production of proteins from established expression 
platforms. If the cultivation in a bench top bioreactor is successful in terms of economic 
perspectives and quality of produced proteins, further up-scaling to pilot-scale bioreactors 
and perhaps industrial-scale operation can be performed. Fermentations in a bench top 
bioreactor gives the opportunity to measure and adjusting temperature, pH, dissolved-oxygen 
concentration, stirrer speed, nutrition and other process variables (Doran, 1995).   
 
HCDC and production of model proteins was examined in 1-litre (Dasgip) and 3-litre 
(Applicon) fed batch bench top fermentors with 0.35 and 0.75 litres media start volume 
respectively. The temperature was automatically regulated to 30°C. 
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2.4.9.1 Preparing inoculums for fermentation 
- Cultures to be fermented were plated out on LA with selection overnight at optimal 
temperature 
- A sterile scoop was used inoculate 100 ml inoculum LB medium (see Attachment E 
for details) with one colony. The culture was incubated at 30°C, 200 rpm for 8 – 16 
hours (depending on growth) 
-  100 ml inoculum Hi-medium (see Attachment E for details) was inoculated with 0.5 
ml LB-culture and incubated for 16 – 18 hours at 30°C (200 rpm) 
 
2.4.9.2 Fermentation conditions 
The following procedure was used to set the conditions of 1-litre and 3-litre fermentors  
- 0.35 l and 0.75 l start volume respectively of Hf.1 medium (for details see Attachment 
D) was added to each fermentor and autoclaved for 30 minutes at 120°C. Thereafter 
cooled to 15°C overnight. The temperature was then set to 30°C 
- pH electrode was calibrated in buffers with pH 7 and 4 before setting the set point to 
6.8. For 3-litre fermentors 12.5 % NH3 (sterile) was used for pH control. When 
bacteria grow with the access to glucose (like for this study), acids are normally 
produced and pH decreases. NH3 will adjust this pH to the set point of 6.8.   
- The oxygen electrodes 0 % level was checked with nitrogen gas. Stirring speed was 
adjusted to 500 rpm on the 1-litre fermentors and to 1000 rpm on the 3-litre fermentors 
and the reported dissolved oxygen (DO)-value was adjusted to 100 %. DO is the 
concentration of dissolved oxygen in the medium and is measured continuously during 
the fermentation. It is controlled by the stirring speed. Set-value for oxygen 
concentration in the medium was 20 %.Stirring speed was set to minimum set point at 
200 and 350 rpm for respectively 1-litre and 3-litre fermentors.  
- Air flow was adjusted to 0.25 vvm (litre air/litre medium, minute). Flow 
measurements of air into the fermentor is measured by a mass-flow-meter and should 
be between 0.25 – 1.0 vvm. 
- Additions were made to the Hf.1 medium following Attachment E 
- 0 % value of CO2 analyzer was calibrated with N2 gas. The set value of CO2 is 
thereafter set to 5 % calibration gas. CO2 concentration from the air leaving the 
fermentor and is reported as percentage of total air flow 
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- Inoculation of the fermentors was done. OD600 samples of the precultures were taken 
to calculate the volume necessary for giving a start OD600 value of 0.05 in the 
fermentors 
- Exponential feeding was started with initial rate of 5.6 g/fermentor·hour (1l-
fermentors) or 12 g/fermentor·hour (3l-fermentors) and exponentially increased with 
μ = 0.20-0.22 h-1 until reaching a feed rate of 12 g/ fermentor·hour (1l-fermentors) or 
25 g/fermentor·hour (3l-fermentors). When this stage was reached, feeding was 
constant thorough out the fermantation 
- Samples for glucose measurements were taken regularly to control the that there was 
not rest of glucose in the medium  
- Cell density was measured regularly before reaching induction time (OD600 ≈80 - 90) 
for strains harbouring expression plasmid constructed in this study (Chapter 2.2). 
Inducer was added to a final concentration of 1 mM.    
 
The different parameters are measured and logged by a computer.  
 
All fermentations were executed in collaboration with SINTEF Materials and Chemistry, 
department of Biotechnology.  
 
2.4.10 Detection and quantification of recombinant protein 
Sodium dodecyl sulphate (SDS) is a commonly used detergent for separating proteins based 
on their mass and shape during SDS polyacrylamide gel electrophoresis (SDS-PAGE). When 
SDS is mixed with a protein sample it binds and partially unfolds them. During 
electrophoresis, where an electric field is applied, the negative charge of SDS will contribute 
to separating the proteins depending on mass and shape, where smaller polypeptides migrate 
more rapidly. After separation the proteins can be visualized with using a suitable stain 
(Nelson and Cox, 2008) or specific proteins can be detected with a method called Western 
Blot. Here the proteins are transferred from the gel to a nitrocellulose membrane using an 
electrical current. A specific protein can be detected using antibodies to elements of the 
proteins, for example c-myc or His6. Method used for detection depends on how the 
secondary antibody is marked, but one example is conjugation with a enzyme which 
facilitates detection using its substrate (Snustad and Simmons, 2010).  
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2.4.10.1 Sample preparation for SDS-PAGE 
Recombinant proteins in prokaryotes can be produced as soluble or insoluble fractions 
(previously referred to as IB). To determine the different amount of these fractions, lysing 
protocols have to be used. The following protocols were developed for E. coli but since P. 
putida also is a gram negative bacterium, it was assumed that the protocols would have the 
same outcome on both E. coli and P. putida. Neither of the protocols will separate proteins 
secreted to the periplasm form proteins inside the cytoplasm.  
 
- 1 ml sample from shake flask or HCDC experiments were centrifuged in 1.5 ml tube 
(Eppendorf) for 10 minutes as 13 – 14 000 rpm (Heraeus) 
- The supernatant was transferred to a 1.5 ml tube (Eppendorf), while the remaining 
pellet was used for lysis either using protocol 1 or 2. The main difference between 
these two are the enzyme used to eliminate DNA, which in protocol 1 is DNaseI and 
in 2 is Benzonase:  
 
Cell lysis protocol 1 
- 250 μl 0.5 M Tris-HCl, pH 8.0 containing 2 mg/ml lysozyme (Fluka) was added to the 
cells and resuspended. Lysozyme is a enzyme that breaks down the cell wall of the 
bacteria. The enzyme is active in pH range 6.0 – 9.0 created by Tris-HCl.  
- 250 μl Sucrose stock solution containing 1 mg/ml DNaseI (Sigma) was added. The 
mixture was incubated for 1 hour at room temperature shaking. The mixture will 
eliminate DNA and prevent protease activity 
- The lysate was centrifuged at 13000 rpm for 8 minutes (Herasus) 
- The supernatant (soluble fraction) was transferred to a clean 1.5 ml tube 
- The pellet was resuspended in 500 μl 1 x Running Buffer (ClearPAGE) 
- If no dilution was necessary, 20 μl of the samples was added 10 μl 3x Sample Buffer 
and boiled at 95°C for 5 minutes. Possible dilution was made in 1 x Running Buffer 
(Clear PAGE) 
 
Cell lysis protocol 2 
- The pellet (P1) was resuspended completely in 500 μl 50 mM Tris-HCl, pH 8.0 
- 500 μl sucrose stock solution was added and mixed carefully to prevent protease 
activity 
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- 10 μl 100 mg/ml lysozyme (Sigma) and there after 10 μl 10 mg/ml Benzonase (Sigma) 
was added 
- The mixtures were incubated while rotating, for 1 hour at room temperature.  
- The samples were then centrifuged at 14 000 rpm  (Eppendorf) for 5 minutes at 4°C  
- The supernatant (soluble fraction) and the pellet (insoluble fraction) were separated 
and the pellet resuspended in 500 μl 1 x Running Buffer (ClearPAGE)  
- The samples were at – 20°C 
- Before using the samples in gel electrophoresis, they were boiled at 95°C in a 2:1 
relationship with 3 x Sample Buffer 
 
2.4.10.2 SDS-PAGE 
- 15 μl of the boiled samples and 10 μl Precision Plus Protein Dual Color Standard 
(Figure C- 3) was transferred to a 10 % or 12 % TEO-CI SDS gel (ClearPAGE) and 
run inside Dual Cool Mini-Vertical PAGE (CBS Scientific) at 150 V (BioRad Power 
Pac 200) for 1 hour in 1 x Running Buffer (ClearPAGE). For this study, the standard 
was always placed in the well furthest to the left.  
 
2.4.10.3 Western Blot  
Using anti-c-myc as primary antibody 
- Gel, filter paper and blotting sponges was incubated in Blotting Buffer while the 
membrane (Immobilon Millipore Transfer membrane) was incubated in methanol for 
10 minutes 
- Afterwards this was placed in the following order in Mini Protean blotting system 
(BioRad): Clear plate, sponge, filter paper, membrane, gel, filter paper, sponge, black 
plate. This was placed in the blotting chamber containing a block of ice. The blotting 
chamber was filled with Blotting Buffer before butting the whole system in a box 
filled with ice to keep the temperature down 
- The blotting was run at 70 V for 1 hour 
- The membrane was washed 3 x 5 minutes with TBS before blocking the membrane for 
unspecific binding with the help of Blotto for 1 hour at room temperature 
- The proteins were detected with 2 μl of the primary antibody anti-c-myc (Invitrogen) 
in 10 ml Blotto. The membrane was kept in this solution shaking overnight at 4°C 
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- The membrane was washed 3 x 20 minutes in TBST before 10 µl Rabbit Anti-Mouse 
(Dako) in 10 ml Blotto for detection of the primary antibody was added. This was kept 
at shaking for 1 hour  
- The membrane was washed 3 x 5 minutes in TBST and then 1 x 5 minutes in TBS 
before the substrates Tetrametylbenzidine and Hydrogen Peroxide (TMB Substrate 
Reagent Set, BD Biosciences) was mixed 1:1 and added to the membrane  
- When the colour reaction was complete, the membrane was transferred to distilled 
water  
 
Using Tetra His Antibody as primary antibody 
- Gel, filter paper and blotting sponges were incubated in Blotting Buffer for 30 
minutes. The membrane (Immobilon Millipore Transfer membrane) was incubated in 
methanol for 15 seconds, 2 minutes in water and 10 minutes in Blotting Buffer 
- Afterwards this was placed in the following order in a BioRad blotting system: Clear 
plate, sponge, filter paper, membrane, gel, filter paper, sponge, black plate. This was 
placed in the blotting chamber containing a block of ice. The blotting chamber was 
filled with Blotting Buffer before butting the whole system in a box filled with ice to 
keep the temperature down 
- The blotting was run at 100 V for 1 hour 
- The membrane was washed one time with TBS 
- The membrane was blocked by incubating it in Blotto (made from 1 g Skim milk 
Powder in 100 g TBST) for 1 hour at room temperature 
- Primary antibody Tetra His Antibody (Qiagen) was diluted 1:7500 in Blotto and added 
to the membrane. This was incubated overnight, shaking at 4 C.  
- The membrane was washed three times with TBST, each time for 10 minutes 
- Secondary antibody Polyclonal Rabbit Anti-Mouse Ig HRP() was diluted 1: 1500 in 
Blotto was added and incubated for 1 hour at room temperature 
- The membrane was washed three times with TBST and one time with TBS, each time 
for 10 minutes 
- The antibodies attached to the proteins of interest were detected by using 3 ml 3,3’5,5’ 
Tetramethylbenzidine (TMB) (Sigma). After incubating until bands were visible, the 
membrane was transferred to distilled water before scanning the result 
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3 Results and discussion  
The work in this study can be divided into two main parts. The first part was the genetic 
construction of expression vectors. In total, 7 different vectors were constructed, where the 
main differences were gene of interest, copy number, and codon optimized genes and signal 
sequence. The second part was cultivation analysis of possible expression platforms and 
evaluation of their production of recombinant proteins. E. coli, P. fluorescens and P. putida 
were evaluated under different conditions with respect to growth and protein production. The 
cultivations were performed in deep well plates, shake flasks and fed batch fermentations.  
3.1 Construction and cloning of wild type copy number plasmids 
pIFNpelB and pGMpelB 
The goal for the first construction strategy (Chapter 1.4, Figure 9, Step 1) was to make two 
expression plasmids with wild type copy number. pIFNpelB and pGMpelB harboured the  
ifn-α2b and gm-csf gene respectively. By using this as starting point, there were many 
possibilities for later genetic modifications.  
 
All of the three initial plasmids, pDI-8_MV_ifna2, pAT64 and pMV11 (Chapter 2.3), were 
present in E. coli DH5α strains. In the first step of this study, the original ifn-α2 of  
pDI-8_MV_ifna2 was replaced gene with the genes ifn-α2b and gm-csf to form pIFNpelB and 
pGMpelB respectively.  
 
The three DH5α strains were grown overnight (37°C, 200 rpm) in 3 ml LB with selection 
before isolating the plasmids (Chapter 2.4.3). Restriction mixtures were made following 
Chapter 2.4.4 with the enzymes MunI (also called MfeI) and NotI. pAT64 and pMV11 were 
both expected to give a 6.9 kb fragment in addition to one smaller fragment with size 2.0 and 
1.9 kb respectively. These two smaller fragments were the genes ifn-α2b and gm-csf, and 
therefore the inserts. pDI-8_MV_ifna2 was expected to be cut in two fragments, one at 7.5 kb 
and one at 2.0 kb, the largest being the vector. The result from the digestion is shown in 
Figure 14.  
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Figure 14: Restriction digestion results of pDI-8_MV_ifna2, pAT64 and pMV11 digested with NotI and 
MunI. The marked DNA fragments were extracted from the gel; 7.5 kb fragment from pDI-8_MV_ifna2, 
2.0 kb fragment from pAT64 and 1.9 kb fragment from pMV11. The sizes were identified with 1 kb DNA 
ladder (NEB) standard (left) (Attachment C, Figure C- 1).  
 
Fragments with the expected size on the gel (Figure 14) were identified and isolated as 
described in Chapter 2.4.6 (QIAquick protocol). Ligation mixtures were made (Chapter 2.4.7) 
in addition to one mixture with vector DNA only. This was a negative control. Ligation 
mixtures were transformed into competent E. coli DH5α cells (Chapter 2.4.8.1) and plated out 
on LA with selection. After overnight incubation at 37 C the plates were inspected. As the 
negative control had no growth, the transformation was interpreted as successful, but still had 
to be evaluated through restriction digestion. Single colonies were transferred to 3 ml 
selective LB medium and incubated overnight at the same temperature (37°C). Plasmids were 
isolated and restriction mixtures were made (Chapter 2.4.3), where pIFNpelB transformants 
were digested with PstI, while BsrGI and XhoI were used on pGMpelB. The correct 
constructed plasmids were expected to give fragments of 4.0, 3.3, 1.2 and 0.9 kb, and 6.2 and 
3.2 kb respectively. Transformants that had the expected fragment sizes, shown in Figure 15, 
were used for further work in this study.  
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Figure 15: Restriction analysis of two transformants after cloning of target genes (ifn-α2b and gm-csf) into 
vector. A) Plasmid expected to be pIFNpelB digested with PstI. B) Plasmid expected to be pGMpelB 
digested with BsrGI and XhoI. The sizes were identified with 1 kb DNA ladder (NEB) standard (left) 
(Attachment C, Figure C- 1). 
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3.2 Evaluation of E. coli RV308 strain as expression host for wild 
type expression vectors 
The plasmids were now present in E. coli DH5α cells, which are general cloning hosts. For 
further experiments and evaluation of ability to produce the recombinant proteins, the 
plasmids were transferred to a production strain of E. coli. These E. coli strains would be used 
for comparisons in the investigation of the Pseudomonas species properties as a protein 
producer. As explained in Chapter 1.3, IFN-α2b and GM-CSF have already been produced in 
E. coli RV308. This strain was therefore chosen to be reference in this study.  
 
The pIFNpelB, pGMpelB, pAT64 and pMV11 were transferred to E. coli strain RV308 by 
transformation (Chapter 2.4.8.1) and different dilutions were placed on selective LA plates. 
After incubating at 37°C overnight, one colony from each strain was transferred to 3ml LB 
with selection and grown overnight before storing the culture in glycerol stocks at – 80°C 
(Chapter 2.4.1).  
3.2.1 Cultivation in deep well plates 
Precultures of RV308 (pIFNpelB), RV308 (pGMpelB), RV308 (pMV11) and RV308 
(pAT64) were grown in 50 ml selective LB medium in 250 ml shake flasks with baffles 
overnight at 37°C (200 rpm). 10 ml of each pre-culture were spun down and cells were 
washed with 10 ml 0.9 % sterile NaCl. The cells were resuspended in 1 ml 0.9 % sterile NaCl 
before transferring 500 μl of the cell suspensions to 50 ml Reduced Hi+YE medium (see 
Attachment D for details). Parallels of 600 μl inoculated Reduced Hi+YE medium were 
transferred to deep well plates (Greiner Bio One). Cultures were incubated at 16 and 25°C, 
800 rpm. OD600 measurements taken regularly and after reaching a value 5, parallels of each 
culture were induced to a final concentration of 0.5 mM m-toluic acid. After induction the 
plates were incubated overnight, before freezing at – 20°C.  
 
Figure 16 shows the growth of RV308 strains during the deep well experiment.  
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Figure 16: Growth (OD600) of E. coli RV308 harbouring pIFNpelB, pGMpelB, pAT64 or pMV11, all 
grown in reduced HiYe medium with selection at 25 °. The densities were measured by OD600. For 
detailed information see Attachment F Table F- 2 
 
E. coli RV308 strains containing pIFNpelB and pGMpelB grew with lower rate compared to 
the strains with pAT64 and pMV11 (Figure 16). The growth curves are almost identical for 
these pairs. One reason might be the different selection markers within the plasmids. 
pIFNpelB and pGMpelB have kanamycin resistance while pAT64 and pMV11 are resistant 
against ampicillin (Chapter 2.2). The dosage and effect of these antibiotics are not the same 
and these curves can therefore not be directly compared.   
 
None of the cultures showed growth at 16°C (results not shown).  
3.2.1.1 Protein production  
The samples induced at OD600 ≈5 to a final concentration of 0.5 mM m-toluic acid were used 
for SDS-PAGE (Chapter 2.4.10.2) after boiling a quantity of the culture diluted with 3x 
sample buffer. In addition, a 20 mg/l Phox reference sample was prepared like the culture 
samples. Western Blots protocols using anti-c-myc as primary antibody was followed 
(Chapter 2.4.10.3). From pAT64 and pIFNpelB it was expected to detect IFN-α2b protein 
with molecular weight 24.7 kDa, and from pMV11 and pGMpelB the protein GM-CSF with 
molecular weight 19.7 kDa. The results are shown in Figure 17.  
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Figure 17: Western Blot results of RV308 strains with plasmids pIFNpelB, pGMpelB, pAT64 and pMV11 
(indicated with the top vertical lines). The cultures were grown in deep well plates at 25°C and induced to 
a final concentration of 0.5 mM m-toluic acid at OD600≈5. Numbers on the left side represents molecule 
sizes in kilo Daltons 
 
Figure 17 shows the detected proteins in the RV308 culture samples from the deep well 
experiment and give an indication on the functionality of the constructed plasmids. Both 
pAT64 and pMV11 are expression vectors with increased copy numbers (see Chapter 2.2), 
and can therefore in theory produce more of the recombinant proteins IFN-α2b and GM-CSF 
respectively. Direct comparison of the amount protein produced from these strains with 
RV308 (pIFNpelB) and RV308 (pGMpelB) can therefore not be performed. Still, comparison 
of the molecular weights of produced recombinant proteins is an assurance that the plasmids 
are successfully constructed. pIFNpelB and pAT64 both harbours the ifn-α2b gene (23.7 
kDa), but the protein is only detected from RV308 (pAT64).  This can indicate that RV308 
has problems with producing the protein and should be investigated further.  
 
Both pMV11 and pGMpelB harbours the gm-csf gene, and produced GM-CSF protein (19.7 
kDa) can detected from the strains harbouring these plasmids (Figure 17). The pGMpelB 
plasmid is therefore considered to function in RV308 cells.  
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The concentration of Phox reference (20 mg/l) is too high to make comparisons with the 
detected bands and should be diluted for further use.  
3.2.2 Growth and production experiment of RV308 (pIFNpelB)in shake 
flasks  
Since production of IFN-α2b from the pIFNpelB in RV308 was negative in the deep well 
experiment (Figure 17), it was decided to run a new experiment with this strain to validate the 
result. It was chosen to increase the culture volume and perform the experiment in shake 
flasks. In addition, the culture medium was changed from reduced HiYe medium to another 
version called HiYe reduced broth and the additional induction solution (see Attachment D 
for details).  
 
RV308 (pIFNpelB) was grown in 50 ml selective LB overnight at 37°C (200 rpm). 2 % (v/v) 
from precultures (Attachment F Table F- 1) were used to inoculate two parallels of 35 ml 
HiYe reduced broth. The strains were grown for 16 hours before 15 ml of the induction 
solution was added to each culture.  One of the parallels was induced to a final concentration 
of 0.5 mM m-toluic acid. After 5 hours incubation, samples for Western Blot analysis were 
collected. 
 
3.2.2.1 Protein production  
1.8 ml culture samples were prepared following the protocol “Cell lysis protocol 1” (Chapter 
2.4.10.1). Western Blot was performed with anti-c-myc as primary antibody (Chapter 2.4.10.2 
and 2.4.10.3).  
 
Results from Western Blot showed no bands at expected sizes (data not shown). This might 
indicate that RV308 has trouble producing the protein. As stated in Chapter 1.3, there has 
previously been detected production of IFN-α2b from this strain, but the amounts detected 
have been lower than for GM-CSF. Since the goal for this study is not to evaluate E. coli as 
producer, but to find an alternative expression platform, there is no requirement that E. coli 
has produced the proteins from the constructed plasmids.  
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3.3 Evaluation of P. fluorescens SBW25 strain as expression 
platform for pIFNpelB and pGMpelB 
For this study, the production potential of two different Pseudomonas species was evaluated. 
Because P. fluorescens SBW25 has proven to function as a recombinant protein producer 
(Chapter 1.2.3.2), this was one of strains evaluated.  
 
Wild type copy number plasmids (pIFNpelB and pGMpelB) were transferred to competent 
cells of the E. coli strain S17.1 (Chapter 2.4.8.1). Conjugation between SBW25 and S17.1 
(pIFNpelB) and S17.1 (pGMpelB), were performed according to the conjugation procedure 
described in Chapter 2.4.8.3 to construct SBW25 (pIFNpelB) and SBW25 (pGMpelB). 
Dilutions were plated out on selective PIA-agar to isolate Pseudomonas species only. One 
colony of each strain was transferred to 10 ml selective LB medium and grown overnight 
(30°C, 200 rpm) and frozen in glycerol stocks according to the protocols (Chapter 2.4.1).  
 
3.3.1 Cultivation in deep well plates 
It was chosen to evaluate SBW25 (pIFNpelB) and SBW25 (pGMpelB) under the same 
conditions as for RV308 in Chapter 3.2.1 to compare their production of recombinant 
proteins.  
 
Precultures of SBW25 (pIFNpelB) and SBW25 (pGMpelB) were grown in 50 ml LB medium 
in 250 ml shake flasks with baffles overnight at 25°C (200 rpm). The reason for choosing this 
temperature (and not 30°C) was previously protocols used for cultivations of Pseudomonas 
species as SINTEF Department of Biotechnology. Precultures were treated as RV308-strains 
in Chapter 3.2.1.  
 
Growth measurements (Attachment F Table F- 2) indicated that none of the SBW25 strains 
grew enough to reach the desired OD600-values for induction (OD600≈5). The reason for this 
lack in growth had to be tested further, but because the strains earlier had shown a relatively 
low OD600 values in the precultures (Attachment F Table F- 1), it was suspected that the strain 
was not able to maintain the plasmid. If the strain loses its plasmid, the antibiotic kanamycin 
will kill the bacteria.  
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3.3.2 Plasmid stability evaluation of P. fluorescens strains SBW25 and 
NCIMB10525 
Because of the low growth rate of SBW25 (data not shown), plasmid instability was 
suspected. To examine this, the plasmid stability of two P. fluorescens strains, NCIMB10525 
and SBW25 were tested. NCIMB10525 was chosen as a possible alternative to SBW25.  
 
1 % (v/v) from overnight precultures (50 ml LB in 250 ml shake flask with baffles, 25°C, 200 
rpm) of the two strains SBW25 (pHH100) and NCIMB (pHH100) (both borrowed from H. 
Jørgensen, Post doc. NTNU) were used to inoculating 20 ml of three different medias; LB, 
PIA (for details see Chapter 2.1) and Hi-10YE-10GLY-2GLU (for details see Attachment D) 
(all with selection). 600 μl parallels were transferred to deep well plates (Greiner Bio One) 
and incubated at 25°C overnight (900 rpm).  
 
The cultures were plated out on LA without selection and incubated at 30°C for 2 days. 75 
colonies were transferred to LA with selection and incubated at the same conditions. For both 
strains, 0 – 13.3 % of the colonies was able to grown on the selective media (Attachment F  
Table F- 3). This result shows low plasmid stability indicating that they would not be suitable 
for recombinant protein production without any genetic modifications of stability elements on 
the expression plasmids. It also reveals that the lack of growth of SBW25 strains in the deep 
well experiment was due to low plasmid stability. Since the focus of this study was expression 
of proteins, and not increasing plasmid stability, it was chosen test other Pseudomonas strains. 
P. fluorescens was therefore not used further in this study.  
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3.4 Evaluation of P. putida KT2440 as expression platform 
for wild type copy number vectors 
Based on the poor plasmid stability of P. fluorescens strains (Chapter 3.3.2) it was decided to 
evaluate an alternative host form the Pseudomonas family. The P. putida strain KT2440 was 
chosen to be the new candidate.  
 
pIFNpelB and pGMpelB were transferred to KT2440 through electro transformation 
according to the protocol (Chapter 2.4.8.2). 
3.4.1 Plasmid stability evaluation of KT2440 
SBW25 and NCIMB10525 plasmid instability (Chapter 3.3.2), made it necessary to evaluate 
the plasmid stability in KT2440 before any analysis of production of recombinant proteins.  
 
1 % (v/v) from overnight precultures of the two strains KT2440 (pHH100) (borrowed from H. 
Jørgensen, Post doc. NTNU) and KT2440 (pIFNpelB) were used for inoculating 20 ml of the 
same three media as in Chapter 3.3.2; LB, PIA and Hi-10YE-10GLY-2GLU (all with 
selection). 600 μl parallels were transferred to deep well plates (Greiner Bio One) and 
incubated at 25°C overnight (900 rpm). KT2440 (pIFNpelB) was induced with 0.5 mM m-
toluic acid at OD600 ≈1. Plasmid stability was testes using the same approach as for SBW25 
and NCIMB10525 (Chapter 3.3.2).  
 
The plasmid stability in KT2440 (pHH100) was calculated to 70 – 100 % (Attachment F 
Table F- 3). Since an essential feature of the production strain is to be able maintain the 
plasmids constructed for this paper, the induced culture of KT2440 (pIFNpelB) were tested 
for plasmid stability as well. The results here were 100 % stability (Attachment F Table F- 3). 
This indicated that the P. putida strain KT2440 was a good candidate for functioning as 
expression platform.  
 
3.4.2 Plasmid stability of KT2440 over 20 generations 
To ensure that the stability of plasmid in KT2440 was high over several generations, plasmid 
stability was tested during growth for 20 generations in PIA and M9 media (for details see 
Chapter 2.1). From this experiment and forward, the incubation temperature was changed to 
30°C.  
Results and discussion 
 
64 
 
 
Precultures of KT2440 (pIFNpelB) was grown in 50 ml selective LB medium overnight at 
30°C, 200 rpm. 50 ml of PIA- and M9 medium were inoculated to an OD600 value of 0.01 and 
0.1 respectively. After reaching OD600 values above 1, plasmid stability samples were taken 
and the cultures were used to inoculate a new shake flask with the same medium to the same 
start cell density. This was repeated until at least 20 generations (one doubling in OD600 
equals one generation) had been grown in each media. Plasmid stability tests were performed 
as before (see Chapter 3.3.2). The results are shown in Table 3 and Table 4.  
 
Table 3: Stability of pIFNpelB in KT2440 over 20 generations (grown in LB medium at 30°C) 
Plasmid stability in 
PIA medium 
Inoculated  
to OD600 
OD600 after 
incubation 
Number of 
generations 
Plasmid 
stability
1
 
Shake flask 1  0,01 2 8 76 % 
Shake flask 2  0,01 2,1 8 81 % 
Shake flask 3  0,01 2,1 8 77 % 
Total number of generations 24   
1
Calculated as % of colonies able to grow in a selective medium after cultivation in unselective medium 
 
Table 4: Stability of pIFNpelB in KT2440 over 20 generations (grown in M9 medium at 30°C) 
Plasmid stability in 
M9 medium 
Induced to 
OD600 
OD after 
incubation 
Number of 
generations 
Plasmid 
stability
1 
Shake flask 1 0,10 1,80 5 81 % 
Shake flask 2 0,10 7,00 7 80 % 
Shake flask 3 0,10 5,90 6 81 % 
Shake flask 4 0,10 7,60 7 84 % 
Total number of generations 25  
1
Calculated as % of colonies able to grow in a selective medium after cultivation in unselective medium 
 
The plasmid stability over more than 20 generations is relatively high ranging from 76 – 81 % 
in LB medium (Table 3) and 80 – 84 % in M9 medium (Table 4).  The reason for this constant 
plasmid stability over several generations (in both media) is not known. One possible reason 
may be the strains viability when transferring colonies. Since the stability did not decrease, 
the strain was interpreted as stable, both in rich (LB) and minimal medium (M9).  
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3.4.3 Growth and production experiment of KT2440 (pGMpelB) and 
KT2440 in shake flasks  
Plasmid stability test had shown that the P. putida strain KT2440 was able to maintain the 
plasmid in rich and minimal medium for over 20 generations (Chapter 3.4.2, Table 3 and 
Table 4). This made interesting to evaluate the production of the model proteins from the 
genes inserted in the vector.  
 
At the time this experiment was planned, electro transformation of pIFNpelB to KT2440 had 
proven to be difficult to complete. It was therefore chosen to test the production of KT2440 
(pGMpelB) in the following experiment. Although the results from this experiment would not 
be directly transferable to KT2440 (pIFNpelB), it could be an indication. The purpose of the 
test was to examine the growth preferences of this strain. This would give valuable 
information about preferable conditions. KT2440 was included for comparisons.  
 
Precultures of KT2440 and KT2440 (pGMpelB) were grown in 50 ml LB (250 ml shake 
flasks with baffles, selection for KT2440 (pGMpelB)) at 30°C for 16 hours. 50 ml of five 
different media (PIA-glucose, M9 and Hi-10Ye-10X
*
 with glucose, fructose or glycerol as 
carbon source (see Chapter 2.1 and Attachment D for details)) was inoculated with 2 % (v/v) 
from precultures (Attachment F Table F- 4). After 4 hours of incubation at 30°C 200 rpm, all 
four cultures containing KT2440 (pGMpelB) were split into two bottles. 20 ml was 
transferred to a new 250 ml sterile shake flask, while the rest (approximately 30 ml) remained 
in the original bottle. The 20 ml cultures were induced with m-toluic acid to a final 
concentration of 0.5 mM. Growth and pH measurements were taken regularly throughout the 
experiment.  
3.4.3.1 Growth measurements  
 The growth (OD660) measurements of KT2440 are shown in Figure 18 and KT2440 
(pGMpelB) in Figure 19. 
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Figure 18: Growth (OD660) measurements of KT2440 cultures in different media (indicated on the right 
side of the graphs) during shake flask growth experiment at 30°C, 200 rpm. For details see Attachment F 
Table F- 5.  
 
The wild type strain of KT2440 displayed the best growth in the different versions of Hi-
10YE-10X medium (Figure 18). All three types of Hi-10YE-10X versions, gave 
approximately the same cell yield after 24 hours incubation. Compared with each other, the 
culture grown in Hi-10YE-10GLU showed higher growth rate in the initial phase of the 
experiment, indicating that glucose may be the preferred carbon source. 
 
pH measurements (Attachment F Table F- 6) showed that cultures grown in M9 and Hi-
10YE-10FRU decreased in pH eight hour after inoculation and stayed low compared with the 
three other media. PIA, Hi-10YE-10GLU and Hi-10YE-10GLY media had pH values of 
approximately 7.5 at the end of the experiment indicating that substrate had run out. Since pH 
was only measured for possible evaluation of trends in the different media, no adjustments 
were done.  
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Figure 19: Growth (OD660) measurements from KT2440 (pGMpelB) cultures in different media (indicated 
on the right side of the graphs) during shake flask growth experiment at 30°C, 200 rpm. Parallels were 
induced with m-toluic acid to a final concentration of 0.5 mM four hours after inoculation. For details see 
Attachment F Table F- 7 
 
In the growth measurement of KT2440 (pGmpelB) shown in Figure 19, the two PIA cultures 
(induced and non-induced) show no difference in growth. During most of the experiment, 
these had the lowest growth rate and were not able to reach the same cell yield after 24 hours. 
This was experienced with KT2440 as well (Figure 18) indicating that PIA not is the optimal 
medium for growth.  
 
KT2440 (pGMpelB) grown in M9 medium, induced and non-induced, grew until 11 hours 
(Figure 19) where medium seemed to be outgrown. The strain grown in Hi-10YE-10GLU 
had, compared to the non-induced strain, a high growth rate. Also here, growth stopped after 
11 hours, probably from outgrowing the medium. HiYe-cultures with the two other carbon 
sources (fructose or glycerol) showed no significance difference from each other. Based on 
these observations, Hi-10YE-10GLU seems like the best cultivation medium for optimal 
growth rate and cell yield.  
 
Both of the PIA cultures had low pH (under 5.5) (Attachment F Table F- 8) after 11 hours. 
After 24 hours the non-induced PIA culture had a relative high value (over 7). The M9 –
cultures had pH values under 7, while all of the HiYe cultures staid at approximately 7.5. 
Since the optimal pH value for maximal effect of the inducer has been shown to be 6.8 
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(Chapter 1.2.4.1.1), it is possible that the inducer did not exploited its potential in Hi-10YE-
10X cultures.  
3.4.3.2 Plasmid stability of KT2440 (pGMpelB) 
To ensure that KT2440 also was able to maintain pGMpelB, this plasmids stability was tested. 
It was expected that the stability was high based on previous results obtained with pHH100 
and pIFNpelB (Chapter 3.4.1 and 3.4.2). 
 
Induced cultures of KT2440 (pGMpelB) grown in PIA, M9 and HiYe was plated out on LA 
plates without selection and grown at 30°C overnight. 100 colonies were transferred to LA 
with selection and incubated under the same conditions. Plasmid stability was calculated as 
the % of colonies able to grow on selective LA after cultivation on LA without selection. The 
results are shown in Table 5.  
 
Table 5: Results of plasmid stability examination from KT2440 (pGMpelB) grown in PIA, M9 and Hi-
10YE-10GLU. The cultures were plated out on LA plates without selection before single colonies were 
transferred to selective LA plates.  
Strain Medium (with selection) Plasmid stability
1 
 
KT2440 (pGMpelB) 
PIA 100 % 
M9 100 % 
Hi-10YE-10GLU 100 % 
1
Calculated as % of colonies able to grow in a selective medium after cultivation in unselective medium 
 
The plasmid stability was high (Table 5), as expected from the result in Chapter 3.3.2 where 
KT2440 (pIFNpelB) were examined. The strain KT2440 was therefore regarded as able to 
stably maintain the relevant plasmids.  
 
3.4.3.3 Protein production 
1.8 ml culture samples were prepared for SDS-PAGE following the protocol “Cell lysis 
protocol 1” (Chapter 2.4.10.1). Western Blot was performed with anti-c-myc as primary 
antibody (Chapter 2.4.10.3), but no recombinant proteins could be detected (results not 
shown). Since plasmid stability is high (Table 5), there is no obvious reason why production 
is absent. The plasmid pGMpelB have been proven to function in RV308, but no recombinant 
proteins have been detected in P. putida or P. fluorescens strains.   
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3.4.4 Growth and production experiment of KT2440, KT2440 (pIFNpelB) 
and KT2440 (pGMpelB) in shake flask  
The lack of detected protein production during the shake flask experiment with KT2440 
(pGMpelB) and KT2440 in Chapter 3.4.3 was not expected. To ensure that no technical errors 
were the reason, an additional growth and production experiment was performed. This time, 
two different media were included in the experiment; HiYe-8GLY-2GLU (for details see 
Attachment D) and M9-10GLU (for details se Chapter 2.1). Glucose was selected as carbon 
source because of better growth compared to the two other (fructose and glycerol) in the 
shake flask experiment in Chapter 3.4.3. PIA medium was eliminated because of previously 
obtained low growth rate and cell yields in the same experiment (Chapter 3.4.3.1, Figure 18 
and Figure 19).  
 
Precultures of KT2440, KT2440 (pIFNpelB) and KT2440 (pGMpelB) were grown in 50 ml 
selective LB (250 ml shake flask with baffles) at 30°C overnight (16 hours). 100 ml medium 
(HiYe-8GLY-2GLU and M9-10GLU) in 500 ml shake flasks with baffles was inoculated 2 % 
(v/v) from precultures (Attachment F, Table F- 9) and incubated at 30°C and 200 rpm. 
Samples for growth (OD600) and pH measurements were taken throughout the experiment. 
Cultures were induced 8.5 hours after inoculation by adding 100 μl 500 mM m-toluic acid 
(final concentration 0.5 mM). pH was adjusted if measured above 7.00 to ensure acidic 
conditions for the inducer. All of the cultures were grown with a non-induced parallel for later 
comparison of production.  
 
3.4.4.1 Growth measurements 
The results for growth in M9-10GLU and HiYe-8GLY-2GLU are shown in Figure 20 and 
Figure 21 respectively.  
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Figure 20: Growth (OD660) measurements from KT2440 strains (indicated in the right column) grown in 
M9-10GLU medium at 30°C. Induction of the strains marked “induced” was performed 8.5 hours after 
inoculation to a final concentration of 0.5 mM m-toluic acid. For details see Attachment F Table F- 10. 
 
 
Figure 21: Growth (OD660) measurements from strains (indicated in right column) grown in HiYe-8GLY-
2GLU medium at 30°C. Induction of the strains marked “induced” was done 8.5 hours after inoculation 
to a final concentration of 0.5 mM m-toluic acid. For details see Attachment F Table F- 12 
 
In M9-10GLU, KT2440 had the highest initial growth rate (Figure 20), but gave 
approximately the same cell yield at the end of the experiment. None of the other strains stood 
out during the growth experiment.  
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pH values decreased throughout the experiments for cultures in M9-10GLU and was therefore 
not adjusted (Attachment F, Table F- 11). One adjustment for cultures in HiYe-8GLY-2GLU 
had to be made 8.5 hours after inoculation (right before induction) to ensure optimal 
conditions for the inducer (Attachment F, Table F- 13).  
3.4.4.2 Protein production  
50 ml of cultures grown for 25 hours (Chapter 3.4.4) were centrifuged at 4000 rpm for 10 
minutes (Eppendorf). 100 mg wet weight cells were transferred to 1.5 ml tubes (Eppendorf) 
by diluting them in 0.9 % NaCl. NaCl was then removed by centrifuging for 8 minutes at 
12 000 rpm. Samples were kept at – 20°C. This preparation would enable direct comparison 
of the different samples as they all contained the same amount of cells (100 mg). 100 mg cells 
were lysed using “Cell lysis protocol 1” (Chapter 2.4.10.1). Both of the Western blot 
protocols were performed (Chapter 2.4.10.2 and 2.4.10.3), but only detection with Tetra His 
as primary antibody gave results. The results are given in Figure 22 and Figure 23.  
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Figure 22: Western Blot results of soluble fractions from KT2440 strains (plasmids indicated in top row). 
The cultures were grown in 100 ml M9-10GLU (indicated with “M”) or HiYe-2GLU-8GLY (indicated 
with “H”) medium at 30°C. “Ind” marks the cultures which were induced with m-toluic acid to a final 
concentration of 0.5 mM. The concentration of the Phox protein is 4 mg/l. Numbers on the left side 
represents molecule sizes in kilo Daltons 
 
By comparing KT2440 and non-induced cultures with induced strains, the effect of induction 
can be observed. It was expected to find the IFN-α2b protein, which KT2440 (pIFNpelB) is 
designed to produce, at 23.7 kDa. In the soluble fractions at this size (Figure 22), the wild 
type strain and non-induced strains have no bands. The induced KT2440 (pIFNpelB) strain on 
the other hand, has one band estimated to be this size. This is observed in both media, and 
implies that the induction of the Pm-promoter has been successful. The bands are significant 
stronger than what is seen for non-induced cultures and for the wild type.  
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Figure 23: Western Blot results of insoluble fractions from KT2440 strains (plasmids indicated in top 
row). The cultures were grown in 100 ml M9-10GLU (indicated with “M”) or HiYe-2GLU-8GLY 
(indicated with “H”) medium at 30°C. “Ind” marks the cultures which were induced with m-toluic acid to 
a final concentration of 0.5 mM. Wells marked “WT H”, “pGMpelB H” and “pGMpelB H ind” are empty 
(transferring of samples were impossible due to high viscosity). The concentration of the Phox protein is 4 
mg/l. Numbers on the left side represents molecule sizes in kilo Daltons 
   
Only one of the wild type insoluble fractions was possible to apply to the gel. The same 
problem was experienced with insoluble fractions of KT2440 (pGMpelB) grown in HiYe-
2GLU-8GLY. The viscosity of these samples is possibly an indication that DNA has not been 
completely digested with DNaseI from “Cell lysis protocol 1” (Chapter 2.4.10.1).     
 
The insoluble fractions of induced KT2440 (pIFNpelB) grown in M9-10GLU have two bands 
at approximately 25 kDa (Figure 23). This is probably due to cleavage of pelB-polypeptide as 
explained in Chapter 1.2.4. IFN-α2b proteins with and without pelB-sequences will both be 
detected causing the formation of two bands. Comparison of the size of IFN-α2b without pelB 
(21.5 kDa) agrees with the smaller band observed. Later detection of these bands will be 
assumed to have the same possible cause. KT2440 and non-induced strain have also 
detectable band at the largest size, but these bands are weaker compared to the induced.  
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Comparison of induced KT2440 (pIFNpelB) grown in HiYe-2GLU-8GLY with non-induced 
and KT2440 (Figure 23), leads to detection of one IFN-α2b band. The size of this protein also 
agrees with the size of IFN-α2b without pelB-polypeptide. Comparison of product yield in the 
two growth media points towards M9-10GLU being the best suited for production by KT2440 
(pIFNpelB).  
 
As explained, viscous insoluble fractions of KT2440 (pGMpelB) grown in HiYe-2GLU-
8GLY caused them not possible to analyze because of high viscosity. The results from M9-
10GLU are therefore the only once discussed for this strain. GM-CSF protein detected from 
induced culture is found stronger than KT2440 and non-induced KT2440 (pGMpelB) (Figure 
23). This shows that induction has enabled expression of GM-CSF. In summary, production 
of both proteins has been successful, but the quantities are low when compared to band 
strength of the reference 4μg/ml Phox.  
 
3.4.5 HCD growth and production experiment (fed batch fermentation) of 
KT2440, KT2440 (pJB861), KT2440 (pIFNpelB) and KT2440 
(pGMpelB) 
Production of recombinant proteins from pIFNpelB and pGMpelB had been detected in low 
cell density experiments (Chapter 3.4.4.2, Figure 22 and Figure 23). For evaluation of 
KT2440s potential as expression host in high cell density cultivations, fed batch fermentations 
were performed. 
 
Fed batch fermentations of KT2440, KT2440 (pJB861), KT2440 (pIFNpelB) and KT2440 
(pGMpelB) was performed following “Production of proteins in HCDC (fermentation)”, here 
in 1-l fermentors (Chapter 2.4.9). pJB861 was used as a reference based on the fact that it is 
an expression vector without any of the genes of interest (ifn-α2b or gm-csf), a empty vector. 
KT2440 was grown in media with no antibiotics.  
 
3.4.5.1 Growth and respiration measurements  
Figure 24 shows the growth for KT2440, KT2440 (pJB861), KT2440 (pIFNpelB) and 
KT2440 (pGMpelB) after inoculation from precultures in LB medium (Attachment F, Table 
F- 14).  
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Figure 24: Growth (OD660) during fed batch fermentation of KT2440 WT, KT2440 (pJB861), KT2440 
(pIFNpelB) and KT2440 (pGMpelB) in Hf.1-medium. Cultures were induced at OD660≈ 80-90 to a final 
concentration of 1 mM m-toluic acid. For details see Attachment F, Table F- 15 
 
The growth curves for KT2440 and KT2440 (pIFNpelB) are somewhat delayed compared to 
KT2440 (pJB861) and KT2440 (pGMpelB) throughout the experiment (Figure 24). The 
highest cell densities were obtained with KT2440 and KT2440 (pIFNpelB) reaching OD660 of 
197.8 and 196.7 respectively 26.25 hours after inoculation. These are similar to what was 
obtained for RV308-strains in Sletta et al, 2007. The feature of reaching high cell yields in 
relatively short time is essential when developing a new expression platform. If the 
production system is successful this will enable higher yield of the recombinant proteins 
compared to expression platforms only able to reach low cell densities in the same time 
period. 
 
The specific growth rate (μ) and doubling time for P. putida KT2440 can be calculated using 
equation (1) in Chapter 1.2.5.  By using measurements from the phase of free growth, μ was 
calculated to be 0.53 h
-1
 and 0.58 h
-1
witch corresponds to a doubling time of 1.20 - 1.31 h 
(Attachment F Table F- 16). Under the same conditions, the growth rate and doubling time for 
E. coli has been reported in Sletta et al. 2004 to be approximately the same as found here for 
KT2440. 
 
Respiration curves from the fermentation are shown in Figure 25.  
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Figure 25: Respiration curve (mmol/L·H CO2) from fermentation of KT2440 WT, KT2440 (pJB861), 
KT2440 (pIFNpelB) and KT2440 (pGMpelB) in Hf.1-medium with selection at 30°C and pH 6.5. 
 
For KT2440 and KT2440 (pIFNpelB), the glucose added form start was utilized after 
approximately 13 hours, seen as a drop in CO2 generation (Figure 25). Feeding was started 
manually leading to the following rapid increase in respiration. For KT2440 (pJB861) and 
KT2440 (pGMpelB), the glucose metabolism was slower. Feeding was for these two started 
after 15 hours. Respiration increases evenly for all strains until the induction time.  
 
KT2440 (pIFNpelB) and KT2440 (pGMpelB) was induced 17.4 and 19.4 hours after 
inoculation respectively. For both strains, it is observed an increase in CO2 generation directly 
after induction. This indicates that KT2440 is able to consume the inducer, something that 
could be expected from the knowledge of this strains origin, toluene degrading P. putida mt-2 
(Chapter 1.2.3.2.1). To determine if this was the case, the amount of inducer consumed or 
diffused into the cells was tried quantified in HPLC analysis performed by SINTEF 
Department of Biotechnology after completed fermentation. It turned out that the setup for 
this method was not suited for detection of m-toluic acid, resulting in unsuccessful analysis 
(data not shown). It can therefore only be assumed that metabolism of the inducer the cause in 
respiration at induction.   
 
3.4.5.2 Plasmid stability 
KT2440 have been shown to have high plasmid stability during low cell density cultivations 
in shake flasks (Attachment F Table F- 3, Chapter 3.4.2 Table 3 and Table 4 and Chapter 
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3.4.3.2 Table 5). To validate that this ability is intact through high cell densities, plasmid 
stability was evaluated from samples taken late in the fed batch fermentation (after induction).  
 
0.16 ml sterile glycerol (Sigma) was added to 0.8 ml culture samples before keeping the 
mixture at – 80°C. The mixture was plated out on LA without selection and incubated 
overnight (30°C) before transferring 100 colonies to LA with selection. After incubating 
overnight at the same temperature, plasmid stability was calculated. The result is shown in 
Table 6.  
 
Table 6: Plasmid stability evaluation of KT2440 (pJB861), KT2440 (pIFNpelB) and KT2440 (pGMpelB) 
during HCD fed batch fermentation.   
Strain 
Number of  
colonies picked 
Plasmid  
Stability
1 
KT2440 (pJB861) 100 92 % 
KT2440 (pIFNpelB) 100 100 % 
KT2440 (pGMpelB) 100 100 % 
1
Calculated as % of colonies able to grow in a selective medium after cultivation in unselective medium 
 
Plasmid stability results (Table 6) indicate that KT2440 is able to carry plasmids also during 
HCDC.  
3.4.5.3 Protein production 
Samples were harvested for SDS-PAGE at induction and the following two, four, six and 
eight hours. The samples were named P0, P1, P2, P3 and P4 respectively and prepared 
following “Detection and quantification of recombinant protein” (Chapter 2.4.10). Also 
samples from induced KT2440 (pIFNpelB) and KT2440 (pGMpelB) grown in M9-10GLU 
and HiYe-2GLU-8GLY from shake flask growth experiment in Chapter 3.4.4, were prepared 
for comparison.  
 
The pellet fraction was prepared by the procedure “Cell lysis protocol 2” because of viscous 
insoluble fractions when using protocol 1 (Chapter 3.4.4.2). Both soluble and insoluble 
fractions were analyzed for protein content by both of the Western Blot protocols (Chapter 
2.4.10.3). As before, the expected band is 23.7 or 21.5 kDa for IFNα2b (with and without 
pelB polypeptide) and 19.7 kDa for GM-CSF.  
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Western Blot with Anti-myc as primary antibody 
Figure 26 shows Western blot results from soluble fraction samples using procedure with anti-
c-myc as primary antibody. No bands were detected at the expected sizes, but all of the 
samples had a band at approximately 50 kDa. Since this band also is detected in the reference 
cultures KT2440 and KT2440 (pJB861), this is probably a protein produced by the KT2440 
strain in general. Later detected proteins with these sizes will not be discussed.  
 
 
 
Figure 26: Western Blot results for soluble fractions from 1-l fed batch fermentation of KT2440 strains 
(second top row) in Hf.1 medium. Samples from induced HiYe-2GLU-8GLY (“HiYe”) and M9-10GLU 
(“M9”) cultures from the shake flask experiment in Chapter 3.4.4 were also included. P0-P4 samples from 
the fed batch fermentation were taken 0, 2, 4, 6 and 8 hours after induction respectively. The numbers on 
the left side represents molecule sizes in kilo Daltons 
 
 
Figure 27 shows soluble fractions from KT2440 (pGMpelB) strain and insoluble fractions 
from reference and pIFNpelB strains.  
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Figure 27: Western Blot results of soluble and insoluble fractions from 1-l fed batch fermentation of 
KT2440 strains (second top row) in Hf.1 medium. Samples from induced HiYe-2GLU-8GLY (“HiYe”) 
and M9-10GLU (“M9”) cultures from the shake flask experiment in Chapter 3.4.4 were also included. P0-
P4 samples from the fed batch fermentation were taken 0, 2, 4, 6 and 8 hours after induction respectively. 
The numbers on the left side represents molecule sizes in kilo Daltons 
 
Recombinant GM-CSF protein is detected at the expected size (19.7 kDa) from KT2440 
(pGMpelB) culture (Figure 27). The sample P1 (taken two hours after induction) has the 
strongest detected amount of the recombinant protein GM-CSF. Since all fermentation 
samples used for SDS-PAGE preparation had the same initial volume (1 ml), P0 to P4 has an 
increasing amount of cells. If the quantity of produced protein is proportional to the amount of 
cells, P2 and P3 are expected to give bands stronger than P1s band. This is not observed. A 
possible explanation for the decrease in detectable GM-CSF-protein in these samples is 
instability of protein or leakage into the culture medium. Leakage of protein can be tested by 
running Western Blot analysis on the supernatant from the culture (Chapter 2.4.10.1). This 
was performed later in the study (Chapter 3.4.6.2) but gave no detection of recombinant 
proteins (results not shown). Instability of GM-CSF is therefore thought to be the reason. 
 
Figure 27 show no detected proteins from KT2440 (pIFNpelB) fermentation samples (P0-P2) 
at the expected size (23.7 kDa). The samples from shake flask experiment reported in Chapter 
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3.4.4, on the other hand, have detected protein at different sizes. During the first detection of 
recombinant protein in these samples (Chapter 3.4.4.2), anti-c-myc protocols (Chapter 
2.4.10.3) gave no results (not shown). This may indicate that “Cell lysis protocol 2” enable 
better protein detection than “Cell lysis protocol 1” (Chapter 2.4.10.1) since the same samples 
were used in both protocols.  
 
Figure 28 shows recombinant protein detected in insoluble fractions from KT2440 
(pIFNpelB) (P0-P2 were shown in Figure 27) and KT2440 (pGMpelB).  
 
 
Figure 28: Western Blot results of insoluble fractions from 1-l fed batch fermentation KT2440 strains 
(second top row) in Hf.1 medium. Samples from induced HiYe-2GLU-8GLY (“HiYe”) and M9-10GLU 
(“M9”) cultures from the shake flask experiment in Chapter 3.4.4 were also included. P0-P4 samples from 
the fed batch fermentation were taken 0, 2, 4, 6 and 8 hours after induction respectively. The numbers on 
the left side represents molecule sizes in kilo Daltons 
 
KT2440 (pIFNpelB) sample P3 and P4 have no detected protein with expected size (24.7 
kDa) (Figure 28). Nor have KT2440 (pGMpelB) samples from experiment described in 
Chapter 3.4.4 at GM-CSF size (19.7 kDa). Fermentation samples of KT2440 (pGMpelB), on 
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the other hand, have weak but visible bands. Form this culture, the sample taken 2 hours after 
induction (P1) has the highest concentration of GM-CSF.  
 
Even though it desirable to only compare samples on the same membrane, one cannot avoid 
notice the difference in band strength between soluble (Figure 27) and insoluble fractions 
(Figure 28) from KT2440 (pGMpelB) fermentation samples. As the SDS-PAGE preparation 
procedure describes (Chapter 2.4.10.1), the insoluble fraction added to the gel is twice as 
concentrated as the soluble fraction. This shows that KT2440 has a larger quantity of the 
produced GM-CSF as soluble fraction under the conditions tested.  
 
Western Blot with Tetra His as primary antibody 
It was chosen to analyse KT2440 (pIFNpelB) samples from this fed batch fermentations using 
Tetra His antibody even though anti-c-myc had already been used (previous section). The 
reason for this was that Tetra His antibody previously had been shown to detect recombinant 
protein in samples where anti-c-myc did not (Chapter 3.4.4.2). For comparison of detection 
methods (anti-c-myc versus Tetra-His), three KT2440 (pGMpelB) samples from this fed 
batch fermentation were also tested.  A sample containing Phox protein with a known 
concentration of 5 mg/l was applied to have the opportunity to estimate the quantity of 
produced protein. This will also function as an internal standard when comparing membranes. 
The results from detection with Tetra-His are shown in Figure 29.  
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Figure 29: Western Blot results of soluble fractions from 1-l fed batch fermentation of KT2440 strains 
(second top row) in Hf.1 medium. Samples from induced HiYe-2GLU-8GLY (“HiYe”) cultures from the 
shake flask experiment in Chapter 3.4.4 were also included. P0-P4 samples were taken 0, 2, 4, 6 and 8 
hours after induction respectively. Arrows indicated the recombinant proteins detected by Tetra His 
antibody, and the numbers on the left side represents molecule sizes in kilo Daltons 
 
Figure 29 shows that the soluble fractions from KT2440 (pIFNpelB) has two bands at IFN-
α2b’s size (21.5- 23.7 kDa). The sample taken at induction (P0) has, compared to the samples 
taken later, the weakest band. This shows that the induction has effected IFN-α2b production. 
As for GM-CSF detected in Figure 27, there is a reduced quantity of IFN-α2b later than four 
hours after induction, indicating protein instability.   
 
As explained, only three of the KT2440 (pGMpelB) samples from the shake flask experiment 
in Chapter 3.4.4 were part of this run. GM-CSF-production had already been detected from 
these samples (Figure 27 and Figure 28) and was also detected here (Figure 29). Comparing 
band strengths from this cultures soluble fractions using anti-c-myc (Figure 27) versus Tetra-
His detection (Figure 29) shows big difference, where Tetra-His clearly gives stronger bands. 
Still, Tetra-His also gives more background noise (more unspecific bands), and detection with 
anti-c-myc is therefore preferred in this study.  
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Comparison between the strength of GM-CSF bands and the strength of Phox (5 mg/l) band 
(Figure 29) enables estimation of the concentration. The soluble fraction of GM-CSF in the 
sample taken 2 hours after induction seems to have approximately the strength as the Phox 
reference. Since 1 ml sample was used to prepare 1 ml soluble fraction (see Protocol in 
Chapter 2.4.10), the concentration of soluble GM-CSF in the culture is estimated to be 5 mg/l. 
To estimate this further, both reference and samples need to be diluted, but since the amount 
detected by Sletta et al. 2007 in E. coli was higher (0.39 ±0.03 g/l), this was not performed.  
 
Figure 30 shows insoluble fractions of the same samples shown in Figure 29.  
 
Figure 30: Western Blot results of soluble fractions from 1-l fed batch fermentation KT2440 strains 
(second top row) in Hf.1 medium. Samples from induced HiYe-2GLU-8GLY (“HiYe”) cultures from the 
shake flask experiment in Chapter 3.4.4 were also included. P0-P4 samples were taken 0, 2, 4, 6 and 8 
hours after induction respectively. The numbers on the left side represents molecule sizes in kilo Daltons 
 
The signals from the Western blot were a bit smeared and thus difficult to discuss. Still, there 
seemed to the same relationships as for soluble fractions.  
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3.4.6 HCD growth and production experiment (fed batch fermentation) of 
KT2440 (pGMpelB) with different inducers  
The induction effect obtained with m-toluic acid was probably reduced based on the signs that 
KT2440 has the ability to consume it. By using different inducers of the Pm/XylS system, 
which the strain is reported to not consume, protein production may be increased. The two 
inducers o-toluic acid and 2-chlorobenzoic acid are chosen to be tested as alternatives to m-
toluic acid (Chapter 1.2.4.1.1). Because of more successful production of recombinant 
proteins from KT2440 (pGMpelB) than KT2440 (pIFNpelB), it was chosen to only examine 
the effect of the different inducers on KT2440 (pGMpelB). If a positive effect is discovered, 
one can expect the same effect on the IFNα2b-strain, and then perform the same test to reveal 
this.  
 
Fed batch fermentations of KT2440 (pGMpelB) was executed as before (Chapter 3.4.5). Four 
cultures of KT2440 (pGMpelB) were run in total, one induced continually with m-toluic acid 
by adding this to the feeding solution. The three remaining strains were induced once with m-
toluic acid, o-toluic acid or 2-cholorbenzoic acid to a final concentration of 1 mM. The 
fermentation culture induced with m-toluic acid once will be a repetition of KT2440 
(pGMpelB) from the fed batch fermentation in Chapter 3.4.5 and therefore function as a 
reference to the previous fermentation result.   
 
Induction was performed following the protocol (Chapter 2.4.9.2). Continuous induction was 
enabled by inducing following the protocol before switch to a 150 ml feeding solution 
(Attachment E) with m-toluic acid to give a final concentration of 2 mM in the fermentation 
culture. Samples for Western blot analysis were taken at the time of induction and after two, 
four and five hours (P0, P1, P2 and P3).  
3.4.6.1 Growth and respiration measurements  
Growth measurements are shown in Figure 31.  
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Figure 31: Growth (OD600) measurements from 1-l fed batch fermentation of KT2440 (pGMpelB) in Hf.1-
medium. Cultures were induced at OD600≈ 80-90. The names to the right indicate which inducer the 
corresponding graphs had. For details see Attachment F, Table F- 17 
 
In Figure 31, KT2440 (pGMpelB) continuously feed with the inducer shows deviation from 
the remaining strains with a lower growth rate. Since all cultures consisted of KT2440 
(pGMpelB) it was expected to experience similar growth in all cultures. The difference in 
growth from this strain might therefore be a result of the continuous feeding of inducer.  
 
 
Figure 32: Respiration curve (mmol/L·H CO2) from fermentation of KT2440 (pGMpelB) in Hf.1-medium 
with selection at 30°C and pH 6.5. The names to the right indicate which inducer the corresponding 
graphs had.  
 
KT2440 (pGMpelB) continuously induced has after the feeding start (15.8 hours after 
inoculation) a lower respiration curve compared to the others (Figure 32).  Since respiration 
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depends on the amount of cells and their consummation of nutrients, the lower cell densities 
of this strain (Figure 31, 16 – 28 hours after inoculation) may be the explanation.   
 
The remaining cultures of KT2440 (pGMpelB) were induced at the same time (20 hours after 
inoculation) but with different inducers. For all induced strains there is an observed by an 
increased CO2 generation. Since the alternative inducers were not thought to be metabolized 
by KT2440, it was not expected to see this increase. The result might indicate that KT2440 is 
able to metabolise both o-toluic acid and 2-chloro-benzoic acid.  
 
3.4.6.2 Protein production 
1 ml culture samples were harvested at induction and the following two, four and six hours. 
The samples were named P0, P1, P2 and P3 respectively and prepared following “Detection 
and quantification of recombinant protein” (Chapter 2.4.10). The pellet fraction was prepared 
by the procedure “Cell lysis protocol 2”. Supernatant from the cultures (see Chapter 2.4.10.1), 
soluble and insoluble fractions were analyzed by Western Blot protocols with anti-c-myc as 
primary antibody (Chapter 2.4.10.3). 
 
The results for recombinant protein production of the two culture of KT2440 (pGMpelB) 
induced with m-toluic acid are shown in Figure 33. As before, the expected band for GM-CSF 
is 19.7 kDa. 
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Figure 33: Western Blot results from insoluble fractions from 1-l fed fermentation of KT2440 (pGMpelB) 
in Hf.1 medium. Samples marked “Cont” were induced continuous while “m-tol” were induced once with 
m-toluic acid. P0-P3 samples were taken 0, 2, 4 and 6 hours after induction respectively. Arrows indicated 
the recombinant proteins detected by anti-c-myc antibody, and the numbers on the left side represents 
molecule sizes in kilo Daltons 
 
No proteins were detected in the supernatant samples (result not shown) indicating that 
protein does not leak out into the cultivation medium. 
 
KT2440 (pGMpelB) induced with o-toluic acid or 2-chloro benzoic acid had no detectable 
recombinant proteins in neither soluble nor insoluble fractions (results not shown). In the 
insoluble fractions of KT2440 (pGMpelB) induced with m-toluic acid (continuously or once) 
(Figure 33), recombinant GM-CSF protein is detected, but in small quantities compared to the 
5 mg/l standard Phox.  
 
KT2440 (pGMpelB) induced with m-toluic acid once is a repetition of the fed batch 
fermentation of KT2440 (pGMpelB) described in Chapter 3.4.5. Comparison of detected 
recombinant protein from these runs (insoluble fractions in Figure 28 and Figure 33) show 
approximately the same amounts of GM-CSF.  
 
Results and discussion 
 
88 
 
There was not detected production of GM-CSF when using o-toluic acid or 2-choloro benzoic 
acid. This indicates that these alternative inducers did not function as desired. Based on their 
induction ratio (m-toluic acid; 18, o-toluic acid; 17 and 2-chloro benzoic acid; 14) (Ramos et 
al., 1990), a slightly lower induction effect was expected. Still, the observed increase in CO2 
generation at induction may indicate that also these inducers were consumed. o-Toluic acid 
and 2-chloro benzoic acid was therefore not be further evaluated as alternatives to m-toluic 
acid in this study. 
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3.5 Construction of copy number mutant plasmids pIFN271pelB 
and pGM271pelB 
It had been shown that KT2440 (pIFNpelB) and KT2440 (pGMpelB) produced the wanted 
model proteins (Figure 23 and Figure 33). The amount of production was low. It was 
therefore tried to increase the production by different strategies (For complete strategy see 
Chapter 1.4). The first approach was increasing the copy number of the plasmids. The gene 
trfA of the plasmids was exchanged with trfAcop271C from pAT64, which also was the 
source of ifnα2b gene. As mentioned in Chapter 1.2.4, it has been shown that this increases 
the copy number from approximately 4-6 to 17-19 (3.5 fold increase) in E. coli. 
 
The plasmid pIFNpelB, pGMpelB and pAT64 were first transferred to competent ER2925 
cells (Chapter 2.4.8.1). ER2925 cells were chosen due to the later use of Dcm methylation-
sensitive enzyme (SexAI). After growing the cells in 3 ml selective LB overnight and isolating 
plasmids following the protocols (Chapter 2.4.3), they were digested with SexAI and AhdI 
(Chapter 2.4.4). DNA fragments were separated by gel electrophoresis (Chapter 2.4.5). It was 
expected that all plasmids should yield a 2.4 kb fragment (trfA and trfAcop271C gene) and 
that the larger fragments of pIFNpelB, pGMpelB and pAT64 should be 7.1, 7.0 and 6.5 kb 
respectively. The results from gel electrophoresis are shown in Figure 34 and Figure 35.  
 
 
Figure 34: Restriction digestion of the isolated plasmids pIFNpelB and pAT64 with SexAI and SexAI + 
AhdI. Blank column indicated undigested plasmids. The trfAcop271C fragment (2.4 kb) from pAT64 were 
to be exchanged with trfA fragment (2.4 kb) from pIFNpelB 
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Figure 35: Restriction digestion of the isolated plasmids pGMpelB and pAT64 with SexAI + AhdI. The 
trfAcop271C fragment (2.4 kb) from pAT64 were to be exchanged with trfA fragment (2.4 kb) from 
pGMpelB 
 
Marked DNA fragments (Figure 34 and Figure 35) had the expected sizes and were extracted 
using QIAEXII Agarose Gel Extraction Protocol (Chapter 2.4.6). The 2.4 kb fragments from 
pAT64 were assumed to be trfAcop271C and were therefore ligated with 7.1 kb fragment 
from pIFNpelB (Figure 34) and 7.0 kb fragment from pGMpelB (Figure 35) as following 
protocols described earlier. Ligation mixtures were transformed to competent DH5α cells 
(Chapter 2.4.8.1).  
 
To control that trfA had been exchanged with trfAcop271C, plasmids were isolated from the 
DH5α-transformants and sequenced by Eurofins MWG Operon. Sequence results were 
compared to trfA-sequence and conclusion was that trfA in pIFNpelB and pGMpelB had been 
replaced by trfAcop271C yielding pIFN271pelB and pGM271pelB (Attachment G).  
 
3.5.1 Transferring copy number mutant plasmids to KT2440 
pIFN271pelB and pGM271pelB were transferred to KT2440 through electro transformation 
(Chapter 2.4.8.2). Colonies were transferred to 3ml selective LB and grown overnight. 
Plasmids were isolated as before (Chapter 3.1) and digested with NotI and NdeI (Chapter 
2.4.4) to control that the up grown strains harboured the correct plasmid. pIFN271pelB and 
pGM271pelB were expected to give a large DNA fragment of 8.9 kb and a smaller of 5.7 and 
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4.5 kb respectively. DNA fragments in the digestions were separated by gel electrophoresis 
(Chapter 2.4.5). The results are shown in Figure 36.  
 
Figure 36: Restriction digestion of pIFN271pelB and pGM271pelB with NotI and NdeI to control 
successful electro transformation of plasmids to KT2440. Expected bands from pIFN271pelB (8894 bp + 
566 bp) and pGM271pelB (8894 bp + 452 bp) were observed.  
 
Figure 36 shows the expected sizes from digested pIFN271pelB and pGM271pelB. Electro 
transformation of the plasmids to KT2440 was therefore concluded to be successful.  
3.5.2 Control of plasmid copy number in KT2440  
To test if the exchange of trfA with trfAcop271C had the same effect for P. putida KT2440 as 
for E coli (Chapter 1.2.4), 3 ml selective overnight LB cultures (30°C, 200 rpm) of KT2440 
(pIFNpelB) and KT2440 (pIFN271pelB) were diluted with sterile H2O to the same OD600 
value. Plasmids were then isolated as before (Chapter 2.4.3). The culture dilution ensured that 
plasmids were isolated from the same amount of cells. Restriction digestions with NotI were 
made following the protocol (Chapter 2.4.4), but with plasmid preparation volumes ranging 
from 1 – 8 μl. NotI was expected to cut the plasmids once and since pIFNpelB and 
pIFN271pelB both have the same size (9460 bp), easy comparison of the band strength 
(equals the number of plasmids) could be done on the gel. Digested plasmids were separated 
by gel electrophoresis (Chapter 2.4.5).  
The results are shown in Figure 37.  
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Figure 37: Different versions of replication protein gene, trfA and cop271 (trfacop271C), cut with NotI. 
The volume indicates the added plasmid to the digestion mixture.   
 
Figure 37 shows that the same amount of KT2440 cells have given different concentration of 
plasmids. This can be observed by comparing the strength of bands form digestion mixtures 
with the same volume. For example, of the 1 μl digestion mixtures of pIFNpelB and 
pIFN271pelB (two left columns), pIFN271pelB (marked cop271 in Figure 36) band is 
stronger than the band from pIFNpelB (marked trfA). By comparing bands, 2 μl of cop271 
(lane 4) seems to have approximately the same strength as 6 – 8 μl trfA (lane 7 and 9). This 
indicates a 3-4 fold increase which is comparable to what was observed in E. coli (3.5-fold) 
(Durland et al., 1990). It is therefore expected that the plasmid copy number in KT2440 has 
increased from 2-3 to approximately 7 – 11.   
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3.6 Construction of codon optimized plasmids pIFNs271pelB, 
pIFNs271pelBs and pGMs271pelBs 
The second strategy for increasing the production of recombinant proteins was codon 
optimization of gene targets and signal sequence with regard to P. putida KT2440 (Chapter 
1.4). This was performed by Eurofins MWG Operon which synthetically produced these new 
versions of the genes including the pelB sequence. Gene sequence results are shown in 
Attachment G. The received DNA material (pCR2.1-IFNspelBs and pCR2.1-GMspelBs) was 
spun down before dissolving in 10 μl TE-buffer. 1 μl of this dissolved gene material was 
transformed to competent E. coli DH5α cells (Chapter 2.4.8.1) and plated out (10x diluted, 
undiluted, and pellet) on selective LA plates. After incubating at 37°C overnight, one colony 
from each transformants (DH5α (pCR2.1-IFNspelBs) and DH5α (pCR2.1-GMspelBs)) was 
transferred to 3 ml selective LB and grown overnight (37°C). The plasmids were isolated 
following the protocol in Chapter 2.4.3.  
 
To replace the recombinant genes with the codon optimized versions, two different digestions 
mixtures were made of pIFN271pelB, pCR2.1-IFNspelBs and pCR2.1-GMspelBs. Digestion 
with NcoI + NotI will cut upstream the pelB sequence while NdeI + NotI will cut downstream. 
This would, from all plasmids, yield recombinant gene fragments with and without pelB-
sequence. The different sizes of these fragments are; ifn-α2b: 504 bp, ifn-α2b+pelB: 566 bp, 
gm-csf: 390 bp and gm-csf+pelB: 452 bp. Codon optimized fragments will have the same 
sizes.  
 
Since the gene will be replaced, digestion of pIFN271pelB, and not pGM271pelB, were made. 
The fragments were separated by gel electrophoresis (Chapter 2.4.5 and 2.4.5.2). The results 
from digestion with NcoI and NotI are shown in Figure 38 and digestion with NdeI and NotI 
in  
Figure 39.  
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Figure 38: Restriction digestion of pIFN271pelB, pCR2.1-IFNspelBs and pCR2.1-GMspelBs (two parallels 
of each) with NcoI and NotI.  
 
 
Figure 39: Restriction digestion of pIFN271pelB, pCR2.1-IFNspelBs and pCR2.1-GMspelBs (two parallels 
of each) with NdeI and NotI.  
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The marked DNA fragments in Figure 38 and Figure 39 were isolated by QIAEX II Agarose 
Gel Extraction Protocols (Chapter2.4.6). DNA fragments cut with the same enzymes were 
ligated following the protocols in Chapter 2.4.7 and transferred to DH5α cells (Chapter 
2.4.8.1).  
 
To control the transformants DH5α (pIFNs271pelB), DH5α (pGMs271pelB), DH5α 
(pIFNs271pelBs) and DH5α (pGMs271pelBs), it was chosen to sequence the genes by the use 
of Eurofins MWG GmbH. The results are shown in Attachment G. The sequences were 
compared with sequence information of codon adapted genes from the same company in 
Clone Manager Professional Suite (Sci Ed Central). This revealed that pIFN271pelBs, 
pIFNs271pelB and pGMs271pelBs were successfully constructed, but that pGM271pelBs had 
an additional restriction site for NcoI inside the codon optimized GM-CSF gene. This led to 
an additional DNA fragment when pCR2.1GMspelBs was digested with NcoI and NotI. It 
caused loss of fragments of the gene when DNA fragments were separated by gel 
electrophoresis. It was tried to get a new version of codon adapted gm-csfs+pelBs without this 
restriction site, but trouble from the company’s side led to too short amount of time left to be 
able to construct pGMs271pelB.  
 
3.6.1 Transferring pIFNs271pelB, pIFNs271pelBs and pGMs271pelBs 
with codon optimized genes to KT2440 
The plasmids (pIFNs271pelB, pIFNs271pelBs, and pGMs271pelBs) were transformed into 
KT2440 cells by electro transformation (Chapter 2.4.8.2). The only exception from this 
protocol was that 6 μl DNA was used instead of 2. Single colonies were picked and plated on 
separate selective LA plates before incubating overnight (30°C). 10 ml selective LB was then 
inoculated with one colony, incubated overnight (30°C, 200 rpm) before making glycerol cell 
stocks (Chapter 2.4.1).   
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3.7 Evaluation of P. putida KT2440 as expression platform for 
plasmids with increased copy number and codon optimized 
genes and signal sequence 
P. putida KT2440 had been proven to have high plasmid stability in both shake flask 
cultivations (Attachment F Table F- 3, Chapter 3.4.2 Table 3 and Table 4 and Chapter 3.4.3.2 
Table 5) and in HCDC cultivations (Chapter 3.4.5.2 Table 6). Production of both recombinant 
proteins (IFN-α2b and GM-CSF) had been detected in shake flask experiment (Chapter 3.4.4, 
Figure 22) and GM-CSF production in HCD fed batch cultivation (Chapter 3.4.5, Figure 29). 
New expression vectors with copy up mutations and codon optimized genes with and without 
codon optimized signal sequences had been constructed  and transferred to KT2440 (Chapter 
3.6). It was now desirable to evaluate the production of recombinant protein in shake flasks 
and possibly fed batch fermentation. Table 7 shows the strains that were used to evaluate P. 
putida KT2440 as expression platform for plasmids with increased copy number and codon 
optimized genes.  
 
Table 7: Plasmids used for evaluation of P. putida KT2440 as expression platform for copy number 
mutants and codon optimized genes 
Strain Plasmid name Gene Signal sequence Replication 
protein 
KT2440 pIFNpelB ifn-α2b pelB TrfA 
KT2440 pGMpelB gm-csf pelB TrfA 
KT2440 pIFN271pelB ifn-α2b pelB TrfAcop271C 
KT2440 pGM271pelB ifn-α2b pelB TrfAcop271C 
KT2440 pIFNs271pelB Codon optimized 
ifn-α2b 
pelB TrfAcop271C 
KT2440 pIFNs271pelBs Codon optimized 
ifn-α2b 
Codon optimized 
pelB 
TrfAcop271C 
KT2440 pGMs271pelBs Codon optimized 
gm-csf 
Codon optimized 
pelB 
TrfAcop271C 
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3.7.1 Growth and production experiment in shake flasks 
Glycerol cell stocks of the strains shown in Table 7 were plated out on selective LA plates and 
grown overnight at 30°C. Single colonies were used to inoculate 50 ml selective LB in 250 ml 
shake flasks with baffles. The precultures were placed in incubators for only 10 hours (in 
contrast to the usually 16 hours in Chapter 3.4.3 and 3.4.4) to prevent experienced outgrowing 
of LB medium during overnight incubations in a prestudy (results not shown).  
 
100 ml of HiYe-8GLY-2GLU with selection was inoculated to 4 % (v/v) from precultures 
(Attachment F,Table F- 18). The reason for this high inoculation volume was the result from a 
prestudy where a long lag period was experienced (data not shown). Two parallels of each 
strain were grown to enable comparison of induced and non-induced strain. 
 
The growth and pH were followed throughout the experiment. Cultures were induced at 
OD600 ≈3-5 to a final concentration of 0.5 mM m-toluic acid. pH was adjusted if measured 
above 7.00. All of the cultures were grown with a parallel which was not induced for later 
comparison of production.  
3.7.1.1 Growth measurements 
Figure 40 and Figure 41 shows the growth curves for induced and non-induced cultures. The 
figures are separated into strains that produce IFN-α2b and GM-CSF proteins respectively.  
 
 
Figure 40: Growth (OD600) measurements from shake flask growth and production experiment with 
KT2440 containing different plasmids with ifn-α2b gene (indicated in the column to the right). The 
cultures were grown in selective HiYe-2GLU-8GLY medium at 30°C and induced with m-toluic acid when 
reaching OD600≈ 3 – 5. For details see Attachment F, Table F- 19 
 
Results and discussion 
 
98 
 
Figure 40 shows the growth after inoculation of KT2440 containing different plasmids with 
ifn-α2b gene. Induced KT2440 (pIFN271pelB) did not reach as high cell yield as the 
remaining strains after overnight incubation. This could indicate that the strain had problem 
maintaining the plasmid. Still, this effect is not observed in all strains harbouring plasmids 
with trfAcop271C. 
 
 
Figure 41: Growth (OD600) measurements from shake flask growth and production experiment with 
KT2440 containing different plasmids with GM-CSF gene (indicated in the column to the right). The 
cultures were grown in selective HiYe-2GLU-8GLY medium at 30°C and induced with m-toluic acid when 
reaching OD600≈ 3 – 5. For details see Attachment F, Table F- 19 
 
Figure 41 shows the growth after induction of KT2440 containing different plasmids with gm-
csf gene. KT2440 (pGMpelB) and KT2440 (pGMs271pelBs) were induced at OD600 ≈ 3-5, 
while KT2440 (pGM271pelB) at OD600≈ 1 because of slow growth rate. KT2440 (pGMpelB) 
yielded the same high cell yield after overnight incubation as the majority of the strains 
(Figure 40 and Figure 41), while KT2440 (pGM271pelB) and KT2440 (pGMs271pelBs) did 
not. Cultivations of these strains had reached a much lower cell yield after complete 
experiment. As for KT2440 (pIFN271pelB) (Figure 40) this might indicate plasmid 
instability.  
 
The genetic modifications of expression vectors (increasing copy number and codon 
optimization) seemed, for some strains, to have effect on the length of lag phase. This can be 
observed by comparing the growth in precultures (Attachment F Table F- 20) of this 
experiment, but it is important to emphasize that the amount cells varies when inoculating 
from agar plates. KT2440 (pIFNpelB) and KT2440 (pGMpelB) reached OD600 values of 
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approximately 7 in ten hours (which means that they are on the edge on outgrowing the 
medium). KT2440 (pIFN271pelB), (pGM271pelB) and (pGMs271pelBs) in the same time 
interval had an OD600 value of 0.5 – 1. If the copy number increase or optimization had been 
the direct effect for this low initial growth rate, KT2440 (pIFNs271pelB) and KT2440 
(pIFNs271pelBs) should also have long lag phases, but this was not the case. They reached 
OD600 7.0 and 8.3 respectively proving that the high copy number not necessarily affected the 
growth rate. One reason that might cause this long lag phase was the cells viability on agar 
plates. It was experienced that the cultures plated out and incubated the day before inoculation 
of precultures, had shorter lag phases (data not shown).  
3.7.1.2 Protein production  
5 ml samples were taken at induction and after 2 and 5 hours. The samples were that were 
centrifuged at 4000 rpm for 10 minutes before separating the supernatant and pellet in 
different tubes and frozen at - 20°C until analysis. The pellets were prepared for SDS-PAGE 
following “Cell lysis protocol 2” (Chapter 2.4.10.1). A sample with known concentration of 
Phox protein was used as an internal standard. This would enable comparison of membranes 
and quantification possibilities. Proteins were detected by Western Blot protocols using anti-
c-myc as primary antibody (Chapter2.4.10.3).  
 
Wild type copy number strains KT2440 (pIFNpelB) and KT2440 (pGMpelB) 
KT2440 harbouring pIFNpelB or pGMpelB had previously been proven to produce the 
recombinant model proteins, but in low quantities (Chapter 3.4.5.3, Figure 29). Their 
production in this experiment was therefore used for evaluation of the effects of increasing the 
copy number and codon optimizing target genes and signal sequences. The detected 
recombinant proteins from KT2440 (pIFNpelB) and KT2440 (pGMpelB) are shown in Figure 
42 and Figure 43 respectively.  
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Figure 42: Western Blot results from insoluble and soluble fractions from growth and production 
experiment in shake flasks. The strains were grown in HiYe-8GLY-2GLU medium at 30°C. The image is 
the result for KT2440 (pIFNpelB). Induction to a final concentration of 0.5 mM m-toluic acid was 
performed at OD600 ≈ 3-5. P0-P2 samples were taken after 0, 2, 5 hours after induction respectively. P3 
was taken after overnight incubation. “ind” marks samples from induced cultures. The arrow indicates 
IFN-α2b protein detected by anti-c-myc antibody, and the numbers on the left side represents molecule 
sizes in kilo Daltons. Phox has a concentration of 1 mg/l.  
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Figure 43: Western Blot results from insoluble and soluble fractions from growth and production 
experiment in shake flasks. The strains were grown in HiYe-8GLY-2GLU medium at 30°C. The image is 
the result for KT2440 (pGMpelB). Induction to a final concentration of 0.5 mM m-toluic acid was 
performed at OD600 ≈ 3-5. P0-P2 samples were taken after 0, 2, 5 hours after induction respectively. P3 
was taken after overnight incubation. “ind” marks samples from induced cultures. The arrow indicates 
GM-CSF protein detected by anti-c-myc antibody, and the numbers on the left side represents molecule 
sizes in kilo Daltons. Phox has a concentration of 1 mg/l. 
 
The highest IFN-α2b yield is measured in the insoluble fraction from sample taken 5 hours 
after induction (Figure 42, “P2 ind”). Compared to the Phox reference with known 
concentration (1 mg/l), this is much weaker. Overnight incubation has less detectable protein 
indicating that the protein may be unstable or leaks into the culture medium. This last 
hypothesis was tested in Chapter 3.4.6.2. Since the result here was no detectable protein in 
culture medium, it is assumed that this is not the case here either.  
 
In Figure 43, where the recombinant protein from KT2440 (pGMpelB) is detected, the highest 
yield of GM-CSF is measured in the sample taken 5 hours after induction (“P2 ind”, insoluble 
and soluble fractions). As for IFN-α2b produced by KT2440 (pIFNpelB), the protein 
concentration is evaluated to be much lower than 1 mg/l when compared to the Phox 
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reference. There is less detectable GM-CSF after overnight incubation of the culture. During 
previous fed batch fermentation, GM-CSF concentrations started to decrease two hours after 
induction (Chapter 3.4.5.3, Figure 27). It was therefore expected to see the same decline in 
GM-CSF after overnight incubation in shake flasks. As for KT2440 (pIFNpelB), the reason is 
probably protein instability.   
 
Copy number mutants KT2440 (pIFN271pelB) and KT2440 (pGM271pelB) 
KT2440 (pIFN271pelB) and KT2440 (pGM271pelB) harboured plasmids with a mutation in 
the gene trfA shown to yield 3.5-fold increase in copy number in E. coli (Chapter 1.2.4). In 
Chapter 3.5.2 it was proven that this mutation had the same effect on P. putida strain KT2440. 
Cultivation of KT2440 (pIFN271pelB) and KT2440 (pGM271pelB) would therefore reveal if 
increased plasmid number would have effect on the production of recombinant proteins. The 
results from protein detection of IFN-α2b and GM-CSF are shown in Figure 44 and Figure 45.  
 
Figure 44: Western Blot results from insoluble and soluble fractions from growth and production 
experiment in shake flasks. The strains were grown in HiYe-8GLY-2GLU medium at 30°C. The image is 
the result for KT2440 (pIFN271pelB). Induction to a final concentration of 0.5 mM m-toluic acid was 
performed at OD600 ≈ 3-5. P0-P2 samples were taken after 0, 2, 5 hours after induction respectively. P3 
was taken after overnight incubation. “ind” marks samples from induced cultures. The arrow indicates 
IFN-α2b protein detected by anti-c-myc antibody, and the numbers on the left side represents molecule 
sizes in kilo Daltons. Phox has a concentration of 1 mg/l. 
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Figure 45: Western Blot results from insoluble and soluble fractions from growth and production 
experiment in shake flasks. The strains were grown in HiYe-8GLY-2GLU medium at 30°C. The image is 
the result for KT2440 (pGM271pelB). Induction to a final concentration of 0.5 mM m-toluic acid was 
performed at OD600 ≈ 1. P0-P2 samples were taken after 0, 2, 5 hours after induction respectively. P3 was 
taken after overnight incubation. “ind” marks samples from induced cultures. The arrow indicates GM-
CSF protein detected by anti-c-myc antibody, and the numbers on the left side represents molecule sizes in 
kilo Daltons. Phox has a concentration of 1 mg/l. 
 
As Figure 44 and Figure 45 shows, the increased plasmid number has had a big effect on the 
production of both IFNα2b and GM-CSF. Single bands from insoluble fractions in Figure 44 
are almost impossible to detect in samples taken later than 5 hours after induction. One wider 
area at IFN-α2b protein size can still be seen (23.7 kDa). When comparing this with detected 
IFN-α2b from KT2440 (pIFNpelB) (Figure 42), there is observed at least 5-10-fold increased 
protein production. This effect on protein production was higher than what was expected from 
the 3.5-fold increase in plasmid number.  
 
In the soluble fraction from the same strain (KT2440 (pIFN271pelB)), the bands have lower 
concentrations of IFN-α2b. When compared to the Phox reference, both samples from after 5 
hours of induction (P2, P3) have approximately the same strength. Based on judgements done 
in Attachment H this indicates that the volumetric yield of IFN-α2b is 0.2 mg/l. Previous 
attempts to produce IFN-α2b from E. coli in both shake flasks and fed batch fermentations 
gave no soluble fraction of this protein (Sletta et al., 2007). KT2440 therefore appears to be a 
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better alternative for IFN-α2b production. Non-induced strains have some weak bands at IFN-
α2bs size which can be due to leakage from the promoter.  
 
The GM-CSF production has increased compared to KT2440 (pGMpelB) where bands were 
almost not detectable (Figure 43). In Figure 45, the bands are easily detected and the highest 
yield of GM-CSF is observed in insoluble fraction after overnight incubation (“P3 ind”). 
Previously fed batch fermentation with KT2440 (pGMpelB), as well this experiment (Figure 
43), indicated that GM-CSF is unstable under longer incubations (Chapter 3.4.5.3, Figure 27).  
If this is true, the high amount of GM-CSF detected after overnight incubation indicates 
production is higher than formation of unstable proteins. There also seems to be an increasing 
amount of soluble GM-CSF through prolonged incubation. Since no band is detected in 
insoluble fraction after overnight incubation of KT2440 (pGMpelB), P2 samples should be 
compared. The increased amount of GM-CSF here is estimated to be 3-4 and can therefore be 
related to increased plasmid number.   
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Copy number mutant with codon optimizes gene KT2440 (pIFNs271pelB) 
 
Figure 46: Western Blot results from insoluble and soluble fractions from growth and production 
experiment in shake flasks. The strains were grown in HiYe-8GLY-2GLU medium at 30°C. The image is 
the result for KT2440 (pIFNs271pelB). Induction to a final concentration of 0.5 mM m-toluic acid was 
performed at OD600 ≈ 3-5.P0-P2 samples were taken after 0, 2, 5 hours after induction respectively. P3 was 
taken after overnight incubation. “ind” marks samples from induced cultures. The arrow indicates IFN-
α2b protein detected by anti-c-myc antibody, and the numbers on the left side represents molecule sizes in 
kilo Daltons. Phox has a concentration of 1 mg/l. 
 
Figure 46 shows that the highest yield of IFN-α2b is in the insoluble fraction from sample 
taken 5 hours after induction. When compared to the highest yield from KT2440 (pIFNpelB) 
(Figure 42), there is obvious that IFN-α2b production has increased. Still, the amount of 
produced IFN-α2b from KT2440 (pIFNs271pelB) is low compared to KT2440 
(pIFN271pelB) production. This suggests that the codon optimization of ifn-α2b gene has a 
negative effect on the production of IFN-α2b protein when compared with copy number 
mutants. This was quite unexpected since adaptation was done to match KT2440 codon usage.  
  
As described earlier (Chapter 3.6), KT2440 (pGMs271pelB) was not completed for this study.   
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Copy number mutants with codon optimized genes and pelB sequence 
 
Figure 47: Western Blot results from insoluble and soluble fractions from growth and production 
experiment in shake flasks. The strains were grown in HiYe-8GLY-2GLU medium at 30°C. The image is 
the result for KT2440 (pIFNs271pelBs). Induction to a final concentration of 0.5 mM m-toluic acid was 
performed at OD600 ≈ 3-5. P0-P2 samples were taken after 0, 2, 5 hours after induction respectively. P3 
was taken after overnight incubation. “ind” marks samples from induced cultures. The arrow indicates 
IFN-α2b protein detected by anti-c-myc antibody, and the numbers on the left side represents molecule 
sizes in kilo Daltons. Phox has a concentration of 1 mg/l. 
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Figure 48: Western Blot results from insoluble and soluble fractions from growth and production 
experiment in shake flasks. The strains were grown in HiYe-8GLY-2GLU medium at 30°C. The image is 
the result for KT2440 (pGMs271pelB). Induction to a final concentration of 0.5 mM m-toluic acid was 
performed at OD600 ≈ 3-5. P0-P2 samples were taken after 0, 2, 5 hours after induction respectively. P3 
was taken after overnight incubation. “ind” marks samples from induced cultures. The arrow indicates 
GM-CSF protein detected by anti-c-myc antibody, and the numbers on the left side represents molecule 
sizes in kilo Daltons. Phox has a concentration of 1 mg/l. 
 
The highest yield of IFN-α2b protein in Figure 47 is from overnight incubation (P3 ind). 
Here, the concentration is evaluated to be lower than 0.1 mg/l when compared to Phox 
reference. When all IFN-α2b producing KT2440 strains are compared, KT2440 
(pIFN271pelB) (Figure 44) has a significant higher production. Codon optimization does 
therefore not seem to have a positive effect on IFN-α2b production. There are relatively small 
differences between KT2440 (pIFNs271pelB) and KT2440 (pIFNs271pelB), but codon 
optimized pelB sequence also seems negative. Summarized, the results indicate that 
increasing the copy number has the best effect on IFN-α2b production. Codon optimization 
has negative effect in combination with increased plasmid copy number.   
 
As shown in Figure 48, the highest yield of GM-CSF protein from KT2440 (pGMs271pelBs) 
is found in the insoluble fraction of sample taken after overnight incubation (“P3 ind”). The 
yield from this strain is significantly higher than what was obtained from KT2440 (pGMpelB) 
(Figure 43) at the same incubation time. When comparing KT2440 (pGMs271pelBs) with 
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KT2440 (pGM271pelB) (Figure 45), there is no clear difference. The effect of codon 
optimization is therefore unknown.  When all GM-CSF producing strains are compared, the 
result indicates that increasing the plasmid number has a positive effect on the production of 
GM-CSF, while further quantification of protein concentration had to be performed to reveal 
the effect of codon optimization.  
 
3.7.2 HCD growth and production experiment (fed batch fermentation)   
The shake flask experiment (Chapter 3.7.1) showed high production of recombinant proteins 
from KT2440 (pIFN271pelB) (Figure 44), KT2440 (pGM271pelB) (Figure 45) and KT2440 
(pGMs271pelBs) (Figure 48). It was therefore of interest to study the production in a fed 
batch fermentation to see if the production would increase with the amount of cells.  
 
Two sets of 100 ml inoculums LB precultures were made (Attachment E), one incubated for 
16 hours and one for 8 hours to ensure that the cells were in exponential growth when 
inoculating the inoculums Hi-medium. The fed batch fermentation was performed following 
the protocol (Chapter 2.4.9), here in 3-litre fermentors. Induction was performed following 
the protocol (Chapter 2.4.9.2). In addition, the cultures were reinduced two and four hours 
after the first induction, both times to a final concentration of 0.5 mM.  
 
3.7.2.1 Growth measurements  
The growth curves from fed batch fermentation are shown in Figure 49.  
 
Figure 49:  Growth (OD600) measurements of KT2440 strains (harbouring plasmids indicated in the right 
column) during fed batch fermentation in Hf-1 medium. Cultures were induced at OD600≈ 80-90. For 
details see Attachment F, Table F- 21 
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As Figure 49 shows, KT2440 (pGMs271pelBs) had reduced growth rate compared to the rest 
of strains participating in the fed batch fermentation. As this was not the case for this strain 
during the shake flask experiment (Chapter 3.7.1.1, Figure 40), it was not expected. KT2440 
(pIFN271pelB) was expected to have a long lag phase, but acted as the majority in the fed 
batch fermentation. KT2440 (pGMs271pelBs) was because of the slow growth rate only 
induced once, when OD600≈35.  
3.7.2.2 Protein production 
Samples were harvested for SDS-PAGE following the protocol (Chapter 2.4.10.1) at 
induction and the following two, four and six hours. The samples were named P0, P1, P2 and 
P3 respectively and prepared following “Detection and quantification of recombinant protein” 
(Chapter 2.4.10).The pellet fraction was prepared by the procedure “Cell lysis protocol 2”. 
Both soluble and insoluble fractions were analyzed for protein content by Western Blot 
protocol using anti-c-myc as primary antibody (Chapter 2.4.10.3). As before, the expected 
band is 23.7 kDa for IFNα2b and 19.7 kDa for GM-CSF. The results are shown in Figure 50.  
 
Figure 50: Western Blot results from insoluble fractions from fed batch fermentation of KT2440 strains 
(plasmid harboured indicated over each well). P2-P3 samples were taken 4 and 6 hours after induction 
respectively. Arrows indicated the recombinant proteins detected by anti-c-myc antibody, and the 
numbers on the left side represents molecule sizes in kilo Daltons 
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No bands were detected in soluble fractions from the fed batch fermentation cultures (result 
not shown). Nor the insoluble fraction of KT2440 (pGMs271pelBs) gave detection of protein. 
Because of high production during cultivation of KT2440 (pGMs271pelBs) in shake flasks, 
this was not expected. The detected recombinant proteins from insoluble fractions of the 
remaining strains are shown in Figure 50. Two of these strains, KT2440 (pIFN271pelB) and 
KT2440 (pGM271pelB), were expected to produce high amount of recombinant protein based 
on their production in shake flask experiment (Figure 44 and Figure 45 respectively). The 
amount produced in the fed batch fermentation (Figure 50) was therefore much lower than 
expected. Plasmid stability was also evaluated here (Attachment F Table F- 22), but was 
found not to be the reason for the low production.  
 
Summarized, the increased protein productions seen in the shake flask experiment were not 
observed in the fed batch fermentation. Since there is one main difference between the 
cultivations of these experiments, it is thought that this might be the reason. During the shake 
flask experiment, induction was performed when the cultures still had glycerol available in 
abundant quantity. The cultures therefore grew without any limitations. In contrast, induction 
during the fed batch fermentation was performed when the cultures growth rate was 
controlled by the exponential feeding of glucose into the fermentor (see Chapter 1.2.5). If the 
inducer is consumed by KT2440, the fermentation culture will metabolize the inducer shortly 
after it is added. Shake flask cultures, on the other hand, have glycerol available and will 
therefore not consume the inducer as fast. The expression of recombinant proteins will thus be 
different when the same culture of KT2440 is cultivated in shake flasks or fed batch 
fermentation.  
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4 Conclusion 
Two broad host range expression plasmids with Pm/XylS system, pelB signal sequence and 
trfA (wild type copy numbers) were constructed for evaluation of recombinant protein 
production in P. fluorescens and P.putia. Two human proteins, IFN-α2b and GM-CSF, were 
chosen as model proteins for the expression system.  
 
During shake flask cultivations, low stability of the expression plasmids in P. fluorescens was 
found.  P. putida KT2440 showed high plasmid stability under the same conditions and was 
chosen for further evaluation as expression platform.  
 
Shake flask cultivation conditions for KT2440 that was optimized for growth and protein 
production revealed production of both model proteins both in rich and minimal media. 
Further evaluation of T2440 fed batch fermentations performed in minimal medium resulted 
in the same growth rate reported for E. coli cultivated under the same conditions. This 
indicated potential for KT2440 as industrial protein producer. Possible metabolism of the 
inducer m-toluic acid was believed to cause low protein production. This led to the evaluation 
of alternative inducers during fed batch fermentation, but nor o-toluic acid or 2-chloro 
benzoic acid gave protein production.  
 
Genetic modifications of expression plasmids were performed to evaluate the effects on 
protein production. The exchange of trfA (the gene for replication protein TrfA) with 
trfAcop271C yielded a 3.5-fold increase of plasmid number in KT2440, the same as reported 
for E. coli. A shake flask experiment showed that the change in plasmid number increased the 
production of IFN-α2b and GM-CSF 3.5-fold or more. Additionally, soluble IFN-α2b was 
detected, something not reported for E. coli under the same conditions. Codon optimization of 
genes and signal sequence to KT2440 did not have significant effects under the conditions 
tested.  
 
Fed batch fermentation of KT2440 harbouring genetically modified expression plasmids was 
performed to further evaluate protein production. Plasmid stability was found as high, but 
protein production obtained was lower than expected from results in the shake flask 
experiment. Additional production experiments performed with higher volumes in shake 
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flasks would reveal if low substrate concentrations during fed batch fermentations caused 
consummation of the inducer and thus lower production. 
P. putida KT2440 have through this study proved as a potential industrial protein producer. It 
has shown similar growth properties as the widely used E. coli during fed batch 
fermentations. In addition, simple genetic modifications of expression plasmids proved to 
positively affect the production of model proteins. It is therefore believed that further 
optimization will increase the volumetric yield of the recombinant proteins.  
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4.1 Suggestions for further work 
Like in most research projects, time is limited and some of the goals are not achieved. 
Choices have to be made, and there are elements that could be changed or might be 
eliminated.  
 
The first point that would have strengthened the study is exact quantification of recombinant 
proteins. For this study, antibodies against C-myc or His6 sequences fused with the target 
genes were used to detect the model proteins. Standards with known concentrations of Phox-
protein was in most cases also part of SDS-PAGE, but with only one dilution. These were 
compared to the amount of detected protein and gave an indication of the concentration. To 
quantify the amount of produced protein accurately there could have been executed several 
dilution of Phox as well as the samples with most amount of detected protein. By comparison 
of these bands, the concentration of protein produced could be measured and compared with 
the amount produced in E. coli. Detection could also been simplified by choosing model 
proteins with other detection possibilities. One example is fusion to fluorescent proteins, like 
mcherry (Clontech). Quantitative imagine directly on the culture would then both shorten 
detection time and enabled accurate quantification.  
 
Two main genetic modifications were done to the expression vectors in this study. These two 
were increased copy number and codon optimization. Increased copy number proved to have 
positive effect on production of both model proteins under the conditions tested, as shown in 
Chapter 3.7.1.2. It would therefore be interesting to try to increase the copy number further 
and observe the following effects on protein production. Durland et al. have reported several 
mutation in trfA proven to increase the copy number of a specific plasmid in E. coli (Durland 
et al., 1990). For trfAcop271C, the 3.5-fold effect reported was also observed in P. putida 
KT2440 (Chapter 3.5.2). In addition, increased gene dosage had positive effect on expression 
of recombinant proteins. It would therefore be interesting to see if other mutations reported in 
Durland et al. 1990 would increase gene dosage and protein production in P. putida KT2440 
further.   
 
There are also other examples of genetic modifications that could increase production of 
recombinant proteins. In this study, pelB was chosen as signal sequence, but there are 
alternatives worth exploring. When testing pelB, ompA and synthetic signal sequence CSP, 
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Sletta et al. showed that the choice had high impact on expression of IFN-α2b and GM-CSF 
in E. coli (Sletta et al., 2007). It would therefore be interesting to see if production would 
increase by changing pelB with one of these alternatives. Other elements proven to effect 
protein expression levels in E. Coli are different sequences in the 5’-untranslated region(UTR)  
of bacterial mRNA (Berg et al., 2009) and Pm promoter mutants (Winther-Larsen et al., 
2000a). Pm mutants are currently being screened for the effect on protein production in P. 
putida. Positive results here would therefore be worthy of testing.  
 
During this study of P. putida KT2440 it was observed an increase in CO2 generation when 
inducing with m-toluic acid. Because KT2440 is derivative of the toluene-degrading P. putida 
mt-2 strain, this was assumed to be a sign of consummation. If this was the case, the inducer 
would be completely removed short time after induction in fed batch fermentations. It was 
tried to confirm this theory by analysing for m-toluic acid in HCDC samples, but the chosen 
method was not suited for this purpose. Finding an appropriate method for this analysis could 
therefore reveal whether KT2440 consume m-toluic acid. If consummation is detected, 
genetic engineering of the strains genome could remove this ability and increase the effect of 
induction.  
 
The variation in production of recombinant proteins in this study makes it necessary to 
perform more studies on the constructed strains. Since there was detected high (but not 
quantified) amount of recombinant proteins in the shake flask experiment in Chapter 3.7.1, 
but not in HCDC of the same strains (Chapter 3.7.2), there is obvious that differences in 
setups effecting  recombinant protein production. New experiments could be performed to 
reveal or if the hypothesis in Chapter 3.7.2.2 that was correct. If the amount of nutrition 
available at induction was the reason, this could be revealed by running similar shake flask 
experiment but with larger media volumes.  
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Attachment A. Abbreviations 
 
A: nitrogen base Adenine 
Amp: Ampicillin 
bp: base pair 
C: nitrogen base Cytosine 
DNA: deoxyribonucleic acid 
DO: Dissolved oxygen 
EDTA: Ethylene Diamine Tetraacetic Acid 
ER: endoplasmic reticulum 
G: nitrogen base guanine  
GOI: gene of interest 
IB: inclusion body 
Kan: Kanamycin 
kb: kilo base pair 
kDa: kilo Daltons 
LB: Lauria Bertani broth 
LA plates: Agar plates made with LB medium 
mRNA: messenger RNA 
NEB: New England Biolabs 
OD(x): Optical density at wave length x 
p: promoter region 
Pm: Promoter controlling the expression of meta-cleavage pathway in pWW0 and 
recombinant protein in Pm/XylS system 
rDNA: recombinant DNA 
RNA: ribonucleic acid 
RNAP: RNA polymerase 
SDS-PAGE: Sodium dodecyl sulphate-polyacrylamide gel electrophoresis 
T: nitrogen base Thymine 
t: termination sequence 
U: nitrogen base Uracil 
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Attachment B. Restriction sites nucleotide sequences  
 
Table B-1: Restriction enzymes used during the clonings of this study. Single letter code N stands for any 
of the four bases (A, C, G or T), while W codes for A or T. Arrows indicate where the enzyme cuts.  
Restriction enzyme Restriction site (nucleotide sequence) 
AdhI 
 
MunI/MfeI 
 
NcoI 
 
NdeI 
 
NotI 
 
SexAI 
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Attachment C. Standards: Gel electrophoresis and SDS PAGE 
Gel electrophoresis 
 
Figure C- 1: 1 kb DNA ladder (NEB) visualized by ethidium staining on a 0.8 % TAE agarose gel. Kilo 
bases (kb) are indicated in the right column   
 
 
 
Figure C- 2 GeneRuler
TM
 DNA Ladder Mix 0.5 μg/μl 50 μg. First line to the left indicate base pair sizes 
(bp) (Fermentas) 
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SDS-PAGE 
 
Figure C- 3: Precision Plus Protein
TM
 Standards Dual Color (BioRad). The number to the left indicate the 
different sizes for poly peptides.   
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Attachment D. Version of Hi-media 
Stock solution for Hi-and Hf.-medium 
6 g/l Fe (III) citrate hydrate (MERCK) 
30 g/l H3BO3 (Sigma) 
10 g/l MnCl2·4H2O (Riedel-deHäen) 
84 g/l EDTA·2H2O (titriplex) (Prolabo) 
15 g/l CuCl2·2H2O (MERCK) 
25 g/l Na2Mo4O4·2H2O (Riedel-deHäen) 
25 g/l CoCl2·6H2O (Riedel-deHäen) 
4 g/l Zn(CH3COO)2·2H2O (Fluka) 
 
20 g/l Citrate solution  
20 g/l  Na-Citrat (Sigma) 
pH adjusted to 7.0 with 1M NaOH 
 
100 g/l Yeast extract HI 
100 g/l Yeast extract (Oxoid) 
Autoclaved at 120°C for 20 minutes 
 
1M MgSO4∙ 7H2O 
246 g/l MgSO4 ∙ 7H2O (Sigma-Aldrich) 
Autoclaved at 120°C for 20 minutes 
 
250 g/l Glucose ·H2O 
250 g Glucose ∙ H2O (Apotekerproduksjon) 
Ion-free water to total volume 1000 ml  
Autoclaved at 120°C for 20 minutes 
 
20 ml/l Glycerol 
590 g/l Glycerol 86-88% (Sigma-Aldrich) 
Ion-free water to total volume 1000 ml 
Autoclaved at 120°C for 20 minutes 
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250 g/l Fructose 
250 g/l Fructose (Sigma) 
Ion-free water to total volume 1000 ml 
Autoclaved at 120°C for 20 minutes 
 
250 g/l Glycerol 
250 g/l Glycerol 86-88% (Sigma-Aldrich) 
Ion-free water to total volume 1000 ml 
Autoclaved at 120°C for 20 minutes 
 
590 g/l Glycerol 
590 g/l Glycerol 86-88% (Sigma-Aldrich) 
Ion-free water to total volume 1000 ml 
Autoclaved at 120°C for 20 minutes 
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Reduced Hi+YE medium 
8.6 g/l  Na2HPO4·2H2O (Sigma-Aldrich) 
3 g/l KH2PO4 (Riedel-deHaën) 
0.3 g/l  NH4Cl (Riedel-deHaën) 
0.5 g/l NaCl (Apotekerproduksjon) 
3.3 ml stock solution/l Fe (III) citrat hydrate  
0.03 ml stock solution/l H3BO3     
0.5 ml stock solution/l MnCl2·4H2O   
0.03 ml stock solution/l EDTA·2H2O    
0.03 ml stock solution/l CuCl2·2H2O   
0.03 ml stock solution/l Na2Mo4O4·2H2O   
0.03 ml stock solution/l CoCl2·6H2O   
0.67 ml stock solution/l Zn(CH3COO)2·2H2O  
10 g/l  MOPS (Sigma) 
817 g/l Ion-free water 
pH adjusted to 7.0 
After autoclavation the following volume of sterile stock solutions was added:  
 
50 ml/l 20 g/l Citrate solution   
100 ml/l Yeast extract HI 
0.9 ml/l 1M MgSO4·7H2O 
20 ml/l 590 g/l Glycerol 
8 ml/l 250 g/l Glucose ·H2O 
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Hi-10YE-10GLY-2GLU 
8.6 g/l  Na2HPO4·2H2O (Sigma-Aldrich) 
3 g/l KH2PO4 (Riedel-deHaën) 
1.0 g/l  NH4Cl (Riedel-deHaën) 
10 g/l MOPS (Sigma) 
0.5 g/l NaCl (Apotekerproduksjon) 
10.0 ml stock solution/l Fe(III) citrat hydrate  
0.1 ml stock solution/l H3BO3     
1.5 ml stock solution/l MnCl2·4H2O   
0.1 ml stock solution/l EDTA·2H2O    
0.1 ml stock solution/l CuCl2·2H2O    
0.1 ml stock solution/l Na2Mo4O4·2H2O   
0.1 ml stock solution/l CoCl2·6H2O    
2.0 ml stock solution/l Zn (CH3COO)2·2H2O  
855.5 g/l Ion-free water 
pH adjusted to 7.0 before autoclaving at 120°C for 20 minutes 
After autoclavation the following volume of sterile stock solutions was added:  
   
100 ml/l Yeast extract HI 
2.5 ml/l 1M MgSO4·7H2O 
8 ml/l 250 g/l Glucose ·H2O 
  20 ml/l 85 % Glycerol 
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HiYe reduced broth  
1. Basis broth 
Solution A 
8.6 g/l  Na2HPO4·2H2O (Sigma-Aldrich) 
3 g/l KH2PO4 (Riedel-deHaën) 
0.3 g/l  NH4Cl (Riedel-deHaën) 
0.5 g/l NaCl (Apotekerproduksjon) 
3.3 ml stock solution/l Fe (III) citrat hydrate  
0.03 ml stock solution/l H3BO3     
0.5 ml stock solution/l MnCl2·4H2O   
0.03 ml stock solution/l EDTA·2H2O    
0.03 ml stock solution/l CuCl2·2H2O   
0.03 ml stock solution/l Na2Mo4O4·2H2O   
0.03 ml stock solution/l CoCl2·6H2O   
0.67 ml stock solution/l Zn(CH3COO)2·2H2O  
2 g/l Yeast extract (Oxoid) 
2 g/l Glucose·H2O (Apotekerproduksjon) 
650 g/l  Ion-free water 
Solution B:  
20 g/l Citric acid (final concentration 1 g/l) 
pH adjusted to 7 
Solution C:  
1 M MgSO4·7H2O stock solution  
The basis broth was made by mixing solution A and solution B and adding 0.9 ml of solution 
C. The mixture was then sterile filtered and eventually added antibiotics.  
 
2. Induction solution  
25.5 g/l Glycerol (100%) (AnalaR NORMAPUR) 
24.0 g/l Yeast extract (Oxoid) 
To 1000 ml Tap water   
Sterile filtered  and eventually antibiotics added before use.  
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Hi-10YE-10X* 
Followed the recipe for “Reduced Hi+YE medium” to and including MOPS. Thereafter the 
following was added: 
805.4 g/l Ion-free water 
pH adjusted to 7.0 
After autoclavation the following volume of sterile stock solutions was added:  
 
50 ml/l 20 g/l Citrate solution   
100 ml/l Yeast extract HI 
0.9 ml/l 1M MgSO4·7H2O 
*
40 ml/l 250 g/l C-source:  
  if X = GLU: Glucose 
  if X = FRU: Fructose 
  if X = GLY: Glycerol  
 
HiYe-8GLY-2GLU 
Followed the recipe for “Reduced Hi+YE medium” to and including MOPS. Thereafter the 
following was added: 
820.5 g/l Ion-free water 
pH adjusted to 6.5 
After autoclavation the following volume of sterile stock solutions was added:  
 
50 ml/l 20 g/l Citrate solution   
100 ml/l Yeast extract HI 
0.9 ml/l 1M MgSO4·7H2O 
16 ml/l 590 g/l Glycerol  
8 ml/l 250 g/l Glucose 
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Attachment E. Fermentation solutions 
 
Inoculum LB-medium 
LB (g) 
10 g/l Trypton (Oxoid) 
10 g/l Yeast Extract (Oxoid) 
5 g/l NaCl (Apotekerproduksjon) 
900 g/l Ione free water 
90 ml is added to 500-ml-shaking flasks and autoclaved for 20 minutes at 120 C 
 
Glucose LB – inoculum and Hi  
100 g/l Glucose (Apotekerproduksjon) diluted in ion free water in a graduated flask 
Autoclaved for 20 minutes at 120 C 
 
Before inoculation 
 10 ml of “Glucose LB-inoculum and Hi” was added to the 500-ml-shaking flask 
containing 90 ml LB (g) 
 Kanamycin (40 mg/ml) was added to a total concentration of 40 g/ml 
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Inoculum Hi-medium 
(For stock solutions see Attachment D) 
Hi-medium 
8.6 g/l Na2HPO4 (Sigma-Aldrich) 
3.0 g/l KH2PO4 (Riedel-deHäen) 
1.0 g/l NH4Cl (Riedel-deHäen) 
0.5 g/l NaCl (Apotekerproduksjon) 
10 ml stock/l Fe (III) citrate hydrate 
0.1 ml stock/l H3BO3  
1.5 ml stock/l MnCl2· 4H2O 
0.1 ml stock/l EDTA·2H2O 
0.1 ml stock/l CuCl2·2H2O 
0.1 ml stock/l Na2Mo4O4·2H2O 
0.1 ml stock/l CoCl2·6H2O 
2.0 ml stock/l Zn (CH3COO)2·2H2O 
900 g/l ion free water 
90 ml is added to 500-ml-shaking flasks and autoclaved for 20 minutes at 120 C 
 
Before inoculation  
 10 ml of “Glucose LB-inoculum and Hi” is added to the 500-ml-shaking flask 
containing 90 ml Hi-medium 
 0.234 ml 1M MgSO4-stock was added to each flask 
 Kanamycin (40 mg/ml) was added to a total concentration of 40 g/ml 
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Glucose 1 stock solution 
96.10 g Glucose ∙ H2O (Apotekerproduksjon) 
Ion-free water to total volume 200 ml  
Autoclaved at 120°C for 20 minutes 
 
Feeding solution 
Glucose 2/ Mg- feeding solution 
1250 g/l Glucose ∙ H2O (Apotekerproduksjon) 
Autoclaved separately  
444 g/l MgSO4·7H2O (Sigma) 
Autoclaved separately  
600 ml autoclaved1250 g/l Glucose·H2O and 50 ml autoclaved 444 g/l MgSO4·7H2O 
is mixed and connected to the fermentors 
 
Antifoam 
1+10 diluted Adecanol (Asahi Denka Kogyo) 
Autoclaved at 120°C for 20 minutes 
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Hf.1 medium 
16.6 g/l KH2PO4 (Riedel-deHaën) 
4 g/l (NH4)2HPO4 (Sigma) 
2.3 g/l Citric acid·H2O (Sigma) 
12.5 ml/l stock Fe (III) citrat hydrate  
0.127 ml/l stock H3BO3     
1.88 ml/l stock MnCl2*4H2O    
0.125 ml/l stock EDTA*2H2O    
0.127 ml/l stock CuCl2*2H2O   
0.124 ml/l stock Na2Mo4O4*2H2O   
0.124 ml/l stock CoCl2*6H2O   
2.5 ml/l stock Zn (CH3COO)2*2H2O 
936 g/l  Ion-free water 
Aliquoted to each fermentor (327.5 ml to 1-L fermentors and 700 ml to 3-L fermentors)before 
autoclavation. 
 
For 1-L fermentations the following was added to each fermentor 
- 20 ml Glucose 1 stock solution 
- 2.15 ml 1M MgSO4·7H2O stock solution 
- 0.35 ml 40 mg/ml kanamycin 
- 0.2 ml Antifoam 
 
For 3-L fermentations the following was added to each fermentor 
- 50 ml Glucose 1 stock solution 
- 4.6 ml 1M MgSO4·7H2O stock solution 
- 0.75 ml 40 mg/ml kanamycin 
- 0.5 ml Antifoam 
 
Ammonia (25 %) diluted 1:1 (w/w) in ion- free water is used for pH control  
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Attachment F. Collection of raw data from experiments 
 
For details concerning measurements of growth and pH, see Chapter 2.4.2 
 
Plasmid stability 
To express a recombinant protein from an expression vector it is essential that the host of this 
vector is able to carry it. Not all bacteria will allow the plasmid inside the cell and therefore 
eliminate it. To calculate the plasmid stability cultures can be grown on agar plates without 
selection. After visible colonies have formed, they can be transferred to a selective plate. Now 
only bacteria harbouring plasmids with resistance will be able to grow.  
 
The plasmid stability is calculated by:  
 
 
number of upgrown coloines on selection
Plasmid stability = 100%
colonies picked from unselected agar
   Eq. (2) 
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Calculation of multiplication factor for OD600 measurements in deep well plates 
The relationship between OD600 measurements in cuvettes and 96-wells UV plates (OD-
costar) (Costar), used for harvesting samples from deep wall plates, had to be established. 
This is done by measuring the OD600 from the same culture both in cuvette and on a well plate 
on Spectra Max (BMG Labtech). The multiplication factor is calculated by finding the 
relationship between OD-cuvette and OD-costar. The calculated factors are shown in Table F- 
1. 
 
Table F- 1: Growth measurements (OD600) in cuvette and costar plates of precultures for deep-well 
experiment with P. fluorescens SBW25 and E. coli RV308 strains (left column). The precultures were 
grown in 50 ml selective LB medium for at 200 rpm 16 hours. The relationship between OD 
measurements in cuvette and on costar plates were used to calculate factor needed for OD600 measurement 
during the experiment. 
Strain (plasmid) OD600 cuvette OD600 costar plates Factor  
(OD600 cuvette/ 
OD600 costar) 
SBW25 (pIFNpelB) 0.0345 0.00800 4.3 
SBW25 (pGMpelB) 0.0265 0.00633 4.2 
RV308 (pIFNpelB) 0.3585 0.06866 5.2 
RV308 (pGMpelB) 0.3485 0.07033 5.0 
RV308 (pAT64) 0.4045 0.07630 5.3 
RV308 (pMV11) 0.3965 0.07700 5.2 
 
The measurements showed in Table F- 2 have been multiplied by their dilution factor from 
Table F- 1.  
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Table F- 2: Growth measurements (OD600) from deep-well experiment of P. fluorescens SBW25 and E. coli 
RV308 strains (first and second column from the right).  The cultures were grown in reduced HiYe 
medium at 25°C (800 rpm). Parallels were induced to a final concentration of 0.5 mM m-toluic acid after 
reaching OD600≈ 5. 
Strain 
Hours after 
inoculation 
 
Pre culture 
3 5,5 6 7,4 8 8,8 9,5 11 22 
P. fluorescens SWB25 (pIFNpelB) 0,35 0,00 0,05 0,09     0,10     0,26 
P. fluoresces SWB25 (pGMpelB) 0,26 0,00 0,06 0,08     0,10     0,34 
E. coli RV308 (pIFNpelB) 3,59 0,10 0,40 0,7 1,5 1,7 2,3 3,4 4,7   
E. coli RV308 (pGMpelB) 3,49 0,10 0,45 0,7 1,1 1,3 2,1 2,8 4,2   
E. coli RV308 (pAT64) 4,05 0,18 0,90 1,1 2,3 2,3 3,7 4,6 6,6   
E. coli RV308 (pMV11) 3,97 0,12 0,94 1,2 2,3 2,7 3,7 4,7 7,7   
 
Table F- 3: Calculated plasmid stability for P. fluorescens and P. putida strains (two left columns) grown 
in 50 ml selective LB, PIA and Hi-10YE-10GLY-2GLU (third column) before plating out on LA without 
selection. 75 colonies were transferred to LA with selection. KT2440 (pIFNpelB) had been induced with 
m-toluic acid to a final concentration of 0.5 mM under cultivation in the different media.  
Strain Media (with selection) Plasmid 
stability 
P. fluorescens 
 
SWB25 (pHH100) 
LB 13,30 % 
PIA 5,30 % 
Hi-10YE-10GLY-2GLU 1,30 % 
P. fluorescens 
 
NCIMB (pHH100) 
LB 2,70 % 
PIA 1,30 % 
Hi-10YE-10GLY-2GLU 0 % 
P. putida 
 
KT2440(pHH100-
synluc) 
LB 100 % 
PIA 92 % 
Hi-10YE-10GLY-2GLU 70 % 
P. putida 
 
KT2440(pIFNpelB) 
LB 100 % 
PIA 100 % 
Hi-10YE-10GLY-2GLU 100 % 
 
Induced   
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Table F- 4: Growth measurements (OD660) of precultures for shake flask growth experiments of KT2440 
WT and KT2440 (pGMpelB). The precultures were grown in 50 ml LB (with antibiotics for KT2440 
(pGMpelB)) at 30°C, 200 rpm for 16 hours. 
Strain: P. putida  OD660 
KT2440 WT 5,6 
KT2440 (pGMpelB) 5,66 
 
Table F- 5: Growth measurements (OD660) of KT2440 WT grown in 50 ml medium (left column). The 
cultures were grown at 30°C and 200 rpm.   
Strain: KT2440 WT         
Hours after inoculation  4 8 11 24 
PIA 1,23 2,40 3,08 4,45 
M9 0,63 3,72 6,10 5,60 
Hi-10YE-10GLU 3,30 8,34 9,32 10,43 
Hi-10YE-10FRU 3,57 6,30 7,30 10,98 
Hi-10YE-10GLY 3,12 5,82 6,79 10,80 
  
Table F- 6: pH measurements from different media (left column) used in shake flask experiment with 
KT2440 WT. The cultures were grown at 30°C and 200 rpm 
Strain: KT2440 WT         
Hours after inoculation  4 8 11 24 
PIA 6,3 5,35 5,24 5,75 
M9 6,71 6 6,3 6,58 
Hi-10YE-10GLU 7,16 7,3 7,38 7,5 
Hi-10YE-10FRU 7,25 7,41 7,49 7,47 
Hi-10YE-10GLY 7,25 7,46 7,53 7,42 
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Table F- 7: Growth measurements (OD660) of KT2440 (pGMpelB) grown and induced in 50 ml medium 
(left column). The cultures were grown at 30°C and 200 rpm. Parallels were induced with m-toluic acid to 
a final concentration of 0.5 mM four hours after inoculation. 
Strain: KT2440(pGMpelB)         
Hours after inoculation 4 8 11 24 
PIA 1,2 2,16 2,97 3,87 
PIA, induced   1,92 2,72 3,67 
M9 0,5 3,78 5,48 4,63 
M9, induced   3,24 3,65 2,81 
Hi-10YE-10GLU 2,28 6,78 9,16 9,86 
Hi-10YE-10GLU, induced   8,7 11,81 10,55 
Hi-10YE-10FRU 2,67 6,6 7,66 9,1 
Hi-10YE-10FRU, induced   6,9 8,33 9,8 
Hi-10YE-10GLY 2,79 6,36 7,34 9,06 
Hi-10YE-10GLY, induced   6,96 7,65 10,06 
 
 
Table F- 8: pH measurements in the different medium (left column) used to grow KT2440 (pGMpelB). 
The cultures were grown at 30°C and 200 rpm. Parallels were induced with m-toluic acid to a final 
concentration of 0.5 mM four hours after inoculation. 
Strain: KT2440(pGMpelB)         
Hours after inoculation  4 8 11 24 
PIA 6,7 5,46 5,43 7,28 
PIA, induced   5,34 5,2 4,8 
M9 6,8 6,18 6,01 6,56 
M9, induced   6,18 5,95 6,12 
Hi-10YE-10GLU 7,15 7,36 7,27 7,56 
Hi-10YE-10GLU, induced   7,2 7,33 7,52 
Hi-10YE-10FRU 7,21 7,36 7,4 7,51 
Hi-10YE-10FRU, induced   7,44 7,43 7,48 
Hi-10YE-10GLY 7,22 7,45 7,52 7,56 
Hi-10YE-10GLY, induced   7,5 7,5 7,48 
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Table F- 9: Growth measurements (OD660) of precultures for shake flask experiment with KT2440 WT, 
KT2440 (pIFNpelB) and KT2440 (pGMpelB). The precultures were grown in 50 ml selective LB (no 
antibiotics for KT2440 WT) at 30°C and 200 rpm for 16 hours 
 
 
 
 
 
 
Table F- 10: Growth measurements (OD660) from shake flask experiment with KT2440 WT, KT2440 
(pIFNpelB) and KT2440 (pGMpelB) (left column).  The cultures were grown in 100 ml M9-10GLU at 
30°C and 200 rpm. Induction was performed 8.5 hours after inoculation by adding m-toluic acid to a final 
concentration of 0.5 mM. 
Strain Hours after inoculation 
  3 8,5 11,5 25 
KT2440 WT 0,37 2,24 5,5 6,53 
KT2440 (pIFNpelB) 0,2 1,16 3,13 5,12 
KT2440 (pIFNpelB) - Induced 0,2 1,4 3,07 5,57 
KT2440 (pGMpelB) 0,2 1,1 3,42 5,63 
KT2440 (pGMpelB) - Induced 0,2 1,2 3,61 6,6 
 
Table F- 11: pH measurements from shake flask experiment with KT2440 WT, KT2440 (pIFNpelB) and 
KT2440 (pGMpelB) (left column).  The cultures were grown in 100 ml M9-10GLU at 30°C and 200 rpm. 
Strain Hours after inoculation 
  3 8,5 11,5 25 
KT2440 WT 6,71 5,86 4,26 3,95 
KT2440 (pIFNpelB) 6,82 6,46 4,52 4,86 
KT2440 (pIFNpelB) - Induced 6,81 6,47 4,82 5,42 
KT2440 (pGMpelB) 6,9 6,41 4,53 5,94 
KT2440 (pGMpelB) - Induced 6,8 6,39 4,55 4,07 
 
Strain OD660 
KT2440 WT 6,43 
KT2440 (pIFNpelB) 4,43 
KT2440 (pGMpelB) 4,72 
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Table F- 12: Growth measurements (OD660) from shake flask experiment with KT2440 WT, KT2440 
(pIFNpelB) and KT2440 (pGMpelB) (left column).  The cultures were grown in 100 ml HiYe-8GLY-2GLU 
at 30°C and 200 rpm. Induction was performed 8.5 hours after inoculation by adding m-toluic acid to a 
final concentration of 0.5 mM. 
Strain Hours after inoculation 
  3 8,5 11,5 25 
KT2440 WT 1,55 7,02 8,41 12,44 
KT2440 (pIFNpelB) 0,6 6,3 8,32 10,45 
KT2440 (pIFNpelB) - Induced 0,5 6,42 9,02 11,39 
KT2440 (pGMpelB) 0,8 6,44 8,47 9,58 
KT2440 (pGMpelB) - Induced 0,7 6,14 8,71 10,75 
  
 
Table F- 13: pH measurements from shake flask experiment with KT2440 WT, KT2440 (pIFNpelB) and 
KT2440 (pGMpelB) (left column).  The cultures were grown in 100 ml HiYe-8GLY-2GLU at 30°C and 
200 rpm. 8.5 hours after inoculation pH was adjusted from approximately 7.0 to 6.5. 
Strain Hours after inoculation 
  3 8,5 11,5 25 
KT2440 WT 7,15 6,99   7,06 7,15 
KT2440 (pIFNpelB) 6,94 6,97 6,53 6,61 6,53 
KT2440 (pIFNpelB) - Induced 6,84 6,97 6,58 6,62 6,59 
KT2440 (pGMpelB) 6,83 6,99 6,53 6,69 6,56 
KT2440 (pGMpelB) - Induced 6,98 6,98 6,54 6,59 6,53 
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Table F- 14: Growth measurements (OD660) of precultures for fed batch fermentation with KT2440 WT, 
KT2440 (pJB861), KT2440 (pIFNpelB) and KT2440 (pGMpelB). The precultures were grown in 100 ml  
selective Hi-medium (no antibiotics for KT2440 WT) at 30°C and 200 rpm for 16 -18 hours 
Strain OD600 
KT2440 WT 4,85 
KT2440 (pJB861) 8,28 
KT2440 (pIFNpelB) 6,89 
KT2440 (pGMpelB) 7,08 
 
 
Table F- 15: Growth measurements (OD600) from 1 l-fed batch fermentation with KT2440 WT, KT2440 
(pJB861), KT2440 (pIFNpelB) and KT2440 (pGMpelB). The fermentation was executed in Hf.1 medium 
at 30°C and pH 6.5. Induction was performed by adding m-toluic acid to a final concentration of 0.5 mM 
when OD600 ≈ 80-90. 
Strain Hours after inoculation  
  0,00 6,25 15,33 17,17 17,43 19,18 19,37 19,60 21,62 23,58 26,25 
KT2440 WT 0,05 1,68 52,8 
   
120 
 
152,2 172 197,8 
KT2440 (pJB861) 0,05 1,34 29,7 
   
85,7 
 
125,1 153,6 178,7 
KT2440 (pIFNpelB) 0,05 1,83 51,3 76,2 79,95 
  
125,9 148,5 172,8 196,7 
KT2440 (pGMpelB) 0,05 1,38 31,65 51 
 
84 93,2 
 
132,4 141,5 175,6 
 
Table F- 16: Calculated specific growth rate (μ) and doubling time based on OD600 measurements during 
free growth in 1-l fed batch fermentation. 
 
OD600 
HAI KT2440 WT KT2440 (pJB861) KT2440 (pIFNpelB) KT2440 (pGMpelB) 
0,00 0,05 0,05 0,05 0,05 
6,25 1,68 1,34 1,83 1,38 
 
Calculated μ and doubling time for each strain 
μ (h-1) 0,56 0,53 0,58 0,53 
Doubling 
time (h) 1,23 1,32 1,20 1,31 
 
Attachment F: Collection of raw data from experiments 
143 
 
 Table F- 17: Growth measurements (OD660) from 1-l fed batch fermentation with KT2440 (pGMpelB). 
The fermentation was executed in Hf.1 medium at 30°C and pH 6.5. Induction was performed OD600 ≈ 80-
90. 
  Pseudonomas putida KT2440 (pDI-gmcsf) 
Hours after inoculation 
Continously  
m-toluic acid m-toluic acid o-toluic acid 
2-chloro  
benzoic 
acid 
0 0,05 0,05 0,05 0,05 
7,25 2,21 2,39 2,41 2,37 
16,18 32,1 44,1 35,6 38,7 
17,43 37,2 53,9 49,5 50,1 
18,67     63,6   
19,67 59,4 89,9     
19,8   93,6 83,4 87 
20,63 79,53       
20,72 79,8       
21,77   133,2 124,5 135,1 
22,8 113,1       
23,37   143,4 145,4 145,02 
24,27 128,1       
24,87   168,6 155,5 160,6 
25,73 138,9       
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Table F- 18: Growth measurements (OD600) of precultures (left column) for shake flask experiment. The 
precultures were grown in 50 ml selective LB medium at 30°C, 200 rpm for 10 hours. 
Strain OD600 
KT2440 (pIFNpelB) 7,15 
KT2440(pGMpelB) 7,10 
KT2440(pIFN271pelB) 1,16 
KT2440 (pGM271pelB) 0,52 
KT2440 (pIFNs271pelB) 6,94 
KT2440 (pIFNs271pelBs) 8,28 
KT2440 (pGMs271pelBs) 1,00 
 
Table F- 19: Growth measurements (OD600) of strains from shake flask experiment in HiYe-8GLY-2GLU 
at 30°C, 200 rpm. Induction to a final concentration of 0.5 mM m-toluic acid was performed when 
cultures reached OD600 1-5. 
 
Hours after inoculation 
Strain (plasmid ) 0 4,75 6,75 10,08 11 15,33 25,5 
KT2440 (pIFNpelB) 0,29 5,2 7,07 10,85 
  
13,33 
KT2440 (pIFNpelB) - induced 
  
7,88 12,01 
  
15,13 
KT2440 (pGMpelB) 0,28 5,29 8,53 11,22 
  
14,26 
KT2440 (pGMpelB) - induced 
  
7,56 11,58 
  
15,6 
KT2440 (pIFN271pelB) 0,04 0,26 0,45 1,56 2,8 10,31 12,47 
KT2440 (pIFN271pelB) - induced 
     
7,82 7,51 
KT2440 (pGM271pelB) 0,02 0,08 0,14 0,302 0,5 2,28 14,16 
KT2440 (pGM271pelB) - induced 
     
0,6 6,67 
KT2440 (pIFNs271pelB) 0,28 4,45 8 11,71 
  
14,92 
KT2440 (pIFNs271pelB) - induced 
  
8,04 13,31 
  
16,07 
KT2440 (pIFNs271pelBs) 0,33 4,82 7,87 11,62 
  
15,36 
KT2440 (pIFNs271pelBs) - induced 
  
7,97 12,8 
  
15,26 
KT2440 (pGMs271pelBs) 0,04 0,28 0,61 2,77 5,43 13,43 16,78 
KT2440 (pGMs271pelBs) - induced 
     
10,42 5,62 
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Table F- 20: Growth measurements (OD660) of precultures for 3-l fed batch fermentation with strains 
indicated in the left column. The precultures were grown in 100 ml selective Hi-medium at 30°C and 200 
rpm for 16 -18 hours 
Precultures OD600 
KT2440 (pIFNpelB) 5,94 
KT2440 (pGMpelB) 5,92 
KT2440 (pIFN271pelB) 4,48 
KT2440 (pGM271pelB) 4,04 
KT2440 (pIFNs271pelB) 4,44 
KT2440 (pIFNs271pelBs) 5,08 
KT2440 (pGMs271pelBs) 3,24 
KT2440 (pJB861) 6,84 
 
Table F- 21: Growth measurements (OD600) from 3 l-fed batch fermentation with strains indicated in the 
left column. The fermentation was executed in Hf.1 medium at 30°C and pH 6.5. Induction was performed 
by adding m-toluic acid to a final concentration of 1 mM when OD600 ≈ 80-90, thereafter reinduction the 
following 2 and 4 hours (both times to a final concentration of 0.5 mM). 
  Hours after inoculation 
Strains 0,0 5,9 13,7 16,1 16,9 18,2 19,2 20,3 21,3 22,3 24,3 26,3 
KT2440 (pIFNpelB) 0,05 2,22 35,30 62,4 
 
89 95 98 104 104 119 
 KT2440 (pGMpelB) 0,05 1,60 26,55 51,5 
 
75 83 94 98 101 112 
 KT2440 (pIFN271pelB) 0,05 2,31 39,75 71,0 82 95,4 107 118 125 
   KT2440 (pGM271pelB) 0,05 2,39 27,00 52,7 
 
76,4 81 94,8 93 94,8 101 
 KT2440(pIFNs271pelB) 0,05 2,41 39,82 70,8 83,1 92,1 100,8 110,4 120,9 
   KT2440(pIFNs271pelBs) 0,05 1,24 22,72 39,8 
 
61,2 
 
80,4 90 93 105,3 118,2 
KT2440(pGMs271pelBs) 0,05 1,07 7,20 13,2 15,15 18,8 
 
23,1 
 
26,4 30,3 38,3 
KT2440 (pJB861) 0,05 1,35 18,90 39,5 
 
63,2 
 
85,2 97,2 99,6 111 124,2 
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Table F- 22: Plasmid stability evaluation of KT2440 (pIFN271pelB), KT2440 (pGM271pelB) and KT2440 
(pIFNs271pelB), KT2440 (pIFNs271pelBs) and KT2440 (pGMs271pelBs) during fed batch fermentation. 
Samples were taken late in the fermentation (after induction)  
 Strain Plasmid stability 
KT2440 (pIFN271pelB) 99 % 
KT2440 (pGM271pelB) 89 % 
KT2440 (pIFNs271pelB) 100 % 
KT2440 (pIFNs271pelBs) 74 % 
KT2440 (pGMs271pelBs) 100 % 
 
Dry weight measurements from KT2440 samples were performed to compare it with known 
values for E. coli.  
 
10 ml ferment cultures were centrifuged at 4000 rpm for 15 minutes. The pellet was washed 
in 10 ml ion free water before centrifuging again at the same settings. The pellet was washed 
and placed in a pre weighted aluminium cup. This was left incubating at 50°C overnight 
before the cup was weighted again. The relationship between OD (600) and dry cell weight is 
calculated. The results are shown in Table F- 23.  
 
Table F- 23: Calculation of OD600/dried-cell-mass relationship for P. putida KT2440. 
OD600 
Cup 
(g) 
Cup +  
dried cell mass (g)  
Dried cell mass  
(g/10 ml) 
Dried cell  
mass (g/l) 
OD600/dried  
cell mass 
125,10 2,18 2,57 0,40 39,56 3,16 
120,90 2,18 2,54 0,36 36,14 3,35 
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Attachment G.  Eurofins sequence data 
Plasmids were isolated by Wizard protocols (see Chapter 2.4.3). 15 µl DNA solutions was 
transferred to clean 1.5 ml tubes (Eppendorf) and marked with a sequence label from Eurofins 
MWG Operon. Before sending in for sequencing, a primer was designed.  
 
This was done in Clone Manager Professional Suite. The sequence was chosen to be about 
100 bp from the wanted sequence start.  
 
After receiving the sequence results, they were aligned with the template sequence in Clone 
Manager Professional Suite.  
 
Results from sequencing transformants of pIFN271pelB and pGM271pelB 
Primer:  trfAseq 
Sequence:           5' CCGATCACCTTCACGTTCTAC 3' 
 
trfAcop271C sequence of pIFN271pelB 
CTGGTCGATCATGGCCGGTATTACACGAAGGCCGAGGAATGCCTGTCGCGCCTACAGGCGACGGC
GATGGGCTTCACGTCCGACCGCGTTGGGCACCTGGAATCGGTGTCGCTGCTGCACTGCTTCCGCGT
CCTGGACCGTGGCAAGAAAACGTCCCGTTGCCAGGTCCTGATCGACGAGGAAATCGTCGTGCTGTT
TGCTGGCGACCACTACACGAAATTCATCTGGGAGAAGTACCGCAAGCTGTCGCCGACGGCCCGAC
GGATGTTCGACTATTTCAGCTCGCACCGGGAGCCGTACCCGCTCAAGCTGGAAACCTTCCGCCTCA
TGTGCGGATCGGATTCCACCCGCGTGAAGAAGTGGCGCGAGCAGGTCGGCGAAGCCTGCGAAGAG
TTGCGAGGCAGCGGCCTGGTGGAACACGCCTGGGTCAATGATGACCTGGTGCATTGCAAACGCTAG
GGCCTTGTGGGGTCAGTTCCGGCTGGGGGTTCAGCAGCCACCGGCATGCAAGCTTGAGAGGGTCAG
CTTTATGCTTGTAAACCGTTT 
 
trfAcop271C sequence of pGM271pelB 
GGTCGATCATGGCCGGTATTACACGAAGGCCGAGGAATGCCTGTCGCGCCTACAGGCGACGGCGA
TGGGCTTCACGTCCGACCGCGTTGGGCACCTGGAATCGGTGTCGCTGCTGCACTGCTTCCGCGTCCT
GGACCGTGGCAAGAAAACGTCCCGTTGCCAGGTCCTGATCGACGAGGAAATCGTCGTGCTGTTTGC
TGGCGACCACTACACGAAATTCATCTGGGAGAAGTACCGCAAGCTGTCGCCGACGGCCCGACGGA
TGTTCGACTATTTCAGCTCGCACCGGGAGCCGTACCCGCTCAAGCTGGAAACCTTCCGCCTCATGTG
CGGATCGGATTCCACCCGCGTGAAGAAGTGGCGCGAGCAGGTCGGCGAAGCCTGCGAAGAGTTGC
GAGGCAGCGGCCTGGTGGAACACGCCTGGGTCAATGATGACCTGGTGCATTGCAAACGCTAGGGC
CTTGTGGGGTCAGTTCCGGCTGGGGGTTCAGCAGCCACCGGCATGCAAGCTTGAGAGGGTCAGCTT
TATGCTTGAAACCCGCC 
  
T: Mutations yielding trfAcop271C  
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Codon optimization results 
IFNpelB adapted (572 bp) from pCR.1-IFNspelBs:  
CATATGAAGTATCTGCTGCCCACTGCAGCCGCAGGGTTGCTGCTGTTGGCGGCCCAACCAGCCATG
GCTTGCGATTTGCCGCAAACCCACAGCCTGGGTAGCCGTCGCACCCTGATGCTGCTGGCCCAGATG
CGGCGCATTTCGCTGTTTTCCTGCCTGAAAGATCGCCATGACTTCGGCTTTCCGCAGGAGGAGTTCG
GCAACCAGTTCCAGAAAGCCGAAACCATTCCCGTCCTGCACGAAATGATCCAGCAGATCTTCAACC
TCTTCTCGACGAAGGACAGCAGTGCGGCCTGGGACGAAACCCTGCTGGACAAGTTCTACACCGAGC
TGTATCAGCAGCTCAATGACCTGGAAGCGTGCGTGATCCAAGGCGTAGGCGTCACCGAAACGCCG
CTCATGAAGGAGGACTCGATCCTGGCCGTTCGCAAGTACTTCCAGCGGATCACCCTGTACCTGAAG
GAGAAGAAGTACAGCCCTTGTGCGTGGGAAGTGGTGCGTGCCGAAATCATGCGCAGCTTCAGCCT
GTCCACCAACCTGCAGGAGTCGTTGCGCAGCAAAGAGGCGGCCGC 
 
GMpelB adapted (458 bp) from pCR2.1-GMspelBs:  
CATATGAAATATCTCCTGCCGACTGCGGCGGCTGGCTTGCTGTTGCTGGCGGCACAACCGGCCATG
GCAGCCCCAGCGCGCAGTCCGAGCCCCAGCACCCAGCCATGGGAGCACGTGAACGCCATTCAGGA
GCCCGTCGCCTGCTGAATCTGTCGCGCGATACCGCCGCCGAGATGAACGAAACGGTTGAGGTGGAT
CAGCGAGATGTTCGACCTGCAGGAACCCACCTGCCTGCAGACCCGCTTGGAGCTGTACAAGCAAG
GCCTGCGGGGTTCGCTGACCAAGCTCAAAGGCCCTCTGACCATGATGGCCTCCCACTACAAGCAGC
ATTGCCCGCCTACCCCGGAAACGAGCTGTGCCACCCAGATCATCACCTTCGAGAGCTTCAAGGAGA
ACCTCAAGGACTTCCTGCTGGTCATCCCGTTTGACTGCTGGGAACCCGTACAGGAAGCGGCCGC 
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Sequence and alignment results of pIFNs271pelB, pGMs271pelB, pIFNs271pelBs and 
pGMs271pelBs 
Plasmid isolated from the transformants DH5α (pIFNs271pelB), DH5α (pGMs271pelB), 
DH5α (pIFNs271pelBs) and DH5α (pGMs271pelBs) were sequenced using the primer 
Pmfwdseq.  
 
Primer:          Pmfwdseq 
Sequence: 5' GACAAATCTGGCTCCCCAACTAATGC 3' 
 
 
Sequence of codon optimized pIFNs271pelB 
ACCAGCATAAACTGTCCGGTTTGATAGGGATAAGTCCAGCCTTGCAAGAAGCGGATACAGGAGTG
CAAAAAATGGCTATCTCTAGAAAGGCCTACCCCTTAGGCTTTATGCAACAGAAACAATAATAATGG
AGTCATGAACATATGAAATCCCTATTGCCTACGGCAGCCGCTGGATTGTTATTACTCGCGGCCCAG
CCGGCCATGGCTTGCGATTTGCCGCAAACCCACAGCCTGGGTAGCCGTCGCACCCTGATGCTGCTG
GCCCAGATGCGGCGCATTTCGCTGTTTTCCTGCCTGAAAGATCGCCATGACTTCGGCTTTCCGCAGG
AGGAGTTCGGCAACCAGTTCCAGAAAGCCGAAACCATTCCCGTCCTGCACGAAATGATCCAGCAG
ATCTTCAACCTCTTCTCGACGAAGGACAGCAGTGCGGCCTGGGACGAAACCCTGCTGGACAAGTTC
TACACCGAGCTGTATCAGCAGCTCAATGACCTGGAAGCGTGCGTGATCCAAGGCGTAGGCGTCACC
GAAACGCCGCTCATGAAGGAGGACTCGATCCTGGCCGTTCGCAAGTACTTCCAGCGGATCACCCTG
TACCTGAAGGAGAAGAAGTACAGCCCTTGTGCGTGGGAAGTGGTGCGTGCCGAAATCATGCGCAG
CTTCAGCCTGTCCACCAACCTGCAGGAGTCGTTGCGCAGCAAAGAGGCGGCCGCTGGATCCGAACA
AAAGCTGATCTCAGAAGAAGACCTAAAGGCCTCGGGGGCCGATCACCATCATCACCATCATTGATA
AGCTTGACCTGTGAAGTGAAAAATGGCGCACATTGTGCGACATTTTTTTTGTCTGCCGTTTACCGCT
ACTGCGTCACGGATCCGGCCGAACAAACTCCGGGAGGCAGCGTGATGCGGCAACAATCACACGGA
TTTCCCGTGAACGGTCTGAATGAGCGGATTATTTTCAGGAAAGT 
  
Sequence of codon optimized pGMs271pelB 
CCAGCATAAACTGTCCGGTTTGATAGGGATAAGTCCAGCCTTGCAAGAAGCGGATACAGGAGTGC
AAAAAATGGCTATCTCTAGAAAGGCCTACCCCTTAGGCTTTATGCAACAGAAACAATAATAATGGA
GTCATGAACATATGAAATCCCTATTGCCTACGGCAGCCGCTGGATTGTTATTACTCGCGGCCCAGC
CGGCCATGGGAGCACGTGAACGCCATTCAGGAAGCCCGTCGCCTGCTGAATCTGTCGCGCGATACC
GCCGCCGAGATGAACGAAACGGTTGAGGTGATCAGCGAGATGTTCGACCTGCAGGAACCCACCTG
CCTGCAGACCCGCTTGGAGCTGTACAAGCAAGGCCTGCGGGGTTCGCTGACCAAGCTCAAAGGCCC
TCTGACCATGATGGCCTCCCACTACAAGCAGCATTGCCCGCCTACCCCGGAAACGAGCTGTGCCAC
CCAGATCATCACCTTCGAGAGCTTCAAGGAGAACCTCAAGGACTTCCTGCTGGTCATCCCGTTTGA
CTGCTGGGAACCCGTACAGGAAGCGGCCGCTGGATCCGAACAAAAGCTGATCTCAGAAGAAGACC
TAAAGGCCTCGGGGGCCGATCACCATCATCACCATCATTGATAAGCTTGACCTGTGAAGTGAAAAA
TGGCGCACATTGTGCGACATTTTTTTTGTCTGCCGTTTACCGCTACTGCGTCACGGATCCGGCCGAA
CAAACTCCGGGAGGCAGCGTGATGCGGCAACAATCACACGGATTTCCCGTGAACGGTCTGAATGA
GCGGATTATTTTCAGGGAAAGTGAGTGTGGTCAGCGTGCAGGTATATGGGCTATGATGTGCCCGGC
GCTTGAGGCTTTCTGCCTCATGACGTGAAGGTGGTTTGTTGCCGTGTTGTGTGGCAGAAAGAAGAT
AGCCCCGTAGTAAGTTTA 
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Sequence of codon optimized pIFNs271pelBs 
AACCAGCATAAACTGTCCGGTTTGATAGGGATAAGTCCAGCCTTGCAAGAAGCGGATACAGGAGT
GCAAAAAATGGCTATCTCTAGAAAGGCCTACCCCTTAGGCTTTATGCAACAGAAACAATAATAATG
GAGTCATGAACATATGAAGTATCTGCTGCCCACTGCAGCCGCAGGGTTGCTGCTGTTGGCGGCCCA
ACCAGCCATGGCTTGCGATTTGCCGCAAACCCACAGCCTGGGTAGCCGTCGCACCCTGATGCTGCT
GGCCCAGATGCGGCGCATTTCGCTGTTTTCCTGCCTGAAAGATCGCCATGACTTCGGCTTTCCGCAG
GAGGAGTTCGGCAACCAGTTCCAGAAAGCCGAAACCATTCCCGTCCTGCACGAAATGATCCAGCA
GATCTTCAACCTCTTCTCGACGAAGGACAGCAGTGCGGCCTGGGACGAAACCCTGCTGGACAAGTT
CTACACCGAGCTGTATCAGCAGCTCAATGACCTGGAAGCGTGCGTGATCCAAGGCGTAGGCGTCAC
CGAAACGCCGCTCATGAAGGAGGACTCGATCCTGGCCGTTCGCAAGTACTTCCAGCGGATCACCCT
GTACCTGAAGGAGAAGAAGTACAGCCCTTGTGCGTGGGAAGTGGTGCGTGCCGAAATCATGCGCA
GCTTCAGCCTGTCCACCAACCTGCAGGAGTCGTTGCGCAGCAAAGAGGCGGCCGCTGGATCCGAAC
AAAAGCTGATCTCAGAAGAAGACCTAAAGGCCTCGGGGGCCGATCACCATCATCACCATCATTGAT
AAGCTTGACCTGTGAAGTGAAAAATGGCGCACATTGTGCGACATTTTTTTTGTCTGCCGTTTACCGC
TACTGCGTCACGGATCCGGCCGAACAAACTCCGGGAGGCAGCGTGATGCGGCAACAATCACACGG
ATTTCCCGTGAACGGTCTGAATGAGCGGATTATTTTCAGGAAAGTGAGTGTGGTCAGCGTGCAGT 
  
Sequence of codon optimized pGMs271pelBs 
ACCAGCATAAACTGTCCGGTTTGATAGGGATAAGTCCAGCCTTGCAAGAAGCGGATACAGGAGTG
CAAAAAATGGCTATCTCTAGAAAGGCCTACCCCTTAGGCTTTATGCAACAGAAACAATAATAATGG
AGTCATGAACATATGAAATATCTCCTGCCGACTGCGGCGGCTGGCTTGCTGTTGCTGGCGGCACAA
CCGGCCATGGCAGCCCCAGCGCGCAGTCCGAGCCCCAGCACCCAGCCATGGGAGCACGTGAACGC
CATTCAGGAAGCCCGTCGCCTGCTGAATCTGTCGCGCGATACCGCCGCCGAGATGAACGAAACGGT
TGAGGTGATCAGCGAGATGTTCGACCTGCAGGAACCCACCTGCCTGCAGACCCGCTTGGAGCTGTA
CAAGCAAGGCCTGCGGGGTTCGCTGACCAAGCTCAAAGGCCCTCTGACCATGATGGCCTCCCACTA
CAAGCAGCATTGCCCGCCTACCCCGGAAACGAGCTGTGCCACCCAGATCATCACCTTCGAGAGCTT
CAAGGAGAACCTCAAGGACTTCCTGCTGGTCATCCCGTTTGACTGCTGGGAACCCGTACAGGAAGC
GGCCGCTGGATCCGAACAAAAGCTGATCTCAGAAGAAGACCTAAAGGCCTCGGGGGCCGATCACC
ATCATCACCATCATTGATAAGCTTGACCTGTGAAGTGAAAAATGGCGCACATTGTGCGACATTTTTT
TTGTCTGCCGTTTACCGCTACTGCGTCACGGATCCGGCCGAACAAACTCCGGGAGGCAGCGTGATG
CGGCAACAATCACACGGATTTCCCGTGAACGGTCTGAATGAGCGGATTATTTTCAGGGAAAGTGAG
TGTGGTCAGCGTGCAGGTATA 
 
The sequences from Eurofins were compared with previously received adapted genes. 
Alignment was performed in Clone Manager professional Suite by using the restriction 
enzymes that was used to insert the synthetically genes on both sequenced sequence and the 
optimized sequence. Alignment had the following results:  
 
Alignment of sequence of codon optimized pIFNs271pelB with IFNpelB adapted 
Percent match: 100 % 
An alignment score of 100 % homology between the blue segments (504 bp) was found 
indicating that the plasmid pIFNs271pelB have been successfully constructed.     
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Alignment of sequence of codon optimized pGMs271pelB and GMpelB adapted 
When the codon optimized sequence of gm-csfs+pelBs was prepared for alignment, it was 
revealed that an additional restriction site for NcoI had become part of the gene. This led to an 
additional DNA fragment when pCR2.1GMspelBs was digested with NcoI and NotI. It then 
caused loss of fragments of the gene when DNA fragments were separated by gel 
electrophoresis. It was tried to get a new version of codon adapted gene and signal sequence 
without this restriction site, but trouble executing this lead to too short amount of time to 
construct pGMs271pelB.  
 
Alignment of sequence of codon optimized pIFNs271pelBs and IFNpelB adapted  
Percent match: 100 %  
The result indicate that the construction of pIFNs271pelBs was successful  
 
 
Alignment of sequence of codon optimized pGMs271pelBs and GMpelB adapted 
Percent match: 100 % 
The result indicate that the construction of pGMs271pelBs was successful  
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Attachment H. Attempt to quantify concentration of 
recombinant proteins in shake flask experiment 
The following is an attempt to quantify concentration of recombinant proteins in the shake 
flask experiment reported in Chapter 3.7.1. It is important to emphasize that further analysis 
would have to be done before the accurate concentrations had been determined.  
 
5 ml culture sample were taken 0, 2, 5 hours after induction and after overnight incubation. 
The samples were centrifuged and cells lysed following ”Cell lysis protocol 2” before 
Western blot analysis. During lysis, 0.5 ml insoluble fraction and 1 ml soluble fraction are 
formed. For insoluble fraction this means that the concentration of insoluble proteins found in 
5 ml culture now is present in 0.5 ml. This equals a 10-fold concentration increase. For 
soluble fractions, the same relationship yields a 5-fold concentration increase. The 
concentration found in these fractions therefore has to be divided by the found relationship to 
determine the concentration in the culture:  
 
Insoluble protein, Western Blot (mg/l)
Insoluble protein, culture (mg/l)=
10
  Eq. (3) 
 
Soluble protein, Western Blot (mg/l)
Soluble protein, culture (mg/l)=
5
  Eq. (4) 
 
The amount of protein produced is dependent on number of cells present. OD600 
measurements therefore have to be taken into account when comparing yields of recombinant 
protein from different samples.  
 
Calculations here are only based on bands comparable to the 1 mg/l reference (Phox). Several 
cultures have therefore produced more than what is calculated.  
 
Wild type copy number strains KT2440 (pIFNpelB) and KT2440 (pGMpelB) 
In Figure 42, the sample with highest IFN-α2b yield from KT2440 (pIFNpelB) is the 
insoluble fraction “P2 ind” (5 hours after induction) (OD600 = 12.01). Concentration of protein 
here is lower than the reference Phox and can therefore only be quantified as lower than 0.1 
mg/l.  
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In Figure 43, the samples with highest GM-CSF yield from KT2440 (pGMpelB) are both the 
insoluble and soluble fractions from “P2 ind” (5 hours after induction) (OD600 = 11.58). Also 
here, concentration is lower than for the reference Phox and can therefore only be quantified 
as lower than 0.1 and 0.2 mg/l respectively.   
 
Copy number mutants KT2440 (pIFN271pelB) and KT2440 (pGM271pelB) 
Concentration of IFN-α2b from KT2440 (pIFN271pelB) is too high to quantify in insoluble 
fractions from P2 (OD600 = 7.82) and P3 (OD600 = 7.5) (Figure 44). The soluble fractions of 
these samples are comparable with Phox in band strength. Using equation (4) gives an 
estimated 0.2 mg/l IFN-α2b in the culture. If one estimates that there is 10-fold more detected 
protein in the insoluble fraction sample “P3 ind” than in the reference (Phox), the calculated 
concentration is 1 mg/l.  
 
KT2440 (pGM271pelB) has the highest yield of GM-CSF in the insoluble fractions from 
overnight incubation (“P3 ind”) (Figure 45). The concentration of GM-CSF here is too high to 
be quantified. Insoluble fraction “P2 ind” (OD600=0.6) and soluble fraction “P3 ind”  
(OD600=6.67) have GM-CSF bands comparable to Phox in strength. Based on this 
information, and equation (3) and (4), the following concentrations were quantified:  
- Insoluble, “P2 ind”: 0.1 mg/l GM-CSF in the culture.  
- Soluble “P3 ind”:  0.2 mg/l GM-CSF in the culture 
Because of the low amount of cells in P2 samples, there is obviously a potential to produce 
more if induction had been performed later.  
 
Copy number mutant with codon optimized gene: KT2440 (pIFNs271pelB) 
The highest yield of IFN-α2b is detected in insoluble fraction “P2 ind” (OD600 = 13.31) 
(Figure 46). This band is evaluated to be stronger than Phox and therefore, based on equation 
(3) and (4) correspond to more than 0.1 mg/l GM-CSF in the culture.  
 
Copy number mutants wit codon optimized genes and pelB sequence: KT2440 
(pIFNs271pelBs) and KT2440 (pGMs271pelBs) 
The highest yield of IFN-α2b from KT2440 (pIFNs271pelBs) is detected in the insoluble 
fraction “P3 ind” (OD600 =15.26). The strength of this band is somewhat weaker than for 
Phox. Concentration of IFN-α2b in the culture is therefore estimated to be lower than 0.1 mg/l  
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The highest yield of GM-CSF from KT2440 (pGMs271pelBs) is detected in the insoluble 
fraction of “P3 ind”, but this band is too strong for comparison with Phox. In addition, Phox 
reference strength compared with its strengths on other membranes indicate weaker blotting. 
Based on these observations, it was chosen not to quantify GM-CSF concentration, but note it 
as high compared with KT2440 (pGMpelB).   
 
 
 
